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Alcohol use disorder (AUD) is a serious public health concern, affecting 
approximately 15.1 million US adults, or 11% of those that consumed alcohol within the 
past month. There are several risk factors that can increase the risk of developing an 
AUD, such as comorbid post-traumatic stress disorder (PTSD) which attributes a 3-fold 
increase in risk of developing an AUD. There is a significant gap in knowledge of how 
PTSD relates to AUD, in part because animal models for this are relatively new. This 
dissertation characterizes exposure to the predator odor 2,5-dihydro-2,4,5-
trimethylthiazoline (TMT) prior to alcohol self-administration as a model of stress-
induced increases in alcohol self-administration. Male rats exposed to TMT show no 
changes in anxiety-like behavior or hyperarousal, but do show increased alcohol self-
administration and reduced basolateral amygdala (BLA) response to alcohol. In order to 
lay groundwork for understanding the overlap between these disorders, this dissertation 
next explores the functional role of an emerging target in both the stress and alcohol 
literature, the mineralocorticoid receptor (MR). It has been shown that MR mediates 
development of contextual fear conditioning, and MR expression in the amygdala is 
downregulated following single prolonged stress, two models relevant to PTSD. Recent 





associated with greater alcohol drinking and anxiety behaviors in rats and monkeys with 
a history of alcohol consumption. Thus MR may be a mediator of stress-induced 
increases in alcohol self-administration. Following TMT exposure, MR is upregulated in 
the CeA of male rats and dorsal hippocampus (dHC) of female, though only male rats 
show increases in alcohol self-administration. Finally, given that evidence linking CeA 
MR to alcohol drinking is only correlative, this dissertation probed the functional role of 
MR in alcohol self-administration. Systemic administration of the MR antagonist 
spironolactone reduced alcohol self-administration in male and female rats, while intra-
CeA but not intra-dHC infusion of the selective MR antagonist eplerenone reduced 
alcohol self-administration in female rats. Furthermore, antisense oligonucleotide 
knockdown of CeA MR transiently reduced alcohol self-administration in female rats. 
Together the experiments in this dissertation outline TMT exposure as an animal model 
to study comorbid PTSD and AUD, leverage this model to identify BLA 
hyporesponsiveness to alcohol and increased MR expression as TMT-induced 
neuroadaptations that may underlie increased alcohol drinking, and establish the 
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CHAPTER 1 : INTRODUCTION 
 
 
ALCOHOL USE AND SOCIETY 
 Alcohol is one of the most widely consumed psychoactive substances in the 
world and has been intertwined in the history of humanity for millennia (SAMHSA, 
2018). Across this lengthy relationship, alcohol has served many purposes including 
religious sacrament, medical anesthetic, water sterilizer, and recreational drug. This 
bond between humans and alcohol is reflected in the US where 55% of adults have 
consumed alcohol within the past month (SAMHSA, 2018) and annual revenues from 
alcohol sales are $117 billion and growing (Park Street, 2016).However, the relationship 
between people and alcohol is not entirely beneficial. Out of approximately 115 million 
US adults that regularly consume alcohol, 14.4 million (1 in 9) are classified as having 
an alcohol use disorder (AUD; as defined by DSM-5) (APA, 2013, SAMHSA, 2018). 
Additionally, alcohol is listed as the third leading cause of preventable death in the US, 
being linked to approximately 88,000 deaths annually (Mokdad et al., 2004). 
Additionally, alcohol use is linked to increased risk of other serious health conditions 
including hypertension, cardiovascular disease, depression, and cancer (Boden and 
Fergusson, 2011, Gardner and Mouton, 2015, Lancet, 2017). Moreover, the impact of 
alcohol is not only limited to individuals. The cost to society of excessive alcohol use in 
the US is estimated at $249 billion (Sacks et al., 2015) over twice the revenues from 




 The impact and prevalence of AUD is compounded by the fact that a large 
treatment gap exists for AUD patients. Factors such as social stigma, financial cost, and 
limited provider knowledge result in low utilization of AUD treatments, with one study 
finding only 14.6% of patients with a lifetime history of AUD receiving treatment (Cohen 
et al., 2007, Huebner and Kantor, 2011, Finlay et al., 2017). Furthermore, many patients 
prefer to utilize solely behavioral interventions, such as 12-step, over combined 
behavioral and pharmacological interventions, even though combined treatment has 
better treatment outcomes (Anton et al., 2006, Kranzler and Soyka, 2018). There are 
currently 3 FDA-approved medications for the treatment of AUD - naltrexone, 
acamprosate, and disulfiram. Disulfiram is the first drug used to treat AUD and acts by 
inhibiting alcohol dehydrogenase, the enzyme that metabolizes alcohol (Mutschler et al., 
2016). When a patient taking disulfiram consumes alcohol it leads to a severe and 
potentially harmful reaction comprised of dizziness, chest pain, respiratory depression, 
and other symptoms (Mutschler et al., 2016). Therefore, treatment adherence is a 
significant obstacle to disulfiram treatment as patients often found it was easier to stop 
taking disulfiram than stop drinking alcohol (Mutschler et al., 2016). Acamprosate is 
thought to work by modulating NMDA glutamatergic transmission (al Qatari et al., 1998). 
One significant hurdle to acamprosate treatment is that it is intended only for early 
abstinent patients to assist in maintaining abstinence (Kranzler and Soyka, 2018). 
Furthermore, follow-up clinical studies have had conflicting results as to the 
effectiveness of acamprosate, leaving it as a treatment with questionable efficacy 
intended for only AUD patients who can maintain abstinence (Kranzler and Soyka, 




good clinical evidence for the efficacy of naltrexone, and it is available in a long-acting 
injectable format to aid in treatment adherence, however utilization of naltrexone still 
remains low due to aforementioned hurdles (Anton et al., 2006, Finlay et al., 2017, 
Kranzler and Soyka, 2018). The reluctance to use pharmacotherapies in combination 
with behavioral interventions is further complicated by the fact that many AUD patients 
have comorbid psychiatric conditions which require more complex multi-drug treatment 
(Taylor et al., 2017, Kranzler and Soyka, 2018). 
 Despite these alarming figures about prevalence, costs, and treatment of AUD, it 
remains that most alcohol drinkers (about 8 in 9) enjoy occasional moderate alcohol use 
with little lasting consequences. Therefore, a major field of alcohol research focuses on 
identifying genetic and environmental risk factors for heavy alcohol drinking, as well as 
the mechanisms that underlie increased alcohol consumption. To date, many genetic 
risk factors have been identified such as polymorphisms of alcohol dehydrogenase, 
serotonin receptors, and GABA receptors (Ferraguti et al., 2015). Likewise, many 
environmental factors that increase the risk of developing an AUD have been identified, 
such as early exposure to alcohol, chronic pain, or the presence of comorbid psychiatric 
disorders including post-traumatic stress disorder (PTSD;(Richmond-Rakerd et al., 
2016, Blaine and Sinha, 2017, Yeung et al., 2017). This dissertation will explore the 
mineralocorticoid receptor (MR), a steroid hormone receptor and potential mediator of 




CORTICOSTEROIDS AND ALCOHOL DRINKING 
Corticosterone 
 Early findings that stressful conditions were associated with increased alcohol 
consumption led to studies in adrenalectomized rats that found corticosterone 
modulated alcohol consumption, presumably through the glucocorticoid receptor 
(Edwards et al., 1972, Mulford, 1977, Fahlke et al., 1994a). Later studies found that 
chronic administration of corticosterone in drinking water could transiently increase 
alcohol self-administration (Besheer et al., 2013), as well as reduce the interoceptive 
effects of alcohol (Besheer et al., 2012b, Besheer et al., 2014, Jaramillo et al., 2015) 
posing a potential mechanism by which corticosterone could mediate stress effects on 
alcohol drinking.  
Aldosterone 
 Compared to corticosterone, relatively little is known about the impact of 
aldosterone on alcohol drinking. While it is known that aldosterone levels are increased 
in AUD patients and alcohol-experienced macaques, and that aldosterone levels 
correlate with measures of alcohol drinking and craving (Bannan et al., 1984, Aoun et 
al., 2018), it is unknown if aldosterone mediates these effects, or if elevated aldosterone 
is a consequence of altered MR function. As aldosterone-sensitive MRs in the brain are 
mainly characterized to modulate salt intake and blood pressure (Joels and de Kloet, 
2017), the latter is a more plausible explanation. 
Glucocorticoid receptor 
 The GR is the canonical effector of corticosterone actions and is highly studied in 




GR has been shown to reduce two-bottle choice alcohol drinking (Koenig and Olive, 
2004, O'Callaghan et al., 2005) as well as the block the development of compulsive 
alcohol self-administration in rats (Vendruscolo et al., 2012). In alcohol dependent rats 
there is a marked downregulation of GR in the bed nucleus of the stria terminalis 
(BNST), PFC, and nucleus accumbens (NAc) during acute withdrawal, and upregulation 
in the NAc core, ventral BNST, and CeA during protracted withdrawal which is thought 
to underlie HPA axis dysfunction in early alcohol abstinence (Kiefer et al., 2006). This is 
marked by dysfunctional corticosterone response to stress in abstinent AUD patients, 
and stimulation of this response serves as one potential mechanism for treatment of 
AUD (O'Malley et al., 2002, Adinoff et al., 2005b, a, Kiefer et al., 2006). As the GR and 
MR both affect corticosterone action and modulate its release, the GR is also examined 
in this study as a potential parallel mediator of predator odor (PO) effects on alcohol 
self-administration. 
Mineralocorticoid receptor 
 The primary receptor of interest in this project is the MR, a steroid receptor that 
exerts both genomic effects as a ligand gated transcription factor, and non-genomic 
effects putatively through crosstalk with g-protein coupled receptors such as the g-
protein coupled estrogen receptor or angiotensin 1 receptor (Gros et al., 2011, Gomez-
Sanchez and Gomez-Sanchez, 2014, Ruhs et al., 2017). The MR binds both 
corticosterone and aldosterone, though it has a higher affinity for corticosterone which 
must be inactivated by 11β-hydroxysteroid dehydrogenase type 2 (HSD-2) to preserve 
MR-aldosterone interactions in aldosterone sensitive tissues (Joels and de Kloet, 2017). 




blood pressure as it is highly expressed in the kidneys and cardiovascular system 
(Belden et al., 2017). As such drug development programs focused on the MR have 
resulted in the antagonists spironolactone and eplerenone which have diuretics and 
anti-hypertensive properties and are used to treat hypertension and heart failure 
(Kolkhof and Barfacker, 2017). However, in the late 1960s it was discovered that MR 
was expressed in the brain as well, primarily in limbic brain regions such as the 
hippocampus, central amygdala, and medial septum (Reul and de Kloet, 1986). Low 
brain expression of HSD-2 coupled with high corticosterone affinity result in tonically 
high occupancy of cytosolic (genomic) brain MR, however the membrane MR 
(nongenomic) has been shown to have similar corticosterone affinity to GR and is thus 
responsive to acute corticosterone release following stress (Joels et al., 2008, Kolkhof 
and Barfacker, 2017).  
 The functional roles of MR in behavior are various, and have only recently been 
revised to include modulation of alcohol drinking as early studies failed to find impacts 
of MR antagonism on alcohol drinking (Koenig and Olive, 2004, O'Callaghan et al., 
2005), or alcohol dependence on MR expression (Vendruscolo et al., 2012). The MR is 
known to regulate various aspects of memory, and antagonism of MR impacts formation 
and recall of contextual fear memories (Zhou et al., 2010). Within the PFC, MR 
modulates response to unconditioned fear (McEown and Treit, 2011) and alcohol-
induced working memory deficits (Dominguez et al., 2017), while hippocampal MR 
regulate aspects of memory and anxiety-like behavior (Oitzl and de Kloet, 1992, Lai et 
al., 2007, McCann et al., 2019). In the CeA, MR influences visceral pain response as 




et al., 2018). One study demonstrated that CeA MR mRNA levels correlate with alcohol 
self-administration in rhesus macaques, as well as compulsive-like drinking in Wistar 
rats (Aoun et al., 2018). Additionally, circulating levels of aldosterone were elevated 
after 6 months of self-administration in macaques and non-abstinent AUD patients, and 
correlated with self-reported alcohol craving and anxiety in AUD patients (Aoun et al., 
2018). This dissertation expands our present understanding of MR’s functional role in 
regulating alcohol drinking by pharmacological and genetic manipulation of MR 
signaling using systemic and brain-regional techniques. 
 
COMORBID POST-TRAUMATIC STRESS DISORDER AND ALCOHOL USE 
DISORDER 
 PTSD is defined as a persistent debilitating mental health condition arising from 
witnessing or experiencing a terrifying/traumatic event. The DSM-5 classifies the 
symptoms of PTSD into 4 clusters: re-experiencing or intrusion, avoidance of traumatic 
stimuli, negative alterations in cognition or mood, and hyperarousal (APA, 2013). In 
addition to these symptoms, PTSD is also associated with increased risk for alcohol and 
other substance use disorders (Jacobsen et al., 2001). It is estimated that annual 
prevalence of PTSD is 3.5% in the US, and is nearly 3 times higher in women than in 
men (Kessler et al., 2005). As the prevalence of PTSD is 3.5% and the prevalence of 
AUD is 5.8%, it is plausible to conclude that comorbid PTSD is a significant contributor 
to the overall disease burden of AUD. The relationship between PTSD and AUD was 
clinically described in 1981 in a study describing increased alcohol consumption and 




(Boscarino, 1981). Further clinical studies and meta-analyses of this phenomena have 
determined that PTSD increases the risk of developing an AUD by up to three-fold 
(Kessler et al., 1997, Jacobsen et al., 2001, Shorter et al., 2015). 
 Animal models of PTSD and AUD represent a powerful tool to identify brain 
regional pathology underlying comorbidity and uncover potential molecular targets for 
pharmaceutical development. There are a variety of preclinical PTSD models, some of 
which have been combined with models of alcohol drinking. The most widespread 
models currently in use include stress enhanced fear learning (SEFL), single prolonged 
stress (SPS), and predator odor stress (PO) (Deslauriers et al., 2018).  
Stress enhanced fear learning (SEFL). SEFL involves exposure of a rodent to 15 
shocks in one context, followed by a single tone-shock conditioning trial in a different 
context, recall of which is significantly potentiated compared to traditional fear 
conditioning (Rau and Fanselow, 2009). SEFL has been shown to increase alcohol 
consumption using a two-bottle choice protocol in rats for over 120 days (Meyer et al., 
2013). The effects of SEFL are known to be mediated by corticosterone, and are 
marked by upregulation of GluA1 in the basolateral amygdala (BLA)(Perusini et al., 
2016).  
Single prolonged stress (SPS). SPS is a model involving sequential exposure of a 
rodent to 2 hours of restraint stress, 20 minutes of forced swim stress, and ether 
exposure until loss of consciousness (Yu et al., 2016). SPS has been shown to increase 
alcohol conditioned place preference (Yu et al., 2016), and alter BLA response to acute 
alcohol (Ornelas and Keele, 2018). The effects of SPS are reliant on glucocorticoid 




the MR in the amygdala and hippocampus (Zhe et al., 2008, Han et al., 2014).  
Predator odor (PO) stress. PO stress involves a 10 – 30 minute inescapable exposure 
of animals to a predator odor such as dirty rat bedding (for mice), bobcat urine, or the 
fox pheromone 2,5-dihydro-2,4,5-trimethylthiazoline (TMT). PO has been shown to 
increase alcohol self-administration or two-bottle choice homecage drinking for periods 
ranging from 7 to 21 days (Edwards et al., 2013, Manjoch et al., 2016, Finn et al., 2018) 
and these effects are shown to be dependent on CeA CRFR1 in rats exposed to bobcat 
urine (Weera et al., 2020). PO is known to upregulate GR in the prefrontal cortex (PFC) 
of female mice. In the hippocampus, PO upregulates corticotropin releasing factor 1 in 
both male and female mice, GR in female mice, and kappa opioid receptor in rats, while 
downregulating delta and mu opioid receptors in rats (Manjoch et al., 2016, Finn et al., 
2018). This dissertation supplements the PO literature by establishing a model of 
increased alcohol self-administration following TMT exposure, and explores the 
response of MR to TMT exposure as well as the contribution of MR signaling to TMT 
evoked sequelae.  
 
RATIONALE 
 Given the significant burden to society posed by AUD (Mokdad et al., 2004, 
SAMHSA, 2018), along with evidence for increased risk of AUD in PTSD patients 
(Kessler et al., 1997), understanding the neurobiological underpinnings of this 
relationship is critical for development of an effective integrated treatment of comorbid  
PTSD and AUD as opposed to current complex treatment regimens (Shorter et al., 




uncover this complex comorbidity, therefore the goal of the present work was to 
optimize and develop a model of comorbid PTSD and AUD utilizing the synthetically 
produced predator odor TMT (Aim 1). 
 As low CeA MR expression is associated with increased alcohol consumption 
(Aoun et al., 2018) and MR is downregulated in response to stress (Zhe et al., 2008, 
Han et al., 2014), we considered MR as a potential mediator of traumatic stress effects 
on alcohol drinking. Furthermore, as MR is known to regulate emotional memory (Zhou 
et al., 2010, Zhou et al., 2011), we aimed to leverage this model of comorbid PTSD and 
AUD to understand if MR signaling was essential for development of the effects of TMT 
on alcohol drinking, anxiety-like behavior, and TMT-context reactivity. Aim 2 sought to 
understand if either MR or GR would be downregulated by TMT exposure, as well as if 
blockade of MR signaling during TMT exposure would alter the behavioral and alcohol 
self-administration effects of TMT exposure.  
Additionally, with the emerging relationship between MR and alcohol drinking 
(Aoun et al., 2018) we sought to broaden our understanding of the functional role of MR 
in alcohol drinking using systemic and intracranial infusion of MR antagonists and 
targeted CeA MR knockdown with antisense oligonucleotides (Aim 3). The potential 
impact of this aim is compounded by widespread clinical use of MR antagonists for 
treatment of heart failure and hypertension (Kolkhof and Barfacker, 2017), conditions 
comorbid with and exacerbated by AUD (Gardner and Mouton, 2015). Thus, this aim 
evaluates the MR as a potential target for further drug development or off-label use of 




Aim 1: Develop and refine animal model of comorbid PTSD and AUD 
 Previous studies utilizing a predator odor to model stress enhanced alcohol 
drinking use naturally derived predator odors such as soiled cat litter, bobcat urine, or 
rat bedding. As such, one purpose of this aim was to determine if synthetically produced 
fox pheromone (TMT) would induce escalations in alcohol drinking. In Chapter 2 male 
Long-Evans rats were exposed to TMT 4 times prior to alcohol self-administration 
training. Additionally, to probe if TMT exposed animals showed differential neuronal 
response to alcohol, we administered 2 g/kg alcohol intragastrically to TMT exposed 
animals and examined brain regional expression of the immediate early gene c-Fos. 
Finally, we compared the effects of single and repeated TMT exposure on alcohol self-
administration, anxiety-like behavior, and hyperarousal. We hypothesized that both 
single and repeated TMT would increase alcohol self-administration, anxiety-like 
behavior, and hyperarousal, with repeated TMT exposure having a greater magnitude of 
effect. Additionally, we hypothesized that TMT exposure would reduce brain response 
to alcohol. 
Aim 2: Investigate role of MR in PO exposure and its involvement in the 
development of lasting effects of PO 
 As hippocampal and amygdalar MR and GR are downregulated by SPS (Zhe et 
al., 2008, Han et al., 2014), and reduced CeA MR expression is correlated with 
increased alcohol drinking (Aoun et al., 2018), one purpose of this aim was to validate 
that TMT exposure had similar effects on GR and MR expression. In Chapter 3 we 
exposed male and female Long-Evans rats to TMT and then assayed dorsal 




as MR blockade reduces development and recall of contextual fear memories, we 
pretreated female alcohol naïve rats with the MR antagonist spironolactone prior to TMT 
exposure and then tested animals for anxiety-like behavior, hyperarousal, TMT-context 
reactivity, and alcohol self-administration. This experiment was then repeated in 
alcohol-experienced male rats. We hypothesized that TMT exposure would reduce both 
GR and MR expression across all brain regions, and that spironolactone pretreatment 
would block the effects of TMT exposure on alcohol self-administration and TMT-
context reactivity.  
Aim 3: Investigate role of MR signaling and CeA expression in alcohol self-
administration  
 In multiple species CeA MR is correlated with alcohol drinking of alcohol-
experienced subjects (Huebner and Kantor, 2011); however, previous studies have 
failed to find an effect of the MR antagonist spironolactone on alcohol drinking in free-
access homecage drinking paradigms using rats with low levels of alcohol history 
(Koenig and Olive, 2004, O'Callaghan et al., 2005). To further probe the functional role 
of MR in alcohol self-administration of alcohol-experienced rats, in Chapter 4 we 
administered the MR antagonist spironolactone to alcohol-experienced male and female 
Long-Evans rats prior to alcohol self-administration and probe-extinction sessions. In 
Chapter 5 we assayed plasma corticosterone of female rats treated with spironolactone 
prior to alcohol self-administration to understand if reductions in self-administration were 
related to inhibited glucocorticoid negative feedback. Further, to identify the brain-
regional locus of MR action on alcohol self-administration, the selective MR antagonist 




functional role of CeA MR expression in alcohol self-administration, CeA MR was 
knocked down by infusion of antisense oligonucleotide prior to alcohol self-
administration. We hypothesized that both systemic and intra-CeA MR antagonism 
would reduce alcohol self-administration, and that the reductions in self-administration 
may correlate with reduced glucocorticoid negative feedback, and that CeA MR 
knockdown would increase alcohol self-administration in both sexes. 
These studies define and utilize an animal model of comorbid PTSD and AUD to 
probe MR as a potential mediator of stress-induced increases in alcohol drinking. The 
findings of the present work have the potential to establish a novel model that can be 
used to further study this condition and identify the MR as a promising pharmacological 






CHAPTER 2 : THE SYNTHETICALLY PRODUCED PREDATOR ODOR 2,5-
DIHYRDRO-2,4,5-TRIMETHYLTHIAZOLINE INCREASES ALCOHOL SELF-
ADMINISTRATION AND ALTERS BASOLATERAL AMYGDALA RESPONSE TO 
ALCOHOL IN RATS 
 
INTRODUCTION 
Alcohol is the one of the most widely consumed and abused psychoactive 
substances in the United States, with approximately 56% of adults having drank alcohol 
in the past month and 6% of adults having an alcohol use disorder (SAMHSA, 
2018).One risk factor for development of alcohol use disorder (AUD) is comorbid post-
traumatic stress disorder (PTSD), which epidemiological studies have estimated nearly 
triples the risk of developing AUD (Kessler et al., 1997, Jacobsen et al., 2001, Shorter et 
al., 2015).  
PTSD stems from a person witnessing or experiencing a traumatic or life-
threatening event. While the symptoms of PTSD have been well-documented (intrusion, 
avoidance, negative alterations in cognition and mood, alterations in arousal), our 
understanding of the neurobiological underpinnings are still emerging. Neuroimaging 
studies have characterized dysregulation of multiple brain regions in PTSD, including 
hyper-responsivity of the amygdala to stressful stimuli and blunted medial prefrontal 
cortex (mPFC) top-down control of attentional and amygdala function (Liberzon and 
Sripada, 2008, Fenster et al., 2018). Unsurprisingly, dysregulation in these brain circuits 




and this overlap is thought, in part, to underlie comorbidity between PTSD and AUD 
(Gilpin and Weiner, 2017).  
Animal models play an important role in experimentally probing the relationship 
between ‘trauma’ exposure and increased alcohol drinking, and a number of animal 
models of PTSD have been shown to increase alcohol drinking.  For example, stress-
enhanced fear learning (SEFL) is a model that involves exposing a rat to 15 shocks in 
one context, which enhances later fear learning in another context (Rau and Fanselow, 
2009). Rats that undergo SEFL show increased alcohol consumption in a two-bottle 
choice protocol for over 120 days (Meyer et al., 2013). Another model of PTSD is 
exposure to a predator or predator odor. Exposure to bobcat urine (Edwards et al., 
2013), soiled cat litter (Manjoch et al., 2016), or a live un-neutered cat in conjunction 
with social instability (Zoladz et al., 2018) have been shown to increase alcohol drinking 
in rats for 20, 21, and 7 days respectively in self-administration or two-bottle choice 
paradigms. Similarly, exposure to dirty rat bedding sex-dependently increases 
homecage alcohol consumption in mice with a history of binge alcohol consumption 
(Finn et al., 2018). These studies have begun to advance our knowledge of the link 
between PTSD and excessive alcohol drinking by contributing models that can be used 
to identify causal neuromolecular and brain circuitry changes.  
The first goal of the present work was to determine if repeated exposure of male 
rats to the synthetically produced predator odor (PO) 2,5-dihydro-2,4,5-
trimethylthiazoline (TMT; a component of fox feces) would increase reward cue salience 
and alcohol self-administration. As maladaptive response to cues is a hallmark of both 




et al., 2017) we hypothesized that increases in cue salience may be related to increases 
in alcohol self-administration. Next, this study quantified alterations in mPFC and 
amygdala neuronal response to alcohol following TMT-exposure using c-Fos 
immunoreactivity. Last, this study examined if a single TMT exposure was sufficient to 
induce changes in alcohol self-administration, and if acute physiological and 
neuroendocrine response to TMT habituated across repeated exposures.  
 
MATERIALS AND METHODS 
Animals 
96 male Long-Evans rats (Envigo-Harlan, Indianapolis, IN) arrived at 7 weeks old 
and were single housed under a 12 hour light/dark cycle (7:00 am/pm). Prior to all 
experiments rats were handled for 1-2 minutes across 7 days. All experiments were 
conducted during the light cycle, with the exception of TMT exposures which occurred 
at the start of the dark cycle (7:00 - 7:30 pm). Animals were under the care of the 
veterinary staff of the UNC-Chapel Hill Division of Comparative Medicine. All 
procedures were carried out in accordance with the NIH Guide for Care and Use of 
Laboratory Animals, and institutional guidelines. All protocols were approved by the 
UNC Institutional Animal Care and Use Committee (IACUC). UNC-Chapel Hill is 
accredited by the Association for Assessment and Accreditation of Laboratory Animal 




Experiment 1: Effect of TMT exposure on Pavlovian conditioned approach (Figure 
2.1A) 
The goal of this experiment was to assess if exposure to TMT would later 
increase the transfer of incentive salience towards reward cues using a Pavlovian 
conditioned approach (PCA) task. PCA was assessed in conditioning chambers (Med 
Associates, St. Alban, VT) located within sound-attenuating cabinets equipped with an 
exhaust fan to provide ventilation and mask outside noise. Chambers were equipped 
with a retractable lever on the back left side of the chamber and a cue light was located 
above the lever. Next to the lever was a port containing an infrared beam to detect 
entries and a liquid receptacle connected to a syringe pump for delivery of sucrose 
(20%, w/v). 
PCA training.  
One day prior to PCA, rats underwent a pretraining session to familiarize them 
with the sucrose reinforcer (Fig 2.1A). The pretraining session consisted of 25 non-
contingent presentations of 20% sucrose (0.1 mL delivered by a syringe pump across 
1.66 s) into the liquid receptacle on a 90 second variable interval (30 – 150 s) schedule. 
Across the next 8 days rats were trained on PCA. PCA sessions consisted of 25 trials 
on a 90 second variable interval schedule. Trials consisted of a 10 second presentation 
of a lever and cue light (conditioned stimulus, CS) during which lever presses and port 
entries were measured. After 10 seconds the lever retracted, the cue light was turned 
off, and 0.1 mL of 20% sucrose (unconditioned stimulus, US) was delivered into the 
liquid receptacle port.  




After 8 PCA sessions rats (n = 6/group) underwent TMT exposures. Animals 
were transported from the vivarium to a well-ventilated room at the onset of the dark 
cycle (7:00pm), to correspond with the rat’s active phase (Woodruff et al., 2018), and 
placed into clean Plexiglas chambers (30.5 cm x 18 cm x 18 cm) with a piece of filter 
paper affixed to the lid. 10 µL of either water (Control group) or TMT was pipetted onto 
the filter paper prior to closing the chamber lids. (Note: Control animals were always 
exposed before TMT animals to avoid any contact with the TMT odor). After 10 minutes 
of exposure, rats were returned to the vivarium. This TMT exposure process was 
repeated 4 times across one week (i.e., every other day; on the intervening days rats 
remained in the home cage undisturbed) to reduce habituation of response to TMT 
(Staples, 2010). PCA training was withheld during this TMT exposure period. 
Following the final TMT exposure, rats underwent 8 additional PCA sessions. 
Before the second PCA session rats underwent an open field test (between 08:00 am - 
12:00 pm) to assess anxiety-like behavior and locomotor behavior.  Rats were 
transported in the home cage and were allowed to habituate to the testing room for 20 
minutes. Rats were placed in the center of the open field arena (43 cm x 43 cm; Med 
Associates, St. Albans, VT) and locomotor activity was recorded by 32 orthogonal 
infrared beams using Activity Monitor software (Med Associates) for 10 min.  
Alcohol self-administration.  
After completion of the PCA phase of the experiment, rats began alcohol self-
administration. The alcohol self-administration chambers were the same chambers used 
for PCA. However, the configuration of the chamber was such that there was an 




two cue lights total, one set on the left side of the chamber, by the fluid port, and one on 
the right side). Additionally, general locomotor activity during the self-administration 
session was measured with 4 parallel infrared beams across the chamber floor. Total 
beam breaks across the session were collected and this number was divided by the 
session length (30 min) to determine locomotor rate (beam breaks/min). Rats were 
trained to self-administer a 15% (v/v) alcohol + 2% (w/v) sucrose solution (15A/2S) on a 
fixed ratio 2 (FR2) schedule of reinforcement in 30 minute sessions, five days a week 
(M-F) via sucrose fading as described in Makhijani et al., 2018. Sucrose fading began 
with self-administration of 10% sucrose (10S; 2-3 sessions), then 2A/10S (1-2 
sessions), 5A/10S (1 session), 10A/10S (2 sessions), 10A/5S (1 session), 15A/5S (2 
sessions), and 15A/2S (2 sessions). Finally there were 5 sessions of 15A reinforcer 
after which the reinforcer returned to 15A/2S for the duration of training (maintenance 
phase). A sweetened alcohol reinforcer was used as we find this results in stable 
alcohol self-administration in these long-term studies (Randall et al., 2017, Jaramillo et 
al., 2018a, Makhijani et al., 2018). 
Experiment 2: Effect of TMT exposure on neuronal response to alcohol (Figure 
2.1B) 
The goal of this experiment was to examine potential changes in neuronal 
response to acute alcohol following predator odor stress. Rats (n = 6/dose control group 
and 10/dose TMT group) experienced the repeated TMT exposure protocol as in 
Experiment 1. Rats remained undisturbed in the home cage for the next 6 days. On the 
final test day (7 days after the final TMT exposure), rats received an alcohol injection (2 




were sacrificed by pentobarbital anesthesia (100 mg/kg) prior to perfusion with 0.1M 
PBS (4°C, pH = 7.4) followed by 4% paraformaldehyde (PFA; 4°C, pH = 7.4). Brains 
were extracted and stored in 4% PFA for 24h at 4°C before being rinsed with 0.1M PBS 
and transferred to 30% sucrose in 0.1M PBS for at least 7 days. Brains were sliced on a 
freezing microtome into 40 µm coronal sections which were stored at -20°C in 
cryoprotectant until immunohistochemistry (IHC).  
c-Fos IHC and quantification of immunoreactivity (IR).  
Free-floating coronal sections were rinsed in 0.1M PBS before quenching of 
endogenous peroxidases with a 5 minute wash in 1% H2O2. Sections were then blocked 
with 3% normal goat serum (NGS; Vector Labs, Burlingame, CA) in 0.3% Triton X-100 
for 2 hours before being incubated in rabbit anti-c-Fos antibody (1:4000 in 3% NGS + 
0.1% Triton; Synaptic Systems, Goettingen, Germany; Lot# 226003/3-45) for 16 hours 
at 4°C. Sections were incubated with biotinylated goat anti-rabbit secondary antibody 
(1:200 in 3% NGS + 0.1% Triton X-100; Vector Labs, Burlingame, CA; Lot# 140893) 
followed by Vectastain Elite ABC HRP (Vector labs, Burlingame, CA). Finally, sections 
were treated with diaminobenzidine (Sigma-Aldrich, St. Louis, MO) and mounted on 
slides for imaging.  
Images were taken with an Olympus CX41 light microscope (Olympus America, 
Center Valley, PA) and analyzed utilizing Image‐Pro Premier image analysis software 
(Media Cybernetics, Rockville, MD). Immunoreactivity data (c-Fos‐positive pixels/mm2) 
were acquired from a minimum of 2 sections/brain region/animal, by an experimenter 
blind to group assignment, and the data were averaged to obtain a single value per 




infralimbic cortex (IL; AP +3.7 to +3.0), central amygdala (CeA; AP -1.9 to -2.8), and 
basolateral amygdala (BLA; AP -1.9 to -2.8). 
Experiment 3: Comparison of single and repeated TMT exposure on behavior and 
alcohol self-administration (Figure 2.1C) 
The goal of this experiment was to determine the consequences of a single vs. 
repeated TMT exposure on alcohol self-administration. Rats were assigned to one of 
the following groups (n = 12/group): Control group – rats underwent 4 water exposures; 
Single TMT (sTMT) group – rats underwent 3 water exposures and a single TMT 
exposure on the final session; Repeated TMT (rTMT) group – rats underwent 4 TMT 
exposures. These exposures were every other day for 1 week as described in 
Experiment 1. In addition, the number of fecal boli in the test chambers following TMT 
exposure was counted and presented as part of Experiment 4. Seven days later, rats 
were tested in the open field as described in Experiment 1, the elevated plus maze, and 
the acoustic startle test. Rats underwent each test in that order on consecutive days. 
For the elevated plus maze, rats were placed into the closed arm of the maze (arm 
dimensions 50 cm x 10 cm; maze elevation 50 cm; Stoelting, Wood Dale, IL) for a 5 
minute test under red lighting conditions. Movement was tracked using a ceiling 
mounted camera (Logitech C615; Logitech, Lausanne, Switzerland) and analyzed by 
AnyMaze software (Stoelting). For the acoustic startle test, rats were placed in an SR-
LAB animal enclosure (San Diego Instruments, San Diego, CA) and testing consisted of 
a 5 minute habituation to background white noise (65dB, matched to ambient noise), 
followed by 30 startle trials (40 msec presentation of 110 dB white noise) with a 30 




accelerometer mounted under the animal enclosure and analyzed with SR-LAB 
software (San Diego Instruments). Sessions were approximately 20 min in total. The 
day following the acoustic startle test, rats began alcohol self-administration as 
described in Experiment 1. 
Experiment 4: Measuring plasma corticosterone response to repeated TMT 
exposure (Figure 2.1D) 
In order to measure the effect of TMT exposure on plasma corticosterone levels, 
rats underwent either 4 water exposures or 4 TMT exposures across one week as 
described previously. Tail blood was collected 30 minutes after exposure on days 1 and 
4 for analysis of plasma corticosterone. Blood was collected into heparinized tubes and 
immediately centrifuged at 4°C for 5 minutes at 2000 rcf. Plasma supernatant was then 
collected and stored at -80°C until analysis. 5 µL plasma samples were then analyzed in 
duplicate using a commercially available colorimetric EIA kit (ArborAssays, Ann Arbor, 
MI) according to the manufacturer’s instructions. 
Reagents 
97% purity 2,5-dihydro-2,4,5-trimethylthiazoline (TMT) was purchased from SRQ 
Bio (Sarasota, FL). Alcohol (95% (v/v); Pharmaco-AAPER, Shelbyville, KY) and sucrose 




 PCA behavior is represented by cumulative number of lever presses across all 




port entries in 10s preceding CS), and latency to port entry and lever press (from CS 
onset). PCA behavior is also summarized by a PCA index, which takes into account 
responses, latency to response, and probability of response during trial as in (Fitzpatrick 
et al., 2019). PCA index was calculated by an evenly weighted average of response 
bias ((lever presses – port entry elevation score)/(lever presses + port entry elevation 
score)), latency score ((latency to port entry– latency to lever press)/10s), and 
probability difference (probability of lever press in trial – probability of port entry). 
Animals with a PCA index below -0.5 are considered “Goal-Trackers”, an index above 
0.5 indicates a “Sign-Tracker”, and animals in between are considered “Intermediate 
Responders” (Fitzpatrick and Morrow, 2016, Fitzpatrick et al., 2019). PCA behavior after 
TMT exposure (session 9-16) was analyzed by two-way repeated measures analysis of 
variance (RM-ANOVA) with TMT exposure as the between-subjects factor and session 
as the within-subjects factor. 
Self-administration 
 For the sucrose fading phase of alcohol self-administration, alcohol lever 
responses, inactive lever responses, and locomotor rate are represented as averages 
across each reinforcer. These data were examined by two-way RM-ANOVA with TMT 
exposure as a between-subjects factor and reinforcer as a within-subjects factor. Total 
alcohol intake (g/kg) during the sucrose fading and maintenance phases of self-
administration is shown as cumulative alcohol consumed by each animal across the 
study (approximated based on body weight and number of reinforcers delivered for 
each session) and compared by t-test for Experiment 1, and one-way ANOVA for 




responses, inactive lever responses, and locomotion are presented as 3-session 
averages. These data were analyzed by two-way RM-ANOVA with TMT exposure as a 
between-subjects factor, and session as a within-subjects factor.  
Other measures 
 c-Fos immunoreactivity was analyzed by two-way ANOVA with TMT exposure 
and alcohol treatment as between-subjects factors. Correlations between brain regional 
c-Fos expression were evaluated by Pearson’s correlation coefficient. Measures from 
the open field test in Experiment 1 were analyzed by t-test. Correlations between post-
TMT change in PCA index and total alcohol consumption were evaluated by Pearson’s 
correlation coefficient. Measures from the behavioral screens (% center time in open 
field [center defined as middle 20 cm x 20 cm of open field], total distance traveled in 
open field, % open arm time in elevated plus maze, total distance traveled in elevated 
plus maze, peak startle response, startle habituation index) in Experiment 3 were 
analyzed by one-way ANOVA with TMT exposure as the between-subjects factor. The 
formula for startle habituation index is: ((Average Peak Startle in First 5 Trials) – 
(Average Peak Startle in Last 5 Trials))/(Average Peak Startle in First 5 Trials)*100
 . Plasma corticosterone levels (ng/ml) following TMT were analyzed by two-way 
RM-ANOVA with TMT exposure as a between-subjects factor and exposure day as a 
within-subjects factor. Fecal boli was analyzed by two-way RM-ANOVA with TMT 
exposure as a between-subjects factor, and exposure day as the within-subjects factor.  






Experiment 1: Effect of TMT exposure on Pavlovian conditioned approach 
The purpose of Experiment 1 was to determine if TMT exposure would increase 
transfer of salience towards reward cues (sign-tracking), and if increased cue 
salience/sign-tracking behavior could predict increased alcohol self-administration. 
Repeated TMT exposure reduces goal-tracking behavior towards a reward cue 
Male rats underwent 8 days of PCA training, after which animals were 
counterbalanced into groups by PCA index (measured on day 8) and assigned to either 
the repeated TMT or Water group. Following TMT exposure, animals showed no 
change in lever presses (Fig 2.2A), but showed significantly lower port entry elevation 
scores than the control group (Fig 2.2B, F(1,10) = 5.18, p = 0.046), with no significant 
main effect of session or TMT by session interaction. There were no main effects of 
TMT or session on latency to first lever press (Fig 2.2C) and there was a trend for a 
main effect of TMT on latency to first port entry (Fig 2.2D, F(1,10) = 4.05, p = 0.072), 
with no main effect of session or TMT by session interaction. There were no main 
effects of TMT, session or interaction on PCA index (Fig 2.2E). Additionally, while all 
rats performed sign-tracking behavior (lever presses) indicating transfer of salience to 
the lever cue, no rats in either group met the classification of sign-tracker (PCA index 
over 0.5). Both groups had 2 goal-trackers (PCA index under -0.5) and 4 intermediate 
responders (PCA index between -0.5 and 0.5). These findings indicate that TMT 
exposure did not alter sign-tracking behavior but did reduce goal-tracking behavior. In 




time in the center of the open field (Table 2.1), indicating the lack of a change in general 
locomotion and anxiety-like behavior.  
Rats with a history of repeated TMT exposure show increased alcohol self-
administration. 
Two-way RM ANOVA across sucrose fading showed main effects of reinforcer 
and TMT on alcohol lever responses with no interaction (Fig 2.3A; F Reinforcer(7,70) = 
36.7, p < 0.001; FTMT(1,10) = 6.14, p = 0.033) indicating greater alcohol lever responses 
in the TMT group than the Control group. The TMT-exposed animals also had 
significantly higher total alcohol intake across sucrose fading (Fig 2.3B; t(10) = 2.59, p = 
0.027). There were no main effects of TMT or reinforcer on inactive lever responses or 
locomotor rate (Table 2.2). 
During maintenance of alcohol self-administration the TMT group had higher 
alcohol lever responses than the control group, as indicted by a significant main effect 
of TMT (Fig 2.3C; F(1,10) = 8.11, p = 0.017). There was also a significant main effect of 
session on alcohol lever responses (F(6,60) = 10.2, p < 0.001) and no interaction. There 
was no significant effect of TMT exposure on total alcohol intake during the 
maintenance phase (Fig 2.3D). There were no main effects of TMT, session, or 
interaction on inactive lever responses (Table 2.3). There was a main effect of session 
on locomotor rate with reduced locomotion in later sessions (Table 2.3; F(6,60) = 5.17, 
p < 0.001), but no main effect of TMT or session by TMT interaction. 
Together these results show that TMT exposure does not increase transfer of 
salience to a reward cue, but can reduce goal-tracking behavior. As it was hypothesized 




consumption, correlation between change in PCA index following TMT exposure 
(difference between sessions 16 and 8) and total alcohol intake during maintenance 
self-administration was examined. There were no significant correlations between 
change in PCA score following TMT exposure and alcohol self-administration in either 
the control or TMT group (R2Control = 0.257, R2TMT = 0.001).  
Experiment 2: Effect of TMT exposure on neuronal response to alcohol 
As rats exposed to repeated TMT showed increased alcohol self-administration, 
the goal of this experiment was to determine whether neuronal response to alcohol was 
altered in rats exposed to TMT. Due to experimenter error and tissue damage during 
sectioning, the animals in the Control + Alcohol group is n = 5 for mPFC regions and n = 
4 for amygdala regions. 
Repeated TMT exposure blocks alcohol-induced reduction in BLA c-Fos 
Following alcohol gavage (2 g/kg), c-Fos IR was significantly reduced in the 
prelimbic (PL; Fig 2.4A; F(1,27) = 4.82, p = 0.0367) and infralimbic (IL; Fig 2.4B; F(1,27) 
= 5.28, p = 0.030) subregions of the mPFC, and increased in the central amygdala 
(CeA; Fig 2.4C; F(1,25) = 6.29, p = 0.019). There were no main effects of TMT 
exposure or TMT exposure by alcohol dose interactions.  
In the basolateral amygdala (BLA) there was a main effect of alcohol (Fig 2.4D; F(1,26) 
= 5.78, p = 0.024) with a significant alcohol by TMT exposure interaction (F(1,26) = 
4.48, p = 0.044). Post-hoc analysis showed alcohol treatment significantly reduced BLA 





Interestingly, the TMT-exposed animals also showed several significant 
correlations between BLA, CeA, PL, and IL c-Fos IR (Table 2.4). Notably, the TMT-
exposed animals treated with alcohol showed significant correlations between PL and 
BLA c-Fos IR (Fig 2.4E; R2 = 0.724, p = 0.002) while the Control and TMT + Water 
groups did not. Both TMT treated groups also showed significant correlations between 
CeA and BLA c-Fos IR (Fig 2.4F; TMT + Water: R2 = 0.448, p = 0.034; TMT + EtOH: R2 
= 0.538, p = 0.016), while neither control group did. 
These data suggest that TMT exposure alone increases correlation between 
activity in the mPFC and amygdalar subregions, while blunting the effects of alcohol on 
BLA neuronal activity. 
Experiment 3: Comparison of single and repeated TMT exposure on behavior and 
alcohol self-administration 
The purpose of Experiment 3 was to build upon the results in Experiment 1 and 
compare the effects of single (sTMT) versus repeated TMT (rTMT) exposure on alcohol 
self-administration. 
TMT exposure does not change behavior in open field, elevated plus maze, or acoustic 
startle response tests. 
7 days after the final TMT exposure, rats began testing in the behavioral screens. 
Open field. There was no effect of TMT exposure on percent center time or total 
distance travelled (Table 2.1). One rat in the control group was identified as an outlier 
(distance travelled 2 standard deviations below the mean) and excluded from the 
experiment. Elevated plus maze. There was no effect of TMT exposure on percent open 




effect of TMT exposure on peak startle amplitude or startle habituation index (Table 
2.1). 
Consistent with Experiment 1, which found no change open field test behavior 2 
days after repeated TMT exposure, this experiment found no changes in open field, 
elevated plus maze, or acoustic startle test behavior 7 days after single or repeated 
TMT exposure. 
Single but not repeated TMT increases alcohol self-administration 
Examination of self-administration behavior with two-way RM ANOVAs across 
sucrose fading showed a main effect of reinforcer on alcohol lever responses (Fig 2.5A; 
F(17,544) = 61.1, p < 0.001), inactive lever responses (Table 2.2; F(17,544) = 1.66, p = 
0.046), and locomotion (Table 2.2; F(17,544) = 4.91, p < 0.001) with no main effect of 
TMT or TMT by by reinforcer interaction. Examination of total alcohol intake (g/kg) 
across sucrose fading showed significantly greater alcohol intake in the sTMT group 
(Fig 2.5B; F(2,32) = 4.85, p = 0.015).  
Analysis of maintenance of alcohol self-administration found a significant main 
effect of TMT exposure on alcohol lever responses (Fig 2.5C; F(2,32) = 5.75, p = 0.007) 
with no significant effect of session or TMT exposure by session interaction. Again, the 
sTMT group showed significantly higher total alcohol intake during the maintenance of 
alcohol self-administration (Fig 2.5D; F(2,32) = 7.70, p = 0.002). There was no effect of 
TMT exposure, session, or TMT exposure by session interaction on inactive lever 
responses (Table 2.3). Two-way RM-ANOVA showed a main effect of session on 
locomotor rate, with decreased locomotor rate across the sessions (Table 2.3) with no 




These results indicate that a single TMT exposure is sufficient to produce lasting 
increases in alcohol self-administration.  
Experiment 4: Measuring plasma corticosterone response to repeated TMT 
exposure 
Fecal boli production does not habituate across multiple TMT exposures. 
Fecal boli production during TMT exposure was measured to assess habituation 
of the acute physiological stress response to repeated TMT exposure (Barone et al., 
1990, Monnikes et al., 1993). Two-way RM-ANOVA found a significant main effect of 
TMT exposure on fecal boli production (Fig 2.6A; F(2,32) = 20.6, p < 0.001) and a 
significant interaction between TMT exposure and exposure day (F(6,96) = 3.76, p = 
0.002). On exposure days 1-3, the rTMT group produced significantly more fecal boli 
than the sTMT group (water exposure days) and Control group (p < 0.05). On the fourth 
exposure day both the rTMT and sTMT (TMT exposure day) groups had more fecal boli 
than the control group (p < 0.05). There was no habituation of fecal boli production 
across repeated TMT exposures. 
Plasma corticosterone response does not habituate across multiple TMT exposures. 
In a separate group of animals, plasma corticosterone response 30 min following 
TMT exposure (at the onset of the dark cycle, approximately between 7:30 - 9:00 p.m.) 
was examined across the course of repeated TMT exposures (Fig 2.6B). Two-way RM-
ANOVA revealed a main effect of TMT (F(1,13) = 8.74, p = 0.011) and day (F(1,13) = 
5.49, p = 0.036), with no TMT by day interaction. This suggests that acute physiological 





The results of this study demonstrate several important findings. First, repeated 
exposure to TMT, a synthetically produced predator odor, can reduce goal-tracking 
behavior in male Long-Evans rats. Second, rats with a history of TMT exposure show 
persistent increases in alcohol self-administration. Third, TMT-exposed rats are 
insensitive to alcohol-induced reductions in BLA c-Fos expression, and show increased 
synchronicity between mPFC and amygdala as indicated by c-Fos expression. Fourth, 
neither fecal boli nor plasma corticosterone response to TMT exposure habituate across 
repeated exposures. Together, these data suggest that exposure to the synthetically 
produced predator odor TMT is a viable model to study stress-induced lasting increases 
in alcohol self-administration, which may be related to changes in BLA response to 
alcohol. 
As PTSD and addiction both involve maladaptive attribution of salience towards 
traumatic and drug cues, respectively, we hypothesized that stress exposure would 
increase the attribution of salience towards reward-related cues (i.e., increased sign-
tracking behavior) as this can predict a pro-addiction phenotype (Tomie et al., 2008, 
Yager and Robinson, 2013, Morrison et al., 2015, Fitzpatrick et al., 2019). To test this 
hypothesis, rats in Experiment 1 were trained on PCA, exposed to TMT and then 
resumed PCA. Contrary to our hypothesis, we found that sign-tracking behavior was not 
increased following TMT exposure, suggesting that TMT did not alter attribution of 
salience towards the reward cue. In fact, we found that goal-tracking behavior was 
decreased following TMT exposure. It is possible that TMT exposure may still increase 




as salience transfer seems well conserved across reinforcers (Morrow et al., 2011, 
Yager and Robinson, 2013). Another possibility is that the low sample size in this study 
(n = 6/condition) compounded with high variability in sign-tracking behavior (Fig 2A; 
Fitzpatrick et al., 2013, Fitzpatrick and Morrow, 2016) and individual differences in 
response to predator odor (Edwards et al., 2013, Manjoch et al., 2016, Dopfel et al., 
2019) may have contributed to the lack of a group difference in sign-tracking behavior. 
Further, our population appeared biased towards goal-tracking behavior (Fig 2G; 
Fitzpatrick et al., 2013), therefore using rats from a supplier whose population 
demonstrates greater levels of sign-tracking behavior, or a different strain of rat may be 
an important consideration for future work. However, the reductions in goal-tracking 
behavior in the TMT-exposed rats is particularly interesting and similar reductions in 
reward approach behavior have been observed in rats following repeated footshock 
stress (Woon et al., 2019). One interpretation of this data pattern is that TMT exposure 
induced an anhedonia-like phenotype, a well-defined symptom of PTSD (APA, 2013, 
Nawijn et al., 2015, Vujanovic et al., 2017), such that a decrease in sucrose reward 
value led to a decrease in goal-tracking behavior in the task. However, during self-
administration training the TMT-exposed animals did not show reduced self-
administration of a 10% sucrose solution (Fig 2.4A) which makes such an explanation 
less likely. An alternative hypothesis is that this reduction in goal-tracking may be due to 
a cognitive impairment often associated with PTSD such as attention dysfunction 
(Esterman et al., 2013, Esterman et al., 2019). Future studies could directly test this by 
evaluating attentional processes in TMT-exposed animals with the rodent psychomotor 




Following PCA, animals began alcohol self-administration training (9 days after 
the last TMT exposure). Rats with a history of TMT exposure showed significant 
increases in alcohol self-administration during the sucrose fading and maintenance 
phases. These findings are consistent with literature using different models of predator 
odor stress and observing increases in alcohol drinking lasting 1-3 weeks (Edwards et 
al., 2013, Manjoch et al., 2016, Finn et al., 2018, Zoladz et al., 2018). However, here we 
show that the increase in self-administration persisted throughout 21 sessions (4 
weeks) of maintenance self-administration which began approximately 5 weeks 
following the last TMT exposure.  
While other studies use a variety of natural predator odors such as cat litter 
(Manjoch et al., 2016), rat bedding (Finn et al., 2018), or bobcat urine (Edwards et al., 
2013) this is the first study to demonstrate that a synthetically produced predator odor 
(TMT) can persistently increase alcohol consumption. Furthermore, a recent study has 
also shown TMT can act as a stressor to induce reinstatement of alcohol-seeking 
behavior in mice (King and Becker, 2019). An advantage to using a synthetically 
produced predator odor such as TMT is in reproducibility, specifically because the 
intensity and composition of the predator odor can be controlled. Natural odorants such 
as bobcat urine can contain a number of different volatile odor compounds (Mattina et 
al., 1991), and their concentrations vary based on factors such as freshness of the 
urine, saturation of bedding, or diet/hydration of the animal (Apfelbach et al., 2015). 
Conversely, TMT as a single odor molecule, may not elicit the full range of behavioral 
and neurobiological responses, such as conditioned avoidance, that a natural odor 




using alternative synthetically produced predator odors such as β-phenylethylamine, 2-
propylthietane, or a combination of odorants (Perez-Gomez et al., 2015). 
To begin to understand the neurobiological basis of increased alcohol self-
administration, Experiment 2 examined whether TMT-exposed rats showed differential 
expression of c-Fos, a marker of neuronal activity, in response to alcohol 1 week after 
TMT exposure. We examined subregions of the mPFC and amygdala, which are 
implicated in both PTSD and AUD, as well as activated by predator odor (Asok et al., 
2013, Edwards et al., 2013, Hwa et al., 2019b). Acute administration of alcohol (2 g/kg, 
i.g.) reduced c-Fos expression in the mPFC (PL and IL) regardless of whether rats had 
been exposed to TMT. Similarly, TMT exposure did not affect the alcohol-induced 
increase in c-Fos in the CeA. However, TMT-exposed rats treated with alcohol were 
insensitive to the alcohol-induced reductions in BLA c-Fos seen in control rats. Although 
TMT alone did not alter BLA activity, the finding that TMT exposure prevented the 
alcohol-induced reduction in BLA c-Fos is particularly notable as BLA hyperactivity is 
implicated in PTSD as well as in anxiety disorders and addiction (Patel et al., 2016, 
Sharp, 2017, Piggott et al., 2019). Moreover, alcohol is known to blunt BLA response to 
fearful stimuli (Sripada et al., 2011) and alcohol self-administration in alcohol 
experienced rats is shown to reduce BLA activity (Vilpoux et al., 2009). Therefore, it is 
possible that if alcohol-induced reductions in BLA activity are disrupted in TMT-exposed 
animals, this lack of feedback could potentially drive increased alcohol drinking. 
Interestingly, the correlation between PL-BLA c-Fos in alcohol-treated TMT-exposed 
animals mirrors patterns evoked by re-exposure to a predator odor paired context 




supporting the hypothesis that maladaptive connectivity in these regions may underlie 
comorbidity of PTSD and AUD (Gilpin and Weiner, 2017). 
Building on the findings of Experiment 1 showing a persistent escalation in 
alcohol self-administration in rats with a history of repeated TMT exposures, the goal of 
Experiment 3 was to determine whether a single TMT exposure would be sufficient to 
increase alcohol self-administration. Surprisingly, results from this experiment showed 
that a single TMT exposure, but not repeated TMT exposures, led to significantly 
elevated alcohol self-administration. Though animals’ conditioning history differed 
between experiments, in both cases the escalations in drinking persisted through 21 
sessions (4 weeks) of maintenance self-administration, approximately 5 weeks after the 
last TMT exposure. A notable difference between the two experiments is that rats in 
Experiment 1 experienced PCA training prior to alcohol self-administration training. 
Therefore, that group had prior experience in the operant chambers with sucrose 
reward and the CS lever was the same as the alcohol lever for later self-administration 
studies. While this confound was mitigated in the context of Experiment 1 as all rats 
received equal CS/US pairings, it could explain the divergent results between the 
repeated TMT groups in Experiments 1 and 3. Further, since a 1-day TMT exposure 
group was not tested in Experiment 1, we cannot conclude whether the repeated TMT 
exposure was necessary to show the subsequent increase in alcohol self-administration 
under those conditions. Interestingly, while repeated TMT did not elicit elevations in self-
administration in Experiment 3, data from Experiments 3 and 4 show that neither the 
acute physiological (fecal boli) nor neuroendocrine (corticosterone) responses 




corticosterone response of mice to rat bedding does not habituate across repeated 
exposures (Finn et al., 2018), and stands in contrast to other modes of repeated stress, 
such as restraint, where corticosterone responses habituate (Schmidt et al., 2019). This 
data pattern highlights the unique nature of PO as a stressor evocative of an 
evolutionarily engrained response (Perez-Gomez et al., 2015). 
In both Experiments 1 and 3, rats with a history of TMT exposure showed 
increased alcohol self-administration. One explanation of the increases in alcohol self-
administration is that TMT exposure may have led to an enhancement in the reinforcing 
value of alcohol. Alternatively, the increases in self-administration could be interpreted 
as a reduction in the reinforcing effects of alcohol such that rats required more alcohol. 
Future studies could further investigate the mechanisms underlying increased self-
administration by examining performance on a progressive ratio test for an alcohol 
reinforcer (Stafford et al., 1998). Another possible explanation is that rats were less 
sensitive to the interoceptive cues of alcohol that signal satiety. Indeed, prior work has 
shown that rats with a history of corticosterone exposure via drinking water show 
blunted sensitivity to the interoceptive effects of alcohol and also show enhanced 
alcohol self-administration (Besheer et al., 2012b, Besheer et al., 2013, Besheer et al., 
2014, Jaramillo et al., 2015).  One caveat to the present findings of increased alcohol 
self-administration is that it is not known if these effects are specific to an alcohol 
reward or to reward in general. As such, it will be important for future work to conduct a 
parallel experiment in rats trained to self-administer a non-drug reward such as sucrose 




One question that remains unanswered by the existing literature is how alcohol 
history can impact the effect of stress exposure on later alcohol drinking. Animals that 
showed increases in alcohol self-administration in this study were alcohol naïve, but two 
studies show that alcohol history is necessary for elevations in alcohol consumption 
following PO or predator and social stress (Finn et al., 2018, Zoladz et al., 2018). 
Another study found that alcohol experience was protective against increases in alcohol 
consumption following SEFL (Meyer et al., 2013). The impact of alcohol history on 
stress-induced escalations in drinking will be an important point to address for clinical 
translation of these studies as alcohol use is prevalent among adults (SAMHSA, 2018) 
and clinical data suggests that alcohol dependence blunts cortisol stress response 
(Sinha et al., 2011). 
It is particularly interesting that 7 days after TMT exposure, there were no 
differences in anxiety-like behavior, or hyperarousal relative to controls. This is in 
contrast to other studies using TMT that show the presence of anxiety-like behavior and 
hyperarousal 7 - 9 days following predator odor exposure (Brodnik et al., 2017, 
Schwendt et al., 2018). The lack of anxiety-like behavior or hyperarousal in this study 
could be due to strain differences, a floor effect, or timing of behavioral testing. Both 
studies showing hyperarousal and anxiety-like behavior in the acoustic startle and 
elevated plus maze use male Sprague-Dawley rats (Brodnik et al., 2017, Schwendt et 
al., 2018), so it is possible that this lack of effect might be specific to Long-Evans rats. 
Additionally, the absence of a difference in elevated plus maze performance may have 
been masked by a floor effect. For example, rats in the control group spent a low 




observe further reductions in open arm time. This may have been due to lighting in the 
testing room or testing during the light cycle, though this does not explain the lack of 
effect in the acoustic startle test. Furthermore, while another study reporting anxiety-like 
behavior in the elevated plus maze following predator odor stress shows immediate 
changes in alcohol consumption (Manjoch et al., 2016), the changes in self-
administration in this study do not emerge until 4-5 weeks after TMT exposure. 
Therefore, it is possible that hyperarousal and anxiety-like behavior would not emerge 
until 4-5 weeks after PO exposure. Future studies could address these limitations by 
testing for behavioral sequelae at multiple timepoints, with a greater variety of 
behavioral tests, or in a different strain of rats. 
Clinical studies suggest higher incidence of PTSD in females than males 
(Bangasser and Valentino, 2014). Therefore, a limitation of the present work is the lack 
of inclusion of female rats. One study that examined sex differences in alcohol 
consumption following predator odor exposure found that only low-drinking female rats 
increased alcohol consumption (Finn et al., 2018), suggesting that the mechanism by 
which stress impacts alcohol drinking may be different between sexes. This is 
supported by data from the single prolonged stress (SPS) model showing potentiation of 
alcohol-induced inhibition of basolateral amygdala neurons in female rats but not males 
following stress exposure (Ornelas and Keele, 2018). Other studies have shown sex 
differences in gene expression following predator odor stress, with females but not 
males showing upregulations in PFC and hippocampal p450scc, an enzyme responsible 
for synthesis of neuroactive steroids that can regulate alcohol drinking (Devaud et al., 




CREB and ERK (Homiack et al., 2017). These observed sex differences suggest the 
possibility for sex differences in the findings of the present work and it will be important 
for future work to include female rats.  
In summary, this study outlines a model by which a single exposure to a 
synthetically produced predator odor, TMT, can induce a persistent increase in alcohol 
self-administration in male Long Evans rats. Rats exposed to TMT also show 
insensitivity to the effects of alcohol on BLA c-Fos expression, a dysregulation that may 
underlie these increases in alcohol self-administration. The acute physiological (fecal 
boli) and corticosterone response to repeated TMT exposure did not habituate, though 
repeated TMT exposure only increased alcohol self-administration in rats trained in 
PCA. Future studies could use this model and others to better define the effects of 
alcohol experience on traumatic stress reactivity, identify stress induced changes in 
mPFC-amygdala circuitry that may underlie escalations in drinking, and characterize 
sex differences in models of stress enhanced alcohol consumption. Through breadth of 
experimental methodologies and careful dissection of variables involved in trauma 
exposure, studies such as this can aid in understanding the highly variable nature of 
PTSD and its relationship with AUD. 
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Figure 2.1. - Timelines for Experiments 1-4.  
(A) In Experiment 1, male rats (n = 6/group) were trained on PCA for 8 sessions prior to 
4 TMT exposures. Rats then returned to PCA for 8 additional sessions and underwent an 
open field test 48 hours after the final TMT exposure. After PCA rats were trained to self-
administer alcohol. (B) In Experiment 2, male rats (n = 6/dose control group and 10/dose 
TMT group) were exposed to TMT 4 times. 7 days later, rats received 2 g/kg alcohol or 
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c-Fos. (C) In Experiment 3, male rats (n = 12/group) were exposed 0, 1, or 4 times to 
TMT and examined for anxiety-like behavior and hyperarousal 7 days later. Rats were 
then trained to self-administer alcohol. (D). In Experiment 4, male rats (n = 8/group) were 
exposed to TMT 4 times and blood was drawn 30 minutes post-exposure on days 1 and 





Figure 2.2 - Effects of TMT exposure on PCA behavior. 
(A&B) Rats exposed to TMT showed no change in lever presses (sign-tracking) and 
significant reductions in port-entry elevation score (goal-tracking) compared to controls. 
(C&D) Rats exposed to TMT showed no change in latency to first lever press, and a trend 
for increased latency to first port-entry as compared to controls. (E) PCA indices for TMT 
exposed rats did not differ significantly from controls. Dotted line represents 4 TMT 
exposures across 7 days, between PCA sessions 8 and 9. * - p < 0.05 versus control.  
p = 0.072
TMT



















































































































































Figure 2.3 - Acquisition and maintenance of alcohol self-administration following TMT 
exposure in Experiment 1.  
 
(A) Rats exposed to TMT showed increased alcohol lever responses across sucrose 
fading compared to controls. (B) TMT-exposed rats consumed significantly more alcohol 
than controls across sucrose fading. (C) TMT-exposed rats showed increased alcohol 
lever responses during maintenance compared to controls. (D) There was no significant 
difference in total alcohol intake across the maintenance phase between TMT-exposed 



























































































































































Figure 2.4 - Alcohol induced c-Fos in naïve and TMT-exposed rats. 
  
(A, B) Following an alcohol (2 g/kg, IG) injection, there were significant reductions in PL 
and IL c-Fos IR. (C) Alcohol treated rats showed increased CeA c-Fos IR regardless of 
TMT history. (D) Alcohol reduces BLA c-Fos IR in naïve, but not TMT-exposed rats. The 
shaded area on the brain atlas illustrations show the quantified region. (E) Alcohol 
treatment increases correlations between PL and BLA c-Fos IR in TMT exposed, but not 
control animals. (F) TMT treated animals show significant correlation between BLA and 



































































































































































Figure 2.5 - Acquisition and maintenance of alcohol self-administration following TMT 
exposure in Experiment 3. 
 
(A) There were no significant differences between groups in alcohol lever responses 
during sucrose fading. (B) The sTMT group showed significantly higher alcohol intake 
than the control group during sucrose fading. (C) The sTMT group showed significantly 
higher alcohol lever responses during maintenance than controls. (D) The sTMT group 
had significantly higher alcohol intake than both the control and rTMT groups across the 
maintenance phase. sTMT: single TMT exposure; rTMT: repeated TMT exposures. * - p 

















































































































































































Figure 2.6 - Acute physiological and neuroendocrine stress responses to TMT across 
repeated exposures.  
 
(A) On days 1-3 the rTMT group produced significantly more fecal boli than the control 
group and sTMT group (control exposure days). On day 4 both rTMT and sTMT (TMT 
exposure day) groups produced significantly more fecal boli than controls. (B) Plasma 
corticosterone 30 minutes after exposure (at onset of dark cycle 7:00 – 9:30 pm) was 
significantly elevated in TMT exposed animals compared to controls on both exposure 
day 1 and 4. sTMT: single TMT exposure; rTMT: repeated TMT exposures. + - p < 0.05 
versus control and sTMT, * - p < 0.05 versus control.

























































Table 2.1 – Behavioral data from Experiments 1 and 3. 
  
 
Table 1.  
Behavioral data from Experiments 1 and 3 














Experiment 1       
Control 13.6 ± 2.9 1633.7 ± 306.9 - - - - 
TMT 20.4 ± 1.4 1283.3 ± 435.3 - - - - 
Experiment 3       
Control 12.8 ± 1.2 1547.2 ± 84.0 4.3 ± 2.6 10.2 ± 1.1 650.2 ± 197.2 0.3 ± 15.3 
sTMT 12.5 ± 1.0 1671.3 ± 109.6 5.7 ± 3.6 8.7 ± 0.9 376.6 ± 91.9 9.1 ± 19.2 
rTMT 10.4 ± 1.3 1495.7 ± 84.8 7.5 ± 2.5 9.5 ± 0.7 358.2 ± 55.3 3.0 ± 20.4 
 









Inactive lever responses and locomotor rate from sucrose fading phase in Experiments 1 and 3 
Inactive Lever Responses
Group 10S 2A10S 5A10S 10A10S 10A5S 15A5S 15A2S 15A
Experiment 1
Control 0.9 ± 0.3 0.8 ± 0.5 1.0  ± 0.4 1.4  ± 0.5 1.2  ± 0.5 2.3  ± 1.0 1.3  ± 0.7 2.5  ± 0.6
TMT 3.1  ± 1.0 5.2  ± 2.1 6.0  ± 2.1 4.4  ± 1.9 3.8 ± 1.5 5.1  ± 3.0 4.2  ± 2.0 5.4  ± 2.9
Experiment 3*
Control 2.1 ± 0.6 2.9 ± 0.8 3.5 ± 1.3 3.6 ± 0.9 2.3 ± 0.9 3.0 ± 0.6 3.0 ± 0.8 2.2 ± 0.6
sTMT 1.9 ± 0.5 2.2 ± 0.6 3.4 ± 0.7 3.2 ± 0.8 4.4 ± 1.0 2.4 ± 0.7 3.3 ± 1.0 2.4 ± 0.6
rTMT 3.7 ± 0.9 2.7 ± 0.6 4.8 ± 1.4 3.3 ± 0.7 4.3 ± 1.1 4.3 ± 1.7 3.1 ± 0.8 2.6 ± 0.5
Locomotor Rate (Beam Breaks/min)
Group 10S 2A10S 5A10S 10A10S 10A5S 15A5S 15A2S 15A
Experiment 1
Control 20.7 ± 3.0 21.6 ± 1.3 22.6 ± 2.3 23.6 ± 1.3 26.0 ± 1.2 24.5 ± 1.4 23.1 ± 1.8 24.3 ± 1.4
TMT 28.4 ± 2.0 28.0 ± 1.6 26.5 ± 2.7 27.3 ± 2.1 28.7 ± 2.6 27.1 ± 2.2 25.1 ± 1.9 25.5 ± 1.7
Experiment 3*
Control 26.7 ± 1.5 26.3 ± 1.2 27.2 ± 1.6 24.7 ± 1.5 23.7 ± 1.5 23.9 ± 1.1 26.5 ± 1.3 25.3 ± 1.3
sTMT 29.8 ± 1.3 29.0 ± 1.7 30.3 ± 2.1 26.9 ± 1.1 26.8 ± 1.3 26.0 ± 0.9 28.3 ± 1.5 27.0 ± 1.4
rTMT 29.1 ± 1.2 29.0 ± 1.4 29.9 ± 1.2 28.6 ± 0.7 29.0 ± 0.8 26.4 ± 1.3 29.3 ± 1.6 27.3 ± 1.4
* - significant main effect of reinforcer p < 0.05 
 










Inactive lever responses and locomotor rate from maintenance phase of self-administration in Experiments 1 and 3
Inactive Lever Responses (3 Session Average)
Group 3 6 9 12 15 18 21
Experiment 1
Control 1.5 ± 0.7 0.9 ± 0.3 0.9 ± 0.3 1.3 ± 0.4 1.1 ± 0.5 1.3 ± 0.5 1.2 ± 0.7
TMT 3.5 ± 1.7 4.7 ± 1.7 3.7 ± 1.6 3.2 ± 1.3 2.9 ± 0.9 3.2 ± 1.0 2.3 ± 0.7
Experiment 3
Control 1.2 ± 0.2 1.2 ± 0.4 0.9 ± 0.2 1.8 ± 0.4 1.5 ± 0.5 1.8 ± 0.3 1.0 ± 0.2
sTMT 1.4 ± 0.6 2.5 ± 0.5 2.5 ± 0.8 1.9 ± 0.5 0.9 ± 0.2 1.8 ± 0.5 2.0 ± 0.7
rTMT 2.0 ± 0.5 1.4 ± 0.4 1.9 ± 0.5 1.4 ± 0.5 1.7 ± 0.5 1.6 ± 0.6 1.2 ± 0.3
Locomotor Rate (Beam Breaks/min; 3 Session Average)
Group 3 6 9 12 15 18 21
Experiment 1*
Control 25.0 ± 1.1 24.7 ± 0.9 24.0 ± 2.2 24.4 ± 1.2 23.7 ± 1.8 23.4 ± 1.2 21.7 ± 1.6
TMT 24.7 ± 1.5 24.4 ± 1.6 24.0 ± 1.6 24.3 ± 1.2 22.4 ± 1.5 22.6 ± 1.4 21.2 ± 1.5
Experiment 3*
Control 24.9 ± 1.3 23.3 ± 1.0 24.9 ± 1.2 23.4 ± 1.1 22.9 ± 1.0 23.1 ± 1.5 22.8 ± 1.6
sTMT 24.2 ± 1.5 25.1 ± 1.6 23.8 ± 1.1 22.9 ± 1.3 23.0 ± 1.5 22.3 ± 1.1 23.4 ± 1.7
rTMT 25.7 ± 1.1 26.3 ± 1.3 25.0 ± 1.3 24.6 ± 1.0 22.4 ± 1.0 22.2 ± 1.3 22.0 ± 1.2
* - significant main effect of session p < 0.05 
 









Correlations between Experiment 2 brain regional c-Fos IR
Group PL – IL PL – BLA PL – CeA IL – BLA IL – CeA BLA - CeA
Control – Water 0.517 0.095 0.149 0.086 0.699* 0.367
Control – Alcohol 0.848* 0.391 -0.066 0.666 0.000 0.321
TMT – Water 0.810* 0.248 0.479* 0.424* 0.570* 0.449*
TMT – Alcohol 0.882* 0.724* 0.806* 0.707* 0.953* 0.539*





CHAPTER 3 : FUNCTIONAL ROLE OF MINERALOCORTICOID RECEPTORS IN 
PREDATOR ODOR STRESS MODEL OF COMORBID PTSD AND AUD 
 
INTRODUCTION 
Alcohol use disorder (AUD) is a major public health problem, affecting 
approximately 15.1 million adults in the United States (2016). There are certain 
environmental and genetic factors that can dramatically increase the risk of developing 
AUD (2016). One such factor is post-traumatic stress disorder (PTSD), with one study 
estimating a 3-fold increase in the risk of developing an AUD (Kessler et al., 1997). 
Given the strong negative impacts on society of both disorders, it is imperative that 
studies use preclinical models of PTSD, such as predator odor stress (Edwards et al., 
2013, Manjoch et al., 2016, Finn et al., 2018), single prolonged stress (Han et al., 2014, 
Yu et al., 2016), or stress enhanced fear learning (Rau and Fanselow, 2009, Meyer et 
al., 2013), to understand the neurobiology underlying comorbidity between PTSD and 
AUD and identify potential therapeutic targets (Edwards et al., 2013, Manjoch et al., 
2016, Brodnik et al., 2017, Gilpin and Weiner, 2017, Schreiber et al., 2017). One such 
target that is uniquely implicated in both stress response and alcohol drinking is the 
mineralocorticoid receptor, which is the focus of this study within the context of a 
predator odor stress model of increased alcohol self-administration. 
Most stress literature focuses on the actions of the stress hormone 
corticosterone/cortisol via the glucocorticoid receptor (GR); comparatively few studies 




which have been primarily studied outside of the brain as the MR is highly expressed in 
the heart, vasculature, and kidneys (Funder et al., 1972, Pearce and Funder, 1987, 
Funder et al., 1989, Kolkhof and Barfacker, 2017). However, the MR is also expressed 
in brain regions such as the amygdala, hippocampus, and medial prefrontal cortex 
(mPFC) (Reul and de Kloet, 1986, Han et al., 2014, Xing et al., 2014), and can bind 
corticosterone to mediate some responses that GRs do not, such as modulating 
hippocampal glutamate transmission (Karst et al., 2005). Preclinical studies have also 
shown that MR expression is sensitive to the effects of stress. For example, one study 
showed that MR gene expression is downregulated in the hippocampus, but not the 
mPFC, of stress-sensitive animals following restraint stress (Nasca et al., 2015). 
Another study showed that MR expression is decreased in the amygdala and increased 
in the mPFC following single prolonged stress exposure (Zhang et al., 2012, Han et al., 
2014). Clinical PTSD literature is mixed with some studies indicating no change in MR 
function or protein levels in peripheral lymphocytes, and one study showing increased 
methylation of sites within the MR gene (Kellner et al., 2002, Otte et al., 2006, Matic et 
al., 2014, Perroud et al., 2014). Additionally, MRs have been shown to mediate the 
development of aversive memories in rodents, with MR antagonism prior to fear 
conditioning blocking contextual fear learning (Zhou et al., 2010), and MR antagonism 
following predator stress blocking the later anxiety-like behavior (Adamec et al., 2007). 
MR signaling is also involved in the retrieval of contextual fear memories, with MR 
antagonism prior to a contextual reminder reducing freezing behavior during the 
reminder, as well as during a reminder 24 hours later (Zhou et al., 2011).  




field of alcohol research. Recently, a convergent multi-species study showed increased 
alcohol self-administration in rhesus macaques with lower central amydala (CeA) MR 
expression, and increased compulsive-like alcohol drinking and anxiety-like behavior in 
alcohol dependent Wistar rats with lower CeA MR.  In addition, both systemic MR 
antagonism with spironolactone and intra-CeA MR antagonism with epelerenone have 
been shown to reduce alcohol self-administration (Makhijani et al., 2018). Taken 
together, MR may be a promising, emerging target to study in the context of comorbid 
PTSD and AUD. 
The purpose of this study was to examine the functional role of MR in response 
to predator odor stress, and in mediating the effects of predator odor on subsequent 
alcohol self-administration. First, MR and GR expression following predator odor stress 
was quantified in both the CeA and dorsal hippocampus, regions where MR is known to 
regulate alcohol consumption and anxiety-like behavior respectively (McCann et al., 
2019). Second, alcohol-naïve female rats were pretreated with the MR antagonist 
spironolactone and exposed to the predator odor 2,5-dihydro-2,4,5-trimethylthiazoline 
(TMT) to assess the role of MR in the development of anxiety-like behavior and 
increased alcohol self-administration following TMT exposure. Third, this experiment 
was repeated in alcohol-experienced male rats. And last, male alcohol-experienced rats 
were treated with spironolactone prior to open field and light-dark box tests, to evaluate 




MATERIALS AND METHODS 
Animals 
116 Long-Evans rats (66 female, 50 male; Envigo-Harlan, Indianapolis, IN) 
arrived at 7 weeks old and housed under a 12 hour light/dark cycle (7:00 am/pm). In 
Experiment 1 male and female rats were single housed throughout. In Experiment 2 
female rats were single-housed throughout. In Experiment 3 males were double housed 
upon arrival then single-housed immediately after TMT exposure, at 9 weeks old. Prior 
to all experiments rats were handled for 1-2 minutes across 5 days. All experiments 
were conducted during the light cycle, with the exception of TMT exposure in 
Experiments 1 and 2 which occurred at the onset of the dark cycle (7:00-7:30pm). 
Animals were under the care of the veterinary staff of the UNC-Chapel Hill Division of 
Comparative Medicine. All procedures were carried out in accordance with the NIH 
Guide for Care and Use of Laboratory Animals, and institutional guidelines. All protocols 
were approved by the UNC Institutional Animal Care and Use Committee (IACUC). 
UNC-Chapel Hill is accredited by the Association for Assessment and Accreditation of 
Laboratory Animal Care (AAALAC).    
Experiment 1: Quantifying steroid receptor expression following TMT exposure 
(Fig 3.1A) 
The goal of this experiment was to quantify changes in brain-regional 
mineralocorticoid and glucocorticoid receptor expression following TMT exposure. 
TMT exposures 
Male and female rats (n = 9/sex/group) were transported from the vivarium to a 




Plexiglas chambers (30.5 cm x 18 cm x 18 cm) with a piece of filter paper affixed to the 
lid. 10 µL of either water (Control group) or TMT was pipetted onto the filter paper prior 
to closing the chamber lids. (Note: Control animals were always exposed before TMT 
animals to avoid any contact with the TMT odor). After 10 minutes of exposure, rats 
were returned to the vivarium and fecal boli in the exposure chambers was counted. 
Behavioral assessments 
2 days after TMT exposure rats began the behavioral assessments: open field, 
light-dark box, and acoustic startle test. Rats underwent each test in that order on 
consecutive days, testing order was arranged so that less stressful tests (open field, 
light-dark) preceded more stressful tests (acoustic startle). Prior to each test rats were 
transported in the home cage and allowed to habituate to the testing room for 20 
minutes. For the open field test, rats were placed in the center of the open field arena 
(44 cm x 44 cm; Med Associates, St. Albans, VT) under ambient lighting conditions and 
locomotor activity was recorded by 32 orthogonal infrared beams using Activity Monitor 
software (Med Associates) for 10 min. For the light-dark box test, a dark box insert (44 
cm x 22.9 cm; Med Associates) was added to the open field arena and the tests were 
run under ambient lighting conditions. Rats were placed in the dark side and locomotor 
activity in the dark and light sides was recorded for 10 minutes as in the open field test. 
For the acoustic startle test, rats were placed in an SR-LAB animal enclosure (San 
Diego Instruments, San Diego, CA) and testing consisted of a 5 minute habituation to 
background white noise (65dB, matched to ambient noise), followed by 30 startle trials 
(10 presentations each of 100, 110, and 120 dB white noise for 250 msec, presented in 




a high-accuracy accelerometer mounted under the animal enclosure and analyzed with 
SR-LAB software (San Diego Instruments). Sessions were approximately 20 min in 
total. 
Tissue collection and preparation 
7 days after TMT exposure, rats were sacrificed by rapid decapitation under deep 
isoflurane anesthesia (Baxter, Deerfield, IL). Brains were flash-frozen in isopentane 
chilled on dry ice and stored at -80°C until tissue punching. Frozen brains were 
sectioned by cryostat and 1.2 mm diameter punches were taken of dorsal hippocampus 
(dHC; dentate gyrus, CA1, CA3; AP -2.2 to -3.2) and central amygdala (CeA; AP -1.8 to 
-2.8). Tissue punches were homogenized by sonication (Branson SLPe; Emerson 
Industrial, St. Louis, MO) in homogenization buffer (10mM Tris-HCl, 1% (w/v) SDS, 1% 
(v/v) HALT protease inhibitor, 5mM EDTA). Protein concentration from lysates were 
determined using a BCA assay (Thermo-Fisher; Rockford, IL). 
Western blotting 
10 µg of protein lysate, LDS sample buffer (Life Technologies, Carlsbad, CA), 
and reducing agent (Life Technologies) were diluted in sterile water and denatured for 5 
minutes at 70°C. Protein samples were then separated using an 18-well 4-20% Criterion 
TGX gel (BioRad, Herculues, CA) in a BioRad western blot apparatus. Each gel had 3 
samples from each group Male-Control, Male-TMT, Female-Control, Female-TMT from 
the same brain region. After electrophoresis, proteins were transferred to PVDF 
membrane using the iBlot system (Thermo-Fisher). Blots were blocked in 3% non-fat 
dry milk (Nestle, Solon, OH) in 0.1% PBST (0.1% Tween-20 in PBS) prior to incubation 




3128832; EMD Millipore, Temecula, CA) or glucocorticoid (1:1000; MAB3660, Lot # 4; 
Cell-Signalling Technologies, Beverly, MA) receptors, and the loading control actin 
(1:5000; MAB1501, Lot #: 3086655; EMD Millipore). After incubation with primary 
antibody, blots were washed and incubated with secondary antibodies: HRP anti-mouse 
(1:10,000, Lot #: X0328; Vector Labs, Burlingame, CA)or HRP anti-rabbit (1:10,000, Lot 
#: ZD0821; Vector Labs). Blots were then developed in chemiluminescent substrate 
(ECL-Prime, GE Healthcare, Little Chalfont, UK) and imaged using an Imagequant LAS 
4000 (GE Healthcare). Band optical density measurements were collected and 
analyzed using ImageQuantTL software (GE Healthcare).  
Experiment 2: Pharmacological blockade of mineralocorticoid receptors during 
TMT exposure of female rats (Fig 3.1B) 
The goal of this experiment was to assess the role of mineralocorticoid receptor 
function in acute reactivity to TMT exposure, as well as behavioral and alcohol self-
administration sequelae of TMT exposure in female rats. 
TMT Exposure 
TMT exposure was similar to that in Experiment 1 with two changes. Rats (n = 
12/group) were treated with spironolactone (0, 50 mg/kg, I.P.) 30 minutes prior to TMT 
or water exposure (6:30 – 7:00 pm), and a yellow plastic stopper (42 mm x 29 mm; 
Kimble) was secured to the floor on the TMT side as an environmental cue to increase 
the salience of the exposure context. In addition, TMT exposures were recorded with a 
digital camera (Vixia HFR80, Canon, Melville, NY) and analyzed for TMT-side 






Rats underwent the open field, light-dark box, and acoustic startle tests as in 
Experiment 1 with slight modifications to the open field and light-dark box protocols. The 
locomotor chambers and the light-dark box test were conducted similarly to Experiment 
1, however the open field arenas were housed in sound-attenuating cubicles with an 
exhaust fan to provide ventilation and mask external noise, and dimmable LED lighting. 
The open field tests were conducted under 100 lux white light emanating from bulbs on 
the rear corners of the cubicle, and the light-dark box tests were conducted under 150 
lux white-light positioned in the center of the light side. 
Context re-exposure 
7 days after the initial TMT exposure, rats were returned to the TMT-paired 
exposure chambers in the absence of either TMT or water for 5 minutes to assess 
conditioned reactivity to the exposure context (including the yellow plastic stopper). 
Behavior during the context re-exposure was recorded and analyzed as described 
previously. 
Alcohol self-administration apparatus 
Self-administration was conducted in operant chambers (Med Associates, 
Georgia, VT) located within sound-attenuating cabinets. Cabinets were equipped with 
an exhaust fan to provide ventilation and mask external noise. Chambers were 
equipped with two retractable levers on opposite sides of the chamber (left and right), 
and a cue light was located above each lever. When the response requirement was met 
on the left (active) lever, a cue light (directly above the lever) and a stimulus tone were 




left side of the chamber across 1.66s). Responses during reinforcer delivery and on the 
right (inactive) lever were recorded, but had no programmed consequences. Chambers 
were also equipped with 4 parallel infrared beams across the bar floor to measure 
general locomotor activity during the session. The number of beam breaks throughout 
the entire session was collected and the total was divided by the session length (30 
min) to represent the locomotor rate (beam breaks/min). 
Two-bottle choice and alcohol self-administration 
8 days after the initial TMT exposure, rats began 9 sessions of 24-hour 
intermittent two-bottle choice drinking across 3 weeks (bottles placed on cages on 
M,W,F) for familiarization with the alcohol reinforcer. At approximately 2:00pm on 
drinking days rats were removed from the central watering system, and one bottle 
containing tap water and one bottle containing 20% (v/v) alcohol was placed on cages.  
Bottle sides were switched every session to account for side-preferences. 24 hours 
later, bottles were removed and weighed to assess alcohol and water consumption, and 
cages were returned to the central watering system. After 9 homecage drinking 
sessions, rats began self-administration of 20% (v/v) alcohol on a fixed ratio 2 (FR2) 
schedule of reinforcement in 30 minute sessions, five days a week (M-F) in the operant 
self-administration chambers. 
Experiment 3: Pharmacological blockade of mineralocorticoid receptors during 
TMT exposure of alcohol experienced male rats (Fig 3.1C) 
The goal of this experiment was to assess the role of mineralocorticoid receptor 
function in acute reactivity to TMT exposure, and behavioral sequelae of TMT exposure 




Two-bottle choice and alcohol self-administration 
 As in Experiment 2, rats began 3 weeks of two-bottle choice in the homecage 
before beginning self-administration of 20% alcohol. Rats self-administered alcohol 5 
days a week (M-F; 30 min sessions) for 5 weeks (25 sessions) prior to TMT exposure. 
10 days after TMT exposure, rats resumed alcohol self-administration for 3 days a week 
(M,W,F). 
TMT Exposure 
Rats were divided into counterbalanced Control-Vehicle (n = 7), Control-
Spironolactone (n = 7), TMT-Vehicle (n = 9), and TMT-Spironolactone (n = 9) treatment 
groups based on average alcohol consumption (g/kg) across their self-administration 
history. The TMT exposure protocol was similar to that in Experiment 2 with several 
changes: TMT exposure lasted 20 minutes and were conducted at the onset of the light 
cycle (7:30 am – 8:30 am), exposure chambers were slightly larger than those used in 
Experiments 1 and 2 (45.7 cm x 17.8 cm x 20.3 cm), and 600 mL of bedding (ALPHA-
dri, Shepherd Specialty Papers, Watertown, TN) was placed in the exposure chambers 
to allow for assessment of digging behavior as an additional measure of behavioral 
reactivity to TMT. 
Context re-exposure and behavioral screening 
After 7 days undisturbed in the homecage following TMT exposure, rats 
underwent context re-exposure, the light-dark box test, and acoustic startle + prepulse 
inhibition (PPI) test across 3 consecutive days before returning to alcohol self-
administration 10 days post-TMT. Context re-exposure and light-dark box were 




trials each (40 trials total) blank trials (no startle stimulus), prepulse-only trials (40ms 80 
dB tone), startle-only trials (40 ms 120 dB tone), and prepulse inhibition (PPI) trials (40 
ms 80 dB tone followed by a 40 ms 120 dB tone 100ms later). 
Experiment 4: Effect of spironolactone on locomotor and anxiety-like behavior. 
(Fig 3.1D) 
The purpose of this experiment was to assess any non-specific effects of 
spironolactone treatment on locomotor behavior in the open field test, and anxiety-like 
behavior in the light-dark box. Following the conclusion of Experiment 3, rats (n = 16) 
with equal alcohol self-administration history were selected from all treatment groups for 
Experiment 4. 
Behavioral testing  
Rats were pretreated with spironolactone (0, 50 mg/kg, I.P.) 30 minutes prior to 
either the open field or light-dark box tests. Both tests were conducted with a between-
subjects design, two weeks apart, treatment groups were reversed between tests (i.e. 
rats that received vehicle in the open field test received spironolactone prior to the light-
dark box test and vice-versa). 
Reagents 
97% purity 2,5-dihydro-2,4,5-trimethylthiazoline (TMT) was purchased from SRQ 
Bio (Sarasota, FL). Alcohol (95% (v/v), Pharmaco-AAPER, Shelbyville, KY) was diluted 
with tap water. Spironolactone (Lot #’s MKCD7812, MKCG6303; Sigma-Aldrich, St. 
Louis, MO) was suspended in 45% β-Cyclodextrin (Sigma-Aldrich), and injected IP at a 







For each protein of interest, band densities were normalized to actin band 
density to account for loading variation, normalized protein levels in the TMT-exposed 
group were then expressed as a percent of the average normalized protein level for the 
same-sex control animals on the blot (i.e. MR/Actin density for each Male-TMT exposed 
animal was expressed a percent of the average MR/Actin density for all Male-Control 
animals on the same blot). For each sex, protein expression between TMT and control 
groups was compared separately by t-tests. Relationships between protein expression 
and light-dark box behavior were evaluated by Pearson’s correlation coefficient. 
Acute TMT exposure and re-exposure measures  
In Experiments 2 and 3, fecal boli production was compared by two-way ANOVA 
with spironolactone dose and TMT exposure as between-subjects measures. Immobility 
(defined as lack of movement for over 2 seconds), TMT side time (%), and digging 
duration (Experiment 3 only) were compared by three-way RM-ANOVA with 
spironolactone dose and TMT exposure as between-subjects measures, and time as 
the within-subjects measure. 
Behavioral screens  
In Experiment 1, distance traveled in the open field, time in center of the open 
field, distance traveled in the light-dark box, and percent light side time of the light-dark 
box were compared by t-test within each sex with TMT exposure as the between-
subjects measure. In Experiments 2 and 3, distance traveled in the open field, time in 




the light-dark box were compared by two-way ANOVA with spironolactone dose and 
TMT exposure as between-subjects measures. In Experiment 2 peak startle in the 
acoustic startle test was assessed by three-way RM-ANOVA with spironolactone dose 
and TMT exposure as between-subjects measures and stimulus intensity as the within-
subjects measure. PPI ratio was calculated by dividing the average peak startle across 
all 10 PPI trials (80dB prepulse stimulus followed by 120dB startle stimulus) by the 
average peak startle across all 10 startle-only trials (120dB startle stimulus alone). In 
Experiment 3, peak startle and PPI ratio are compared by two-way ANOVA with 
spironolactone dose and TMT exposure as between-subjects measures. In Experiment 
4, distance traveled in the open field, time in center of the open field, distance traveled 
in the light-dark box, and light side time (%) in the light-dark box were analyzed by two-
way RM-ANOVA with spironolactone dose as the between-subjects measure, and time 
as the within-subjects measure. 
Homecage two-bottle choice  
Two bottle choice data is presented as daily alcohol consumed (approximated 
from decreased weight of 20% alcohol bottle and animal weight) and analyzed by three-
way RM-ANOVA with TMT exposure and spironolactone dose as between-subjects 
factors, and session as a within-subjects factor. 
Alcohol self-administration  
In Experiment 2, maintenance alcohol self-administration session data: alcohol 
lever responses, inactive lever responses, and locomotion are presented as 5-session 
weekly averages. Alcohol consumed (approximated from the number of reinforcers 




In Experiment 3, alcohol lever responses (presented as a percentage of pre-TMT 
exposure baseline [5 sessions prior to TMT exposure]), inactive lever responses and 
locomotion are presented as 3-session weekly averages. Alcohol intake (approximated 
from the number of reinforcers delivered and body weight) is presented as session 
average (% baseline) across the entire experiment. Alcohol lever responses, inactive 
lever responses, and locomotor rate data analyzed by three-way RM-ANOVA with TMT 
exposure and spironolactone dose as between-subjects factors, and week as a within-
subjects factor. Alcohol intake was analyzed by two-way ANOVA with TMT exposure 
and spironolactone dose as between-subjects measures. 
 
RESULTS 
Experiment 1: Quantifying steroid receptor expression following TMT exposure  
The purpose of Experiment 1 was to determine if TMT exposure would impact 
brain regional expression of MR and GR, and if these changes would differ based on 
brain region or sex. Due to experimenter error while processing tissue, the rats in the 
male control group are n = 8. 
TMT exposure sex-dependently upregulates mineralocorticoid receptors and has no 
effect on glucocorticoid receptor expression 
Dorsal hippocampus and central amygdala tissue was collected 7 days after TMT 
exposure and MR and GR expression was quantified by Western blot. Following TMT 
exposure, male but not female rats showed significant increases in MR protein 
expression relative to control in the central amygdala (CeA), (Fig 3.2C t(15) = 2.91, p = 




exposure (Fig 3.2C&D). In the dorsal hippocampus (dHC) female but not male rats 
showed significant increases in MR protein expression (Fig 3.3B; t(16) = 2.27, p = 
0.038). GR protein expression was not changed in the dHC (Fig 3.3C&D). 
In female rats, upregulation of dHC mineralocorticoid receptors correlates with less 
anxiety-like behavior as measured by the light-dark box 
Interestingly, female rats showed anxiety-like behavior following TMT exposure as 
indicated by significantly reduced light side time (%) during the light-dark box test (Fig 
3.3H; t(16) = 3.14, p = 0.006). When light side time (%) was correlated with MR 
expression, a significant positive correlation was found between dHC MR expression 
and light side time in female TMT-exposed rats (Fig 3.3H; Control: R2 = 0.172, p = 
0.267; TMT: R2 = 0.672, p = 0.007). No significant correlations were observed in the 
males (Fig 3.3I; Control: R2 = 0.121 p = 0.398; TMT: R2 = 0.000, p = 0.960).   
Experiment 2: Pharmacological blockade of mineralocorticoid receptors during 
TMT exposure of female rats 
 The purpose of this experiment was to examine the functional involvement of MR 
signaling in TMT exposure of female rats. One female rat in the Veh-TMT group did not 
acquire self-administration behavior (Average alcohol lever responses < 5 for first week 
of self-administration) and was excluded from the self-administration portion of the 
study. 
Spironolactone antagonism of MR alters acute defensive behavior during TMT exposure 
in female rats 
 Two-way RM-ANOVA of fecal boli production (Fig 3.4A) showed a trend for an 




spironolactone (F(1,44) = 4.72, p = 0.035), and a significant TMT x spironolactone 
interaction (F(1,44) = 4.72, p = 0.035). Tukey’s post-hoc test revealed that the Veh-TMT 
group had significantly more fecal boli production than both control groups and that this 
effect was reversed in the Spiro-TMT group (p < 0.05). 
Three-way RM-ANOVA of percent TMT side time (Fig 3.4B) showed a significant 
main effect of TMT exposure (F(1, 44) = 52.4, p < 0.001) and time (F(4, 176) = 5.79, p < 
0.001), indicating that the TMT-exposed rats spent significantly less time on the TMT 
side of the exposure chamber (e.g., avoidance of the TMT side). There were no 
significant interactions. 
 Three-way RM-ANOVA of immobility during TMT exposure (Fig 3.4C) showed a 
significant main effect of TMT exposure (F(1, 44) = 17.0, p < 0.001) and time (F(4, 176) 
= 282, p < 0.001). There were significant interactions of TMT exposure by time 
(F(4,176) = 96.1, p < 0.001), TMT exposure by spironolactone (F(1, 44) = 4.46, p = 
0.040), and TMT exposure by spironolactone by time (F(4, 176) = 4.38, p = 0.002). 
Post-hoc tests showed that the Veh-TMT group showed significantly more immobility 
than controls at minute 6 onwards, and the Spiro-TMT group showed significantly more 
immoblity than controls in minute 8, indicating a delay in immobility response. 
  
TMT exposure did not alter locomotor, anxiety-like, acoustic startle, or context reactivity 
behavior 
 Two-way ANOVA showed no effects of TMT exposure, spironolactone, or TMT 
exposure by spironolactone interaction in distance travelled in the open field (Fig 3.5A), 




3.5C), or light side time in the light-dark box (Fig 3.5D). Three-way ANOVA showed an 
effect of stimulus intensity on peak startle amplitude (Fig 3.5E; F(2, 88) = 169, p < 
0.001), indicating increased startle response as the stimulus intensity was increased. 
There were no effects of TMT exposure, spironolactone, and no significant interactions. 
 Three-way RM-ANOVA analysis of immobility (Fig 3.6A) during the context re-
exposure session showed a significant main effect of time (F(4, 176) = 15.8, p < 0.001) 
with increased immobility in all groups across the test. There were no significant effects 
of TMT exposure, spironolactone, and no significant interactions. Analysis of percent 
TMT side time (Fig 3.6B) during the context re-exposure test showed no effect of TMT 
exposure, spironolactone, time, and no significant interactions. 
TMT exposure did not alter alcohol self-administration behavior 
 Following behavioral testing, rats began homecage two-bottle choice drinking. 
Analysis of two-bottle choice daily alcohol consumption showed no significant effects of 
TMT exposure, spironolactone, and no significant interactions (Fig 3.7A). Following two-
bottle choice, rats began alcohol self-administration, analysis of which showed a 
significant main effect of week on alcohol lever responses (Fig 3.7B; F(5, 215) = 56.3, p 
< 0.001). There were no significant effects of TMT exposure, spironolactone, and no 
significant interactions. Total alcohol consumed across the study did not differ across 
the groups as confirmed by a two-way ANOVA (Fig 3.7C). There were no significant 
effects of TMT exposure, spironolactone, and no significant interactions on inactive 
lever responses or locomotor rate (Table 3.1). These findings suggest that under these 
conditions TMT exposure and spironolactone pretreatment did not affect later alcohol 




Experiment 3: Pharmacological blockade of mineralocorticoid receptors during 
TMT exposure of alcohol experienced male rats 
The purpose of this experiment was to examine the functional involvement of MR 
signaling in TMT exposure of alcohol experienced male rats.  
Spironolactone had no effect on acute TMT behavior in alcohol experienced male rats 
 Two-way ANOVA found a significant effect of TMT exposure on fecal boli 
production (Fig 3.8A; F(1, 28) = 7.87, p = 0.009) with no effect of spironolactone or TMT 
exposure by spironolactone interaction, indicating that all TMT-exposed groups 
produced significantly more fecal boli than controls. 
 Percent time immobile during TMT exposure is illustrated in Figure 3.8B. The 
three-way RM-ANOVA found significant main effects of TMT exposure (F(1, 28) = 19.8, 
p < 0.001) and time (F(9, 252) = 141, p < 0.001). There were also significant 
interactions including TMT exposure by time (F(9, 252) = 32.4, p < 0.001) and TMT 
exposure by drug by time (F(9, 252) = 3.28, p < 0.001). Tukey’s post-hoc analysis 
revealed that the Veh-TMT group showed greater immobility than the Veh-Control group 
from minute 10 onwards (p < 0.05). 
 Percent time digging is shown in Figure 3.8C. The three-way RM-ANOVA found 
significant main effects of TMT exposure (F(1, 28) = 25.3, p < 0.001) and time (F(9, 
252) = 20.5, p < 0.001). Significant interactions included TMT exposure by time (F(9, 
252) = 18.6, p < 0.001), spironolactone by time (F(9, 252) = 2.24, p = 0.020), and TMT 
exposure by spironolactone by time (F(9, 252) = 2.77, p = 0.004). Tukey’s post-hoc 
analysis showed that the Veh-TMT group showed greater digging than the Veh-Control 




 Percent TMT side time is illustrated in Figure 3.8D. There was a significant main 
effect of TMT exposure (F(1, 28) = 31.1, p < 0.001), and time (F(9, 252) = 6.16, p < 
0.001) and a significant TMT exposure by time interaction (F(9, 252) = 6.01, p < 0.001). 
Tukey’s post-hoc test showed that the Spiro-TMT group spent significantly less time on 
the TMT side than both control groups from 10 minutes onwards, and that the Veh-TMT 
group spent significantly less time on the TMT side than the Veh-Control group from 18 
minutes onwards, indicating that spironolactone may have decreased the latency to 
TMT avoidance. 
Spironolactone treatment significantly increased later acoustic startle independent of 
TMT exposure 
 Analysis of distance travelled in the open field test (Fig 3.9A) and the percent 
light side time of the light-dark box (Fig 3.9B) showed no effect of TMT exposure or 
spironolactone pretreatment. PPI ratio was also not affected by TMT exposure or 
spironolactone pretreatment (Figure 3.9C). However, there was a significant main effect 
of spironolactone on peak startle amplitude at 120dB (Fig 3.9D; F(1, 28) = 7.00, p = 
0.013) with no effect of TMT exposure or TMT exposure by spironolactone interactions, 
suggesting that spironolactone alone could increase startle response 10 days later. 
TMT-exposed animals displayed context reactivity independent of spironolactone 
pretreatment 
 Analysis of immobility during re-exposure to the TMT paired context found a 
significant main effect of time (Fig 3.10A; F(4, 112) = 12.5, p < 0.001) and a significant 
time by TMT interaction (F(4, 112) = 2.65, p = 0.037), indicating increased immobility in 




spironolactone, time, or any significant interactions on percent TMT side time (Fig 
3.10B). There were significant main effects of TMT exposure and time on digging (Fig 
3.10C; FTMT(1, 28) = 5.60, p = 0.025; Ftime(4, 112) = 9.85, p < 0.001), indicating that 
context re-exposure elicited increased digging in all TMT-exposed rats. 
TMT exposure significantly increased alcohol self-administration which was not 
reversed by spironolactone 
 Prior to TMT exposure rats were trained to self-administer 20% alcohol and 
divided into treatment groups based on average alcohol lever-responses over the past 5 
sessions (baseline). Baseline self-administration is represented in Table 3.2 along with 
raw self-administration data. Alcohol self-administration starting 10 days following TMT 
exposure is shown in Figure 3.11.  Three-way RM-ANOVA showed a main effect of 
TMT on alcohol self-administration (Fig 3.11A; F(1, 28) = 4.18, p = 0.050) and a 
significant TMT by time interaction (F(4, 112) = 3.92, p = 0.005). When examining 
average alcohol consumption (Fig 3.11B) there were no significant effects of TMT 
exposure, spironolactone, or TMT by spironolactone interactions. 
Experiment 4: Effect of spironolactone on locomotor and anxiety-like behavior 
 The purpose of this experiment was to understand if spironolactone would cause 
deficits in locomotor behavior, or increased anxiety-like behavior that may underlie its 
effects on alcohol self-administration or acute TMT reactivity. 
Spironolactone had no non-specific effects on locomotor or anxiety-like behavior 
 In order to test for non-specific effects of spironolactone, rats were treated with 
spironolactone 30 minutes prior to the open field and light-dark box tests. Two-way RM-




3.12A; F(5, 70) = 42.5, p < 0.001) and on time in center (Fig 3.12B; F(5, 70) = 13.3, p < 
0.001) indicating increased distance travelled and decreased percentage of time spent 
in the center across the test, indicating that as rats continued to explore the open field, 
they spent more time in the periphery. There were no effects of spironolactone or 
spironolactone by time interactions. 
 Two-way RM-ANOVA found a main effect of time on distance travelled in the 
light-dark test (Fig 3.12C; F(9, 126) = 95.01, p < 0.001), with no effects of 
spironolactone or spironolactone by time interactions, indicating increased distance 
travelled across the test. There were no effects of spironolactone, time, or 
spironolactone by time interaction on time spent in the light (Fig 3.12D). 
 
DISCUSSION 
These studies provide evidence that the MR is involved in both acute and chronic 
response to predator odor stress. First, it was identified that upregulation of MR, but not 
GR is present 7 days after TMT exposure in the dHC of female rats, and CeA of male 
rats, and that dHC MR upregulation is inversely correlated with anxiety-like behavior in 
female rats. Second, it was demonstrated that MR antagonism alters the physiological 
stress response to TMT exposure, as measured by fecal boli, in alcohol-naïve female 
rats. Third, it was shown that alcohol-experienced male rats showed elevations in 
alcohol self-administration following TMT exposure. Lastly, this study found that MR 
antagonism has no acute effects on locomotor behavior or anxiety-like behavior. 




to TMT, and that upregulation of MR may play a role in resilience to the anxiogenic 
effects of TMT exposure. 
One week after TMT exposure MR was upregulated in the dHC of female rats, 
and CeA of male rats. These findings are in contrast with our hypothesis and previous 
studies showing downregulation of amygdala and hippocampal MR in male Wistar rats 
following SPS (Zhe et al., 2008, Han et al., 2014). These divergent results could be due 
to differences in the stress exposure as SPS is a multi-modal form of physical stress 
including restraint, forced swim, and loss of consciousness (Zhe et al., 2008, Han et al., 
2014), whereas predator odor is an ethological psychological stressor with no physical 
component. Another possible explanation is that MR upregulation is indicative of a 
resilient subtype of animals, as increased dHC MR expression in females was 
correlated with less anxiety-like behavior in the light dark box. This is in agreement with 
literature suggesting increased MR function promotes resilience to stress (Bonapersona 
et al., 2019, Kanatsou et al., 2019) and reduced anxiety-like behavior (Mitra et al., 
2009); however there is no broad consensus as to the functional role of dHC MR as 
other studies find upregulated MR in the hippocampus of stress susceptible mice and 
rats (Ellenbroek and Cools, 2000, Nasca et al., 2015).  
In contrast to female rats, males showed upregulation of MR in the CeA, where 
MR is thought to influence alcohol drinking as described in Chapter 4 and in Aoun et al., 
2018. This finding may explain why increases in alcohol self-administration following 
TMT exposure are observed in male rats but not female rats. One caveat is that the 
increase in CeA MR is inconsistent with the findings of a study where reduced MR 




the difference in timepoints between increased self-administration and MR expression 
are measured. While increased CeA MR is observed 7 days post-TMT, the full response 
of MR to TMT is potentially dynamic with a decrease following an increase. Future 
studies could clarify this point by examining if MR is downregulated around 4 weeks 
post-TMT, where rats show increased alcohol self-administration. Another factor that 
could explain the difference is that increases in total CeA MR protein do not inform 
whether these changes are in cytosolic or membrane MR that have genomic and non-
genomic effects, respectively (Karst et al., 2005). Future studies could further our 
understanding of MR response to TMT by examining expression at later time point after 
TMT exposure, or by doing fractionation of protein extracts to better determine levels of 
membrane and cytosolic MR. Altogether these data support the hypothesis that CeA 
MR modulate alcohol consumption. 
The acute behavioral effects of TMT exposure appear relatively conserved 
across sexes with significantly elevated fecal boli production, immobility, and TMT-side 
avoidance in both sexes. This is in agreement with previous studies showing these sex-
independent responses to TMT exposure (Homiack et al., 2017). In alcohol-naïve 
female rats, spironolactone treatment reversed the production of fecal boli. In alcohol-
experienced male rats there was no effect of spironolactone on fecal boli production. 
Possible explanations for this include the difference in alcohol experience, or animal sex 
between studies. There is evidence that alcohol experience can moderate TMT 
reactivity (Hwa et al., 2019a), and therefore it is possible this explains the lack of 
spironolactone effect on fecal boli in Experiment 3. An alternative explanation is that the 




females. Future studies could also examine if these sex differences in response to TMT 
and spironolactone are linked to the hypotensive effect of spironolactone, which is 
known to be sexually dimorphic (Merrill et al., 2019). The effects of spironolactone on 
immobility, avoidance, and digging are more difficult to interpret, as statistical 
differences between both TMT groups and the Vehicle-Control group emerge at 
different times during TMT exposure, but there are no significant differences between 
the TMT groups. Thus, we conclude that MR may still play a role in the acute response 
to TMT exposure, but that it is not a primary mediator of response to TMT exposure. 
Following TMT exposure there were no observed changes in locomotor or 
anxiety-like behavior, and no change in acoustic startle response in either male or 
female rats. These findings are similar to our previous work and discussed in (Makhijani 
et al., 2018). Interestingly, the MR antagonist spironolactone alone significantly 
increased startle response peak amplitude at 120dB in both the control and TMT 
groups. This is surprising as spironolactone has been shown to reverse the effects of 
predator stress (exposure to a live cat) on acoustic startle when administered IP 
immediately after stress (Adamec et al., 2007), and produce acute anxiolytic effects in 
the light-dark box when infused into the dorsal hippocampus (Smythe et al., 1997). A 
possible explanation for this outcome could be due to the mechanism of action of 
spironolactone in blocking glucocorticoid negative feedback through the MR, resulting in 
increased corticosterone, akin to a stressful experience that increased startle response 
9 days later. Indeed, the findings of Smythe et al. show that pretreatment time 
influences the behavioral effects of spironolactone, with spironolactone producing 




light-dark box 3 hours post-infusion, so spironolactone mediated hyperarousal is 
plausible. As TMT exposure did not produce significant alterations in locomotion, 
anxiety-like behavior, or startle response in these animals, we cannot infer the role of 
MR in the development of these effects, though previous literature suggests its 
involvement (Adamec et al., 2007). 
Another lasting consequence of predator odor stress is animals exhibiting 
reactivity to the predator odor paired context in the absence of the predator odor 
(Edwards et al., 2013).In the Experiment 2 rats did not show context reactivity as 
measured by immobility or avoidance of the TMT-side of the context; however, when 
bedding was added to the TMT exposure context in Experiment 3, TMT-exposed male 
rats showed increased digging behavior when re-exposed to the context. This highlights 
digging as a conditioned response to TMT exposure, and confirms reports that a single 
chamber exposure model does not produce conditioned avoidance as in a two or three-
chamber exposure model (Endres and Fendt, 2007, Edwards et al., 2013). Interestingly, 
spironolactone pre-treatment did not alter context reactivity. This outcome contradicted 
our hypothesis, based on the finding that spironolactone could reduce expression of 
tone-shock fear conditioning (Zhou et al., 2010). Possible explanations for this include 
difference in circuits encoding memories of an ethologically relevant stressor like 
predator odor versus painful stimulus like footshock, along with differences in the 
behaviors evoked by context re-exposure. There are several regions where TMT 
evokes significant c-Fos expression that footshock stress does not, such as the central 
amygdala and lateral division of the bed nucleus of the stria terminalis (Smith et al., 




context-induced freezing in a fear conditioning paradigm (Zhou et al., 2010), the TMT-
paired context only evoked digging, which further underlines differences in the nature of 
these stimuli and the neural substrates that may underlie the behaviors. 
Alcohol naive female TMT-exposed rats showed no increases in alcohol self-
administration, while male rats showed significant elevations in alcohol self-
administration relative to pre-TMT baseline. The lack of effect in females is surprising, 
given similar acute reactivity to TMT between sexes, and epidemiological data 
suggesting higher incidence of PTSD in females (Bangasser and Valentino, 2014). 
However, this is not wholly unexpected given that traditional rodent models of stress 
have been mostly developed using male rats and effects are not always reproducible in 
female rats (Keller et al., 2015). Along with sexually dimorphic upregulation of MR seen 
in Experiment 1, a previous study showed TMT reduced phosphorylation of cyclic-
adenosine monophosphate response element binding protein (CREB) in the 
hippocampus of only male rats, suggesting female rats were resilient to the effects of 
this stressor (Homiack et al., 2017). While there was a main effect of TMT on alcohol 
self-administration in male rats, this effect was not present when examining alcohol 
consumption, potentially due to high variability within the TMT group. Additionally, while 
there is no significant difference between the Vehicle-TMT and Spironolactone-TMT 
groups, the large difference between group means and high variability make it difficult to 
conclusively state that spironolactone did not impact the effects of TMT exposure on 
alcohol self-administration. 
Although spironolactone (50 mg/kg) altered locomotor rate in male rats during 




the open field test or anxiety-like behavior in the light-dark box. One possible 
explanation for this difference is that spironolactone is blocking an MR-modulated 
locomotor response to alcohol as it does with acute cocaine administration (Fiancette et 
al., 2010). Chronic alcohol consumption can increase basal locomotion in rodents 
(Wscieklica et al., 2016, Olney et al., 2018), as can acute moderate doses of alcohol 
(Brabant et al., 2014, Karlsson and Roman, 2016), therefore future studies could 
directly examine the effects of spironolactone on locomotion following acute alcohol 
administration. While some previous studies have demonstrated an anxiolytic effect of 
spironolactone and other MR antagonists (Korte et al., 1995, Smythe et al., 1997, 
Hlavacova et al., 2010) lack of anxiolytic effects seen in this study are not entirely 
surprising as these effects appear to be transient and dependent on the time of 
spironolactone pretreatment (Smythe et al., 1997). 
Together, these data show that TMT has sex-dependent effects on brain regional 
MR expression, that dHC MR upregulation may be involved in stress resilience, and that 
MR modulates some aspects of the acute response to TMT. While alcohol-experienced 
male rats exposed to TMT showed significant elevations in alcohol self-administration, 
female rats showed no changes in alcohol self-administration, suggesting that this 
model may need further optimization to study the effects of stress on alcohol drinking in 
female rats. This study was unable to conclusively state if MR antagonism would 
reverse the lasting effects of TMT exposure on anxiety-like behavior, hyperarousal, and 
alcohol self-administration, though given the prevalence of MR antagonist use in the 




data to evaluate the impacts of MR antagonists on alcohol consumption and post-
traumatic stress disorder. 
 Figure 3.1 – Timelines for Experiments 1-4. 
 
(A) In Experiment 1 male and female rats were exposed to either TMT or water (n = 
9/sex/group), behaviorally screened, then sacrificed 7 days later to examine brain 
regional GR and MR expression. (B) In Experiment 2, female rats were pretreated with 
spironolactone or vehicle prior to a TMT or water exposure (n = 12/group), then 
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male rats were trained to self-administer alcohol, then pretreated with spironolactone or 
vehicle prior to a TMT or water exposure (n = 7/group/control, n = 9/group/TMT). Rats 
were then behaviorally screened and returned to alcohol self-administration. (D) Rats 






Figure 3.2 – CeA MR is upregulated in male rats following TMT exposure. 
(A) Representative western blots showing MR labeled at 107kD and actin at 42kD. (B) 
CeA MR protein is unchanged following TMT exposure in female rats. (C) MR protein is 
significantly upregulated in TMT-exposed male rats. (D) Representative western blots 
showing GR labeled at 91kD and actin at 42kD. (E&F) CeA GR protein levels are 
unchanged in male and female rats after TMT exposure. (G) Representative CeA tissue 



























































































































Figure 3.3 – dHC MR is upregulated in female rats following TMT exposure. 
(A) Representative western blots showing MR labeled at 107kD and actin at 42kD. (B) 
dHC MR protein is upregulated in female rats following TMT exposure. (C) dHC MR 
protein is unchanged in TMT-exposed male rats. (D) Representative western blots 
showing GR labeled at 91kD and actin at 42kD. (E&F) dHC GR protein levels are 
unchanged in male and female rats after TMT exposure. (G) Representative CeA tissue 
punch placement. (H) Female rats show reduced time in light (%) during the light-dark 
test which correlates with dHC MR expression. (I) Time in the light is unchanged in male 








































































































































































Figure 3.4 – Spironolactone alters acute reactivity to TMT in female rats. 
(A) The Veh – TMT group shows significant increases in fecal boli production which is 
reversed by in the Spiro – TMT group. (B) TMT exposed animals show reduced TMT 
side time (%) versus controls. (C) Veh – TMT and Spiro – TMT groups show increased 
freezing relative to Veh – Control from minute 6 and 8 onwards, respectively. * - p < 
0.05, # - p < 0.05 main effect of TMT versus control, $ - p <0.05 Veh – TMT versus Veh 
– Control, & - p < 0.05 Spiro – TMT versus Veh – Control.  
Acute TMT Reactivity








































































































































Figure 3.5 – TMT exposure does not alter locomotion, anxiety-like behavior, or 
hyperarousal in female rats. 
 
(A-B). TMT has no effect on distance travelled or percent time in center in the open field 
test, (C-D) distance travelled or percent time in light in the light-dark test, or (E) peak 
startle at all stimulus intensities in the acoustic startle test, and this is not altered in the 



















































































































































































Figure 3.6 – Female rats do not show reactivity to the TMT-paired context. 
 
(A&B) The Veh – TMT group shows no significant increases in immobility or decreases 
in TMT Side Time (%) when re-exposed to the TMT-paired context, and this effect is 
unchanged in the Spiro – TMT group.  

















































 Figure 3.7 – Female rats show no differences in alcohol drinking following TMT exposure. 
 
(A-C) The Veh – TMT group shows no significant changes in two-bottle choice alcohol 
consumption, alcohol self-administration, or total alcohol consumption across alcohol 
self-administration, and this effect is unchanged in the Spiro – TMT group.  







































































































Figure 3.8 – Spironolactone alters acute response to TMT in alcohol-experienced male 
rats. 
 
(A) TMT exposed animals show significant increases in fecal boli production relative to 
controls. (B) The Veh – TMT group shows significantly increased time immobile (%) 
relative to the  Veh – Control group from minute 10 onward, (C) and significant 
increases in time digging relative to the Veh – Control group. Both the Veh – TMT and 
Spiro – TMT groups show significantly reduced TMT side time (%) relative to the Veh – 
Control group. * - p <0.05, $ - p < 0.05 Veh – TMT versus Veh – Control, & - p <0.05 








































































































































































Figure 3.9 – TMT exposure does not alter anxiety-like behavior, hyperarousal, or 
prepulse-inhibition in male rats. 
 
(A&B) Neither the Veh – TMT or Spiro – TMT groups show changes in behavior in the 
light-dark test. (C) Spironolactone treatment increases peak startle response measured 
1 week later, irrespective of TMT exposure. (D) Neither the Veh – TMT or Spiro – TMT 










































































































































































Figure 3.10 – Exposure to the TMT-paired context elicits digging behavior in male rats. 
 
(A&B) TMT exposed animals show no changes in time immobile (%) or TMT side time 
(%) when re-exposed to the TMT-paired context. (C) TMT exposed animals show 
increased time digging (%) versus controls when exposed to the TMT-paired context. # 
- p < 0.05 main effect of TMT versus control.  



































































Figure 3.11 – TMT exposure increases alcohol self-administration relative to pre-TMT 
baseline. 
 
(A) TMT exposed animals show significantly increased alcohol lever responses relative 
to baseline. (B) TMT exposed animals do not show increases in average session 
alcohol consumption relative to baseline. # - p < 0.05 main effect of TMT versus control. 
  


































































































Figure 3.12 – Spironolactone had no non-specific effects on locomotor or anxiety-like 
behavior. 
 
(A-B) Spironolactone treated animals (n = 8/group) showed no alterations in distance 
traveled or time in center (%) during the open field test. (C-D) Spironolactone treated 
animals showed no alterations in distance travelled or time in light (%) during the light-
dark test.



























































































Table 3.1 – Inactive lever responses and locomotor rate from Experiment 2.
Table 1.
Inactive lever responses and locomotor rate from Experiment 2
Inactive Lever Responses (5 Session Average)
Group 1 2 3 4 5
Veh – Control 7.4 ± 4.3 5.4 ± 2.4 4.6 ± 2.1 2.8 ± 0.7 3.6 ± 1.9
Spiro – Control 2.5 ± 0.4 2.6 ± 0.6 3.3 ± 0.4 2.5 ± 0.4 3.5 ± 0.8
Veh - TMT 3.5 ± 0.9 3.3 ± 0.7 3.3 ± 0.7 3.2 ± 1 3.6 ± 0.9
Spiro - TMT 3.8 ± 1 3.4 ± 0.8 3.4 ± 0.6 3.1 ± 0.6 3.6 ± 0.6
Locomotor Rate (Beam Breaks/min; 5 Session Average)
Group 1 2 3 4 5
Veh – Control 26.4 ± 1.5 27.1 ± 1.1 26.4 ± 1.3 25.7 ± 1.2 25.4 ± 1.3
Spiro – Control 27.1 ± 1.7 29.8 ± 1.6 28.8 ± 1.1 28.7 ± 1.3 28 ± 1.4
Veh - TMT 29.9 ± 1.8 28.6 ± 1.1 29.7 ± 1.5 29.3 ± 1.7 26.5 ± 1.6






Table 3.2 – Baseline and raw data from Experiment 3 maintenance self-administration. 
 
Table 2.
Baseline and raw data from Experiment 3 maintenance self-administration
Weekly Active Lever Responses (3 Session Average)
Group BL 1 2 3 4 5
Veh – Control 56.0 ± 8.0 67.5 ± 9.9 62.7 ± 8.2 60 ± 8.4 59.2 ± 10.3 57.2 ± 9.9
Spiro – Control 58.3 ± 8.6 67.7 ± 11.3 65 ± 14.0 62.5 ± 12.2 53.8 ± 8.4 53.7 ± 11.4
Veh - TMT 55.1 ± 7.7 55.3 ± 9.7 70.6 ± 9.5 78.7 ± 8.5 74.5 ± 8.5 74.8 ± 9.5
Spiro - TMT 57.4 ± 5.2 65.7 ± 7.1 77.1 ± 8.4 72.6 ± 8.8 60 ± 7.9 70.2 ± 8.6
Weekly Inactive Lever Responses Rate (3 Session Average)
Group BL 1 2 3 4 5
Veh – Control 3.7 ± 1.1 4 ± 1.1 3.5 ± 1.2 2.1 ± 0.8 2.4 ± 1.3 2.4 ± 0.7
Spiro – Control 1.5 ± 0.4 2.9 ± 1.3 2.7 ± 1.0 1.9 ± 0.8 4 ± 1.9 2.9 ± 1.5
Veh - TMT 1.7 ± 0.5 2.6 ± 0.9 2 ± 0.9 2.1 ± 0.6 2 ± 0.9 1.4 ± 0.5
Spiro - TMT 1.6 ± 0.2 2 ± 0.8 2.3 ± 1.0 1.9 ± 0.9 1.2 ± 0.5 1.2 ± 0.4
Weekly Alcohol Intake (3 Session Average)
Group BL 1 2 3 4 5
Veh – Control 0.67 ± 0.09 0.76 ± 0.10 0.7 ± 0.09 0.66 ± 0.09 0.6 ± 0.12 0.6 ± 0.10
Spiro – Control 0.65 ± 0.10 0.7 ± 0.12 0.68 ± 0.15 0.64 ± 0.12 0.54 ± 0.08 0.55 ± 0.11
Veh - TMT 0.64 ± 0.08 0.6 ± 0.09 0.76 ± 0.09 0.81 ± 0.10 0.76 ± 0.08 0.78 ± 0.09
Spiro - TMT 0.67 ± 0.06 0.72 ± 0.08 0.82 ± 0.09 0.76 ± 0.09 0.62 ± 0.07 0.72 ± 0.09
Weekly Locomotor Rate (Beam Breaks/min; 3 Session Average)
Group BL 1 2 3 4 5
Veh – Control 25.4 ± 2.2 25.6 ± 3.0 25.7 ± 2.9 25.3 ± 2.8 25.7 ± 2.8 24.3 ± 2.6
Spiro – Control 21.2 ± 1.7 21.6 ± 2.7 23.1 ± 2.9 21.2 ± 2.8 21.7 ± 2.2 19.4 ± 2.2
Veh - TMT 21.5 ± 1.1 21.0 ± 1.3 22.1 ± 1.4 21.1 ± 1.6 21.4 ± 1.5 21.8 ± 1.4




1 This chapter has previously been published (Makhijani VH et al., (2018) The mineralocorticoid 
receptor antagonist spironolactone reduces alcohol self-administration in female and male rats. 





CHAPTER 4 : THE MINERALOCORTICOID RECEPTOR ANTAGONIST 
SPIRONOLACTONE REDUCES ALCOHOL SELF-ADMINISTRATION IN FEMALE 
AND MALE RATS1 
 
INTRODUCTION 
There is a wealth of literature examining the role of the hypothalamic-pituitary-
adrenal (HPA) axis and corticosteroids in alcohol consumption, seeking, and 
dependence (Koenig and Olive, 2004, Vendruscolo et al., 2012, Vendruscolo et al., 
2015). Within the HPA axis, cortisol (corticosterone in rodents) is one of the primary 
hormonal stress signals, and several studies in male adrenalectomized rats have shown 
that corticosterone moderates alcohol drinking (Fahlke et al., 1994a, Fahlke et al., 
1995). To date, most alcohol studies have focused on the role of glucocorticoid 
receptors (GRs), which primarily bind corticosterone, in alcohol-related behaviors. For 
example, in preclinical studies of male rats, the GR and progesterone receptor 
antagonist mifepristone has been shown to block escalation of alcohol drinking following 
induction of dependence by chronic alcohol vapor exposure (Vendruscolo et al., 2012), 
and reduce alcohol consumption in a homecage limited-access two-bottle choice study 
(Koenig and Olive, 2004). Additionally, in alcohol-dependent male rats, GRs are 
downregulated in the prefrontal cortex (PFC), nucleus accumbens (NAc), and bed 
nucleus of the stria terminalis (BNST) during acute alcohol withdrawal, and upregulated 
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in the NAc core, ventral BNST, and central amygdala (CeA) 3 weeks into abstinence 
(Vendruscolo et al., 2012). Overall these studies suggest that glucocorticoid signaling 
via the GR plays a dynamic role in both acute alcohol consumption and alcohol 
dependence, though it is important to note the bias towards utilizing male subjects in the 
literature as the HPA axis is known to be sexually dimorphic, both in normal and 
diseased states (Bangasser and Valentino, 2014). For example, in female mice with a 
history of predator stress and alcohol drinking GR is upregulated in the PFC during 
acute withdrawal, while males show no change (Finn et al., 2018).  
Surprisingly, few alcohol-related studies have focused on the functional role of 
the mineralocorticoid receptor (MR). The MR has mainly been studied for its peripheral 
effects such as modulating fluid balance and blood pressure via its endogenous ligand, 
aldosterone, but is also known to modulate memory formation, fear extinction, and recall 
in male rats (Zhou et al., 2010, Dorey et al., 2011, Zhou et al., 2011, Ter Horst et al., 
2012, Gomez-Sanchez and Gomez-Sanchez, 2014). Furthermore, there are sizeable 
sex differences in the role of MR in fear extinction, with female mice showing greater 
extinction deficits following MR deletion in the forebrain than male mice (Ter Horst et al., 
2012). While the MR is traditionally thought of as a cytosolic ligand-dependent 
transcription factor that effects genomic changes on the time-scale of hours, recent 
studies have identified a membrane bound variant of the MR that can act on the time-
scale of minutes (Karst et al., 2005, Khaksari et al., 2007, Dorey et al., 2011, Gomez-
Sanchez and Gomez-Sanchez, 2014). In fact, the MR also binds corticosterone, and is 
expressed in brain regions generally associated with addiction such as the prefrontal 
cortex, hippocampus, and amygdala (Reul and de Kloet, 1986, Fuller et al., 2000). The 
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MR has also been shown to mediate some responses to corticosterone that GR does 
not, such as modulating hippocampal glutamate signaling (Karst et al., 2005) and 
corticosterone-induced impairment of memory retrieval (Khaksari et al., 2007). Earlier 
studies reported the lack of modulatory effect of MR antagonism on alcohol drinking 
(Koenig and Olive, 2004, O'Callaghan et al., 2005) (see later discussion), and MR 
mRNA levels are not changed during acute withdrawal in alcohol dependent male rats 
(Vendruscolo et al., 2012). However, a recent multi-species study linked lower MR gene 
expression levels in the central amygdala (CeA) to higher alcohol drinking behavior in 
male primates with a history of alcohol consumption and more compulsive-like alcohol 
drinking in alcohol dependent male rats (Aoun et al., 2018). In male and female humans 
it was confirmed that higher levels of the MR ligand aldosterone correlated with higher 
alcohol craving in recovering alcohol use disorder (AUD) patients, and that non-
abstinent patients had higher levels of aldosterone than abstinent patients (Leggio et al., 
2008, Aoun et al., 2018). As such, there is growing evidence that MR signaling may play 
an important role in alcohol drinking behavior, and that there may be sex differences in 
this role, but it is unclear if this receptor may prove a potential therapeutic target.  
One of the goals of the present study was to assess the role of MR signaling in 
the maintenance of alcohol self-administration using the MR antagonist spironolactone. 
Another goal of this study was to examine the effects of spironolactone on behavior 
under extinction conditions. To do this, probe extinction tests were used in which the 
cues associated with the reinforcer were presented, but alcohol delivery was withheld. 
This test allows for the examination of the persistence of responding in the presence of 
drug-associated cues, but absence of the primary reinforcer, which is an important 
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feature of drug seeking behavior. Based on the literature, we hypothesized that MR 
antagonism would reduce alcohol self-administration, the persistence of non-reinforced 
alcohol responding. We also hypothesized that females would be more sensitive to this 
MR antagonism given greater behavioral response to MR knockout as well as 
documented HPA axis dimorphism (Ter Horst et al., 2012, Bangasser and Valentino, 
2014). To test this hypothesis male and female Long-Evans rats were trained to self-
administer a sweetened alcohol solution (15% (v/v) alcohol + 2% (w/v) sucrose) and 
administered spironolactone prior to alcohol self-administration and probe extinction 
sessions. Furthermore, to explore the specificity of this effect to an alcohol reinforcer, 
spironolactone was tested in a separate group of male and female Long-Evans rats 
trained on sucrose self-administration. Together with recent studies implicating MR 
signaling in alcohol drinking behavior, these findings suggest that the MR may be an 
important avenue for research in the alcohol field. 
 
MATERIALS AND METHODS 
Animals 
38 adult Long-Evans rats (19 male/19 female) were single housed under a 12h 
light/dark cycle (7am/pm). All experiments were conducted during the light cycle. 
Animals were continuously monitored and cared for by the veterinary staff of the UNC-
Chapel Hill Division of Comparative Medicine. All procedures were carried out in 
accordance with the NIH Guide for Care and Use of Laboratory Animals and institutional 
guidelines. All protocols were approved by the UNC Institutional Animal Care and Use 
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Committee (IACUC). UNC-Chapel Hill is accredited by the Association for Assessment 
and Accreditation of Laboratory Animal Care (AAALAC).  
Apparatus 
Self-administration was conducted in operant chambers (Med Associates, 
Georgia, VT) located within sound-attenuating cabinets equipped with an exhaust fan to 
provide ventilation and mask outside noise. Chambers were equipped with two 
retractable levers on opposite sides of the chamber (left and right), and a cue light was 
located above each lever. When the response requirement was met on the left (active) 
lever, a cue light (directly above the lever) and a stimulus tone were presented for the 
duration of the alcohol reinforcer delivery (0.1mL of solution into a well on the left side of 
the chamber across 1.66s). Responding during reinforcer delivery and on the right 
(inactive) lever was recorded, but had no programmed consequences. Chambers were 
also equipped with 4 parallel infrared beams across the bar floor to measure general 
locomotor activity throughout the session. The number of beam breaks for the entire 
session was collected and this total was divided by the session length (30 min) to 
represent the locomotor rate (beam breaks/min).  
Alcohol self-administration training 
Rats were trained to self-administer a 15% (v/v) alcohol + 2% (w/v) sucrose solution 
(15A/2S) on a fixed ratio 2 (FR2) schedule of reinforcement  in 30 minute sessions, five 
days a week (M-F) via sucrose fading as described in (Randall et al., 2017). Sucrose 
fading began with self-administration of 10% sucrose (10S), then 2A/10S, 5A/10S, 
10A/10S, 10A/5S, 15A/5S, 15A/2S on subsequent sessions, 5 sessions of 15A, and 
then remained at 15A/2S for the duration of training. A sweetened alcohol reinforcer 
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was used as we find this results in stable alcohol self-administration in these long-term 
studies (Randall et al., 2015, Randall et al., 2017, Jaramillo et al., 2018a). Rats that did 
not consistently self-administer at least 0.4 g/kg alcohol were excluded, there were two 
male rats that did not meet this criterion and were not included in this study. Rats had 
approximately 4 months of self-administration training and were used in an unrelated 
non-drug study (i.e., involved exposure to a single stressor and self-administration was 
unaltered (unpublished)) a month prior to the initiation of this study.  
Sucrose self-administration training 
Rats were trained to self-administer a 0.8% (w/v) sucrose solution (0.8S) on an FR2 
schedule over 30 minute sessions, five days a week (M-F) via sucrose fading as 
described above. Sucrose fading began with self-administration of 10S, then 5S, 2S, 
1S, then 0.5S for one week before returning to 0.8S for the remainder of the study. This 
dose of sucrose was selected as it resulted in similar levels of lever responding as the 
alcohol self-administration group (Jaramillo et al., 2018a). 
Experiment 1: Effect of spironolactone on maintenance of alcohol self-
administration 
To measure the effect of spironolactone on maintenance of alcohol self-administration, 
rats received spironolactone (0, 10, 25, 50 mg/kg, IP) 30 minutes prior to a self-
administration session. A within-subject design was used such that each rat (n=12 
females; n=10 males) received each treatment in a random order and doses were 
equally represented for each sex on each test day. Test days were on Tuesdays and 
Thursdays with standard self-administration sessions on Monday, Wednesday, and 
Friday. Alcohol lever responses had to be at least 80% of baseline (average responding 
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in the 2 sessions preceding the study) self-administration in order for a rat to be tested, 
all rats met this criterion. One week after the conclusion of testing, rats began 
Experiment 2. 
Experiment 2: Effect of spironolactone on alcohol response persistence 
To assess the effects of spironolactone on  alcohol lever responding in the absence of 
the alcohol reinforcer, but presence of the cues associated with alcohol, probe 
extinction tests were used as we previously describe in (Randall et al., 2015). During 
these tests, responses on the alcohol lever were not reinforced with alcohol (i.e., 
extinction). That is, for each completed FR2 the cue light and tone were activated but no 
alcohol was delivered. Rats received spironolactone (0, 25, 50 mg/kg, IP) 30 minutes 
prior to test session. A within subject design was used and test days and intervening 
standard self-administration days were scheduled as described in Experiment 1.  
Experiment 3: Effect of spironolactone on maintenance of sucrose self-
administration 
To measure the effect of spironolactone on maintenance of sucrose self-administration 
the same testing procedure described in Experiment 1 was used (n=7 females; n=7 
males). At the conclusion of testing the spironolactone dose range (0, 10, 25, 50 mg/kg, 
IP), rats underwent a follow-up test in which all rats received a higher spironolactone 
dose (100 mg/kg, IP). One week after this follow-up test, rats began Experiment 4. 
Experiment 4: Effect of spironolactone on sucrose response persistence 
To assess the effects of spironolactone on persistent responding in the absence of 
sucrose reinforcement, the same probe extinction testing was used as described in 
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Experiment 2. Rats received spironolactone (0, 25, 50 mg/kg, IP) 30 minutes prior to 
these tests.  
Drugs 
Alcohol (95% (v/v), Pharmaco-AAPER, Shelbyville, KY) and sucrose were diluted with 
tap water for all self-administration sessions. Spironolactone (Sigma-Aldrich, St. Louis, 
MO; Lot # MKBV2039V, MKBZ9531V, MKCD7812) was suspended in 45% 2-
hydroxypropyl-β-cyclodextrin (Sigma-Aldrich, St. Louis, MO) and injected at a volume of 
1 mL/kg. 
Data Analysis 
Alcohol or sucrose lever responses, inactive lever responses, alcohol or sucrose intake 
(g/kg or mL/kg, respectively; estimated from the number of reinforcers received) and 
locomotor rate were analyzed with two-way repeated measures analysis of variance 
(RM-ANOVA) with sex and spironolactone dose as factors. Based on our hypothesis 
that females and males would respond differently to MR antagonism, a significant main 
effect of sex or spironolactone dose was followed up with one-way ANOVAs to examine 
the effects of spironolactone within each sex separately. Cumulative alcohol lever 
responses across the session were analyzed by two-way RM-ANOVA with 
spironolactone dose and session time as factors for each sex separately. In all cases, 
post-hoc analysis (Tukey) was used to determine specific differences from the vehicle 





Experiment 1: Effect of spironolactone on maintenance of alcohol self-
administration 
The baseline alcohol lever responses (mean and S.E.M. of the two days prior to 
the initiation of spironolactone testing) was as follows: females 42.1 ± 3.51 and males 
88.0 ± 9.53. Males had significantly higher responses (t(20) = 4.84, p < 0.001), but there 
was no significant difference in alcohol intake (females: 0.80 ± 0.06 g/kg; males: 0.93 ± 
0.10 g/kg). Female rats had a higher locomotor rate (27.1 ± 1.40 beam breaks/min) than 
male rats (21.9 ± 0.10 beam breaks/min; (t(20) = 2.92, p = 0.008)).  
Alcohol lever responses following spironolactone treatment in males and females 
are shown in Figure 4.1A. The two-way ANOVA showed a significant main effect of 
spironolactone dose (F(3,60)=8.52, p<0.001), and a significant main effect of sex 
(F(1,60)=7.47, p=0.01), with overall higher alcohol lever responses in the males 
(p<0.05), consistent with our previous work (Randall et al., 2017). In the females, there 
was a significant reduction in alcohol lever responses following the 50 mg/kg dose 
relative to vehicle (F(3,33) = 6.03, p = 0.002). In the males, there was a significant 
reduction in alcohol lever responses following the 25 mg/kg dose relative to vehicle 
(F(3,27) = 5.07, p = 0.006). There was no significant sex by spironolactone dose 
interaction. The corresponding alcohol intake is shown in Table 4.2. There was a 
significant main effect of spironolactone dose (F(3,60) = 8.49, p < 0.001), with a 
significant reduction in alcohol intake following 50 mg/kg spironolactone. There was no 
main effect of sex on alcohol intake, indicating that while alcohol lever responses 
differed between sexes, alcohol intake was the same, consistent with our previous work 
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(Randall et al., 2017). In the females, alcohol intake was reduced at the 50 mg/kg 
spironolactone dose relative to vehicle (F(3,33) = 6.23, p = 0.002; Table 4.2). In the 
males, alcohol intake was reduced at the 25 mg/kg spironolactone dose relative to 
vehicle (F(3,27) = 4.56, p = 0.01).  There was no significant sex by dose interaction. 
There was no significant effect of spironolactone on inactive lever responses (Table 
4.1). 
Given the lack of interaction between sex and spironolactone dose on total 
session alcohol lever responses, the pattern of alcohol lever responses across the 
session were examined in females and males separately. In the females (Fig 4.1B), 
there was a significant main effect of dose (F(3,165) = 5.56, p = 0.003), time (F(5,165) = 
52.40, p < 0.001), and a significant dose x time interaction (F(15,165) = 4.71, p < 
0.001). Treatment with 50 mg/kg spironolactone reduced alcohol lever responses at 10 
min and throughout the remainder of the session relative to vehicle (p<0.05). In the 
males (Fig 4.1C), there was a significant main effect of dose (F(3,135) = 5.63, p = 
0.004), time (F(5,135) = 60.08, p < 0.001), and a significant dose x time interaction 
(F(15,135) = 3.68, p < 0.001). Relative to vehicle, treatment with 25 mg/kg 
spironolactone reduced alcohol lever responses at 20 min and throughout the 
remainder of the session (p<0.05), and following 50 mg/kg spironolactone responses 
were reduced at 25 min and throughout the remainder of the session (p<0.05). 
Analysis of spironolactone effects on locomotor rate (Fig 4.1D) showed a 
significant main effect of spironolactone dose (F(3,60)=8.00, p<0.001), and a significant 
main effect of sex (F(1,60)=7.01, p=0.02). In the females, spironolactone treatment did 
not affect locomotor rate. In the males, there was a significant reduction in locomotor 
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rate at both the 25 mg/kg and 50 mg/kg spironolactone doses relative to vehicle 
(F(3,27) = 11.94, p < 0.001). There was no spironolactone dose by sex interaction. 
These results suggest that the decreases in alcohol self-administration in the males 
may be related to a general suppression of motor activity.  
Experiment 2: Effect of spironolactone on alcohol response persistence 
Examination of spironolactone on alcohol lever responding during the probe 
extinction sessions (Fig 4.2A), showed a significant main effect of spironolactone dose 
(F(2,40)=11.84, p<0.001), with a significant reduction at the 50 mg/kg spironolactone 
dose relative to vehicle (p<0.05). In female rats, there was a significant reduction in 
alcohol lever responses at 50 mg/kg spironolactone relative to vehicle (F(2,22) = 8.89, p 
= 0.001). In the males, there was a significant reduction in alcohol lever responses, but 
no spironolactone dose was significantly different from vehicle (F(2,18) = 3.84, p = 
0.04). There was no main effect of sex and no spironolactone dose by sex interaction. 
The lack of a main effect of sex suggests that the females and males show similar 
persistence of lever responding under extinction conditions, which is interesting given 
that males have higher rates of alcohol lever responses under alcohol reinforced 
conditions (see Discussion). Spironolactone treatment did not affect inactive lever 
responses (Table 4.1). In the females, analysis of cumulative alcohol lever responses 
across the probe extinction session (Fig 4.2B) showed a significant main effect of dose 
(F(2,110) = 9.68, p < 0.001), time (F(5,110) = 53.36, p < 0.001), and a significant dose x 
time interaction (F(10,110) = 3.23, p = 0.001). Alcohol lever responding was reduced 
following treatment with 50 mg/kg spironolactone at 10 min and continuing throughout 
the session relative to vehicle (p<0.05). In the males (Fig 4.2C), there was a significant 
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main effect of dose (F(2,90) = 3.61, p = 0.048), time (F(5,90) = 43.54, p < 0.001), with a 
trend for a significant dose by time interaction (F(10,90)=1.85, p=0.06).  
Analysis of locomotor activity (Fig 4.2D) showed a significant main effect of 
spironolactone dose (F(2,40)=16.42, p<0.001), and a significant main effect of sex 
(F(1,40)=8.93, p=0.007), with significantly greater locomotor activity in the females. In 
both the females and males, there was a significant reduction in locomotor activity at the 
50 mg/kg spironolactone dose relative to vehicle (F(2,22) = 8.06, p = 0.002; F(2,18) = 
12.15, p < 0.001, respectively). This pattern of results suggests that the reductions in 
alcohol lever responses during these extinction sessions following treatment with the 50 
mg/kg dose may be related to a general inhibition of locomotor behavior.   
Experiment 3: Effect of spironolactone on maintenance of sucrose self-
administration  
The baseline sucrose lever responses (mean and S.E.M. of the two days prior to 
the initiation of spironolactone testing) was as follows: females 36.4 ± 8.02 and males 
80.4 ± 14.3. Males had significantly higher responses (t(12) = 2.69, p = 0.02), but there 
was no significant difference in sucrose intake (females: 6.70 ± 1.39 mL/kg; males: 9.13 
± 1.57 mL/kg). There was no difference in locomotor rate (females: 27.5 ± 1.16 beam 
breaks/min; males: 26.3 ± 1.65 beam breaks/min).  
 Sucrose self-administration in males and females is shown in Figure 4.3A. The 
two-way RM-ANOVA showed a significant main effect of sex (F(1,48) = 6.98 , p=0.02), 
with overall higher sucrose lever responses in the males (p<0.05). In the females, 
sucrose lever responses were significantly reduced following spironolactone 
(F(4,24)=5.43, p=0.003), but no dose was significantly different from vehicle - there was 
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a trend for a reduction at the 100 mg/kg dose (p=0.068). Spironolactone did not affect 
sucrose self-administration in the males. There was no main effect of spironolactone 
dose and no sex by spironolactone dose interaction. The corresponding sucrose intake 
is shown in Table 4.2. There was a significant main effect of spironolactone dose on 
sucrose intake (F(4,48) = 4.62, p = 0.003) with 100 mg/kg spironolactone significantly 
reducing sucrose intake. The significant main effect of spironolactone dose in sucrose 
intake by the two-way ANOVA, but not in sucrose lever responding may be a 
contribution of the overall reduced variability given that there is no sex difference in 
sucrose intake. In the females, sucrose intake was significantly reduced following the 
100 mg/kg spironolactone dose (F(4,24)=7.46, p<0.001). Spironolactone did not affect 
sucrose intake in the males. There was no main effect of sex, and no spironolactone 
dose by sex interactions on sucrose intake. There was no significant effect of 
spironolactone on inactive lever responses (Table 4.1). 
Given the lack of interaction between sex and spironolactone dose on total 
session sucrose lever responses, the pattern of alcohol lever responses across the 
session were examined in females and males separately. In the females (Fig 4.3B), 
there was a significant main effect of spironolactone dose (F(4,120) = 4.78, p = 0.006), 
time (F(5,120) = 41.03, p < 0.001), and a significant dose by time interaction (F(20,120) 
= 4.60, p < 0.001). Treatment with 100 mg/kg spironolactone reduced sucrose lever 
responses at 25 min and 30 min relative to vehicle (p<0.05). In the males (Fig 4.3C), 
there was a significant main effect of time (F(5,120) = 53.79, p < 0.001), and no effect of 
dose or dose by time interaction. 
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Analysis of spironolactone on locomotor rate showed a significant main effect of 
spironolactone dose (F(4,48)=7.05, p<0.001; Fig 4.4.D), with 100 mg/kg spironolactone 
significantly reducing locomotor rate. In the females, there was a significant reduction in 
locomotor rate at the 100 mg/kg spironolactone dose relative to vehicle (F(4,24)=3.88, 
p=0.01). In the males, there was also a significant reduction in locomotor rate, but no 
spironolactone dose was significantly different from vehicle (F(4,24)=3.38, p=0.03). 
There was no effect of sex, and no sex by dose interaction. These data suggest an 
overall suppression of motor activity at the highest spironolactone dose (100 mg/kg).  
Experiment 4: Effect of spironolactone on sucrose response persistence 
Analysis of sucrose lever responding during the probe extinction session is 
shown in Figure 4.4A. Two way RM-ANOVA revealed no main effect of sex or 
spironolactone dose, and no sex by spironolactone dose interaction. Spironolactone 
treatment did not affect inactive lever responses (Table 4.1). In the females (Fig 4.4B) 
and males (Fig 4.4C), cumulative sucrose lever responses across the probe extinction 
session showed a significant main effect of time (females: F(5,60) = 25.63, p < 0.001; 
males: (F(5,60) = 81.98, p < 0.001). There were no main effects of spironolactone dose, 
and no time by spironolactone dose interactions. Spironolactone treatment did not affect 
locomotor rate (Fig 4.4D). As there was no main effect of spironolactone dose, no main 
effect of sex, and no sex by dose interaction. Overall, spironolactone did not appear to 





This study demonstrates that pharmacological antagonism of the MR with 
spironolactone reduces alcohol self-administration in both male and female rats, albeit 
at a higher dose in female rats. In male, but not female rats this reduction in self-
administration was accompanied by a reduction in locomotor activity during the self-
administration session. Spironolactone also reduced the persistence of alcohol 
responding in the presence of alcohol-associated cues in female rats, but not male rats; 
however, at these spironolactone doses locomotor activity during the session was 
reduced in both sexes. Interestingly, the same spironolactone doses that were found to 
reduce alcohol self-administration did not affect sucrose self-administration or 
persistence of sucrose responding under probe extinction conditions, suggesting 
specificity to the alcohol reinforcer at those doses. Together these findings add to the 
growing body of literature suggesting that MR signaling may play a role in ongoing 
alcohol drinking. 
The results of Experiment 1 suggest that MR signaling is involved in self-
administration of a sweetened alcohol reinforcer in female rats, while in male rats this 
relationship is less clear due to the concomitant reduction in locomotor activity during 
the session. Additionally, females were less sensitive to the effects of spironolactone 
than males, showing a reduction in alcohol self-administration at 50 mg/kg as compared 
to 25 mg/kg in males. This contradicts our original hypothesis that female rats would be 
more sensitive to MR antagonism and could be due to the influence of gonadal 
hormones such as estrogen which play a complex modulatory role in both aldosterone 
and corticosterone signaling, both acutely and as part of the estrous cycle (Xue et al., 
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2013, Bangasser and Valentino, 2014, Minni et al., 2014). In humans, spironolactone 
can cause hypotension when combined with alcohol (Pfizer, 2008), and this may 
contribute to the reduction in locomotor activity observed in the male rats. This possible 
interaction is supported by the finding that the spironolactone-induced reduction in 
alcohol self-administration emerges late in the self-administration session after alcohol 
has been consumed. Interestingly, female rats show reduced alcohol self-administration 
without concomitant reduction in locomotor activity, which may be due to reduced 
effects of spironolactone on blood pressure in females, as suggested by one study 
(Michaelis et al., 2012). Together, this pattern of results could suggest potentiated 
sensitivity to the motor suppressant effects of spironolactone in the presence of alcohol 
and that females may be less sensitive to this interaction. While we did not directly 
assess any interactions between spironolactone and alcohol, it is also possible that the 
reduction in locomotor activity seen in male rats is due to spironolactone potentiating 
alcohol-induced ataxia. 
In the sucrose self-administration group, the increased spironolactone dose (100 
mg/kg) resulted in a significant decrease in sucrose intake (ml/kg) in the females only, 
while there was an overall reduction in sucrose lever responses and a trend for a 
reduction at 100 mg/kg. This could be related to the increased variance in lever 
responses at this dose, difference between lever responses and reinforcers delivered 
(i.e. lever responses during reinforcer delivery), or variance in animal weight that was 
corrected by examining intake rather than responding. These differences may also 
arise, in part, due to the low sample size (n=7) which is a limitation of this experiment. 
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In the present work, probe extinction sessions were used to examine the 
persistence of responding in the absence of the primary reinforcer. Interestingly, in both 
the alcohol self-administration trained and sucrose self-administration trained rats, no 
sex differences were observed under these conditions. This is important given that 
males in both self-administration groups had greater lever responses than the females 
during self-administration. Therefore, the males had a greater conditioning history than 
females (i.e., greater number of pairings with the cues associated with alcohol/sucrose 
delivery), which would be predicted to result in greater persistence of responding or 
greater resistance to extinction in the presence of the cues than the females (Jimenez-
Gomez and Shahan, 2007, Nevin, 2012). As such, the lack of a sex difference in 
responding under these extinction conditions suggests that for the males this richer 
conditioning history did not result in greater response persistence or greater resistance 
to extinction than the females, which is interesting. This result could suggest that the 
males were more sensitive to the change in the reinforcement conditions. Consistent 
with this suggestion, we have previously shown that male and female Long Evans rats 
trained under self-administration conditions similar to those used here have similar 
breakpoints under progressive ratio conditions, even though males have greater alcohol 
lever response during self-administration training (Randall et al., 2017).  
The results of Experiment 2 show that spironolactone (50 mg/kg) reduced the 
persistence of responding in female, but not male rats. However, this dose resulted in 
reduced locomotor activity in both sexes, making it difficult to definitively conclude 
whether MR is implicated in persistence of alcohol responding as measured under 
these probe extinction tests. Additionally, the lack of effect of spironolactone on alcohol 
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lever responding in the males is an example where the reduction in locomotor activity 
was not accompanied by a reduction in alcohol lever responses, and where this 
reduction in locomotor activity occurs in the absence of alcohol consumption. 
Interestingly, Experiment 4 showed that spironolactone had no effect on the persistence 
of sucrose responding under the same extinction conditions in male or female rats 
trained to self-administer sucrose. One interpretation of the locomotor data is that 
having a history of alcohol self-administration promoted a neuroadaptation that 
increased sensitivity to the motor suppressant effects of spironolactone. While rats with 
a history of alcohol self-administration as in the present work are generally not 
considered alcohol dependent and do not exhibit somatic signs of withdrawal, it has 
been shown that daily intake of at least 1.2 g/kg alcohol over six months is sufficient to 
increase serum aldosterone in male rhesus macaques (Aoun et al., 2018). This 
suggests potential for an interaction between MR and alcohol drinking that long-term 
alcohol self-administration history may be sufficient to induce. As such, future studies 
should be conducted to examine the importance of alcohol history in the effects of 
spironolactone on alcohol self-administration and persistence of alcohol responding.  
The present findings are in contrast to two previous studies which reported no 
effect of spironolactone on alcohol consumption or preference in rats and mice under 
home cage drinking conditions (Koenig and Olive, 2004, O'Callaghan et al., 2005). 
However, there are some key methodological differences that may have contributed to 
the different outcomes. Koenig et al. (2004) tested MR antagonism in male Long-Evans 
rats in a limited-access two-bottle choice model of homecage drinking that incorporated 
23 hours of water deprivation in between 1 hour sessions of drinking 10% (v/v) alcohol 
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and water. Given that MR and its ligand aldosterone are important in regulating fluid 
balance, it is possible that the stress of water deprivation dysregulated the MR system, 
and thus masked the effects of spironolactone on alcohol drinking (Gomori et al., 1960, 
Tang et al., 2011, Ali et al., 2012). The present studies were conducted under ad-libitum 
fluid access. Additionally, in that study spironolactone was administered immediately 
prior to the 1 hour drinking session, whereas in the present study a 30 minute 
pretreatment time was used. This may be important because while spironolactone itself 
is an MR antagonist with a half-life under 2 hours, it also produces two long-acting MR 
antagonist active metabolites, canrenone and 7-thiomethyl-spironolactone with half-lives 
of 13.8 and 16.5 hours respectively (Kolkhof and Barfacker, 2017), which may be 
important for the reductions in alcohol self-administration observed in the present work. 
The O’Callaghan et al. (2005) study was conducted in male and female C57/BL10 mice 
with 24 hour free-access to 8% (v/v) alcohol and water. Spironolactone (50 mg/kg) was 
administered daily over 3 weeks and alcohol consumption was measured 3 times a 
week. One major difference between this study and the present work was the timescale 
over which alcohol drinking was measured, as shown here, spironolactone can reduce 
alcohol self-administration in a 30 minute session. An additional consideration of both 
studies is the length of alcohol history that the animals have prior to spironolactone 
testing (15 weeks in the present study versus 3 and 4 weeks, respectively in these two 
cited studies), as this long-term alcohol history may be important for the effects of 
spironolactone. 
An important consideration for the present findings is the potential off-target 
effects of spironolactone. While spironolactone is the MR antagonist most frequently 
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used in the literature (Zhou et al., 2010, Zhou et al., 2011, Nasca et al., 2015), in 
addition to the MR (Ki = 2.32 nM) spironolactone is active at the glucocorticoid receptor 
(Ki = 32.6 nM), androgen receptor (Ki = 39.4 nM), progesterone receptor (Ki = 400 nM), 
and estrogen receptor (Ki > 1100 nM) (Bell et al., 2007). Therefore, while the 
spironolactone doses used in this study are within the range used in the literature (with 
the exception of 100 mg/kg), we cannot definitively conclude the contribution of these 
off target effects to the observed reductions alcohol self-administration and locomotor 
behavior. Future studies may benefit from testing newer MR antagonists such as 
eplerenone, that exhibit greater selectivity for the MR and greater safety profile 
(spironolactone carries an FDA black box warning for tumorigenicity) (de Gasparo et al., 
1987, Struthers et al., 2008), to clarify the role of MR in alcohol self-administration. 
Another interesting consideration is whether aldosterone and/or corticosterone mediates 
MR’s role in alcohol self-administration, as MR can bind both (Fuller et al., 2000). 
Metyrapone, which blocks synthesis of both corticosterone and aldosterone (Tucci et 
al., 1967, Gomez-Sanchez et al., 1997), can reduce alcohol preference and intake in 
high alcohol preferring male Wistar rats, and this effect is reversed by exogenous 
administration of corticosterone (Fahlke et al., 1994b). However corticosterone is a 
precursor for aldosterone (Ikeda et al., 2012), so an additional study using an 
aldosterone synthesis inhibitor such as FAD286 could clarify this point. 
The results from the present work show a functional role for the MR in alcohol 
self-administration. Future experiments will be important to clarify the role of MR 
signaling in alcohol drinking-related behaviors (i.e. examining the effects of MR 
antagonism on alcohol-seeking and self-administration following abstinence or 
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extinction, under progressive ratio schedules of reinforcement, or compulsive drinking of 
quinine adulterated alcohol).  Additionally, interesting differences observed in response 
to MR antagonism in males and females merit further investigation and highlight the 
importance of studying both male and female subjects. Altogether, these findings 
suggest that the MR-aldosterone system poses an exciting and novel avenue to study in 
relation to alcohol reinforcement processes contributing to alcohol consumption and 
neuroadaptations that may accompany alcohol drinking and dependence as a potential 
target for novel therapeutics to treat AUDs. 
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Figure 4.1 – Spironolactone reduces alcohol self-administration in male and female rats. 
 
 (A) Effects of spironolactone on alcohol self-administration. Mean (± S.E.M.) alcohol 
lever responses for female (n = 12) and male (n = 10) rats treated with spironolactone. 
(B, C) Cumulative alcohol lever responses across the session in females and males, 
respectively. (D) Locomotor activity (beam breaks/min) during the self-administration 
session in males and females. Spironolactone reduced alcohol lever responses in male 
and female rats, and decreased locomotor rate in male, but not female, rats. * - p < 0.05 
versus female vehicle, † - p < 0.05 versus male vehicle.  
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Figure 4.2 – Spironolactone reduces alcohol response persistence in female, but not 
male rats. 
 
 (A) Effects of spironolactone on alcohol response persistence (under “probe extinction” 
conditions). Mean (± S.E.M.) alcohol lever responses for male and female rats treated 
with spironolactone. (B, C) Cumulative alcohol lever responses across the session in 
females and males, respectively. (D) Locomotor activity (beam breaks/min) during the 
probe-extinction session in males and females. Spironolactone reduced alcohol 
response persistence in female, but not male rats, and decreased locomotor rate in both 
male and female rats. * - p < 0.05 versus female vehicle, † - p < 0.05 versus male 
vehicle.  



















































































































































































































































































































































































































































Figure 4.3 – High dose spironolactone reduces sucrose self-administration in female 
rats. 
 
 (A) Effects of spironolactone on sucrose self-administration. Mean (± S.E.M.)  sucrose 
lever responses for female (n = 7) and male (n = 7) rats treated with spironolactone. (B, 
C) Cumulative sucrose lever responses across the session in females and males, 
respectively. (D) Locomotor activity (beam breaks/min) during the self-administration 
session in males and females. Spironolactone reduced sucrose self-administration 
across the session in female, but not male rats, and decreased locomotor rate in both 
male and female rats. * - p < 0.05 versus female vehicle, † - p < 0.05 versus male 
vehicle.  
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Figure 4.4 – Spironolactone has no effect on sucrose response persistence. 
 
 (A) Effects of spironolactone on sucrose response persistence (under “probe extinction” 
conditions). Mean (± S.E.M.) sucrose lever responses for male and female rats treated 
with spironolactone. (B, C) Cumulative sucrose lever responses across the session in 
females and males, respectively. (D) Locomotor activity (beam breaks/min) during the 
probe extinction session in males and females. Spironolactone had no effect on sucrose 
response persistence or locomotor activity


















































































































































































































































































































































































































































Table 4.1 – Inactive lever responses for all experiments. 
  
Table 1. 
Inactive lever responses for all experiments.
Spironolactone Dose (mg/kg)
Males 0 10 25 50 100
Alcohol Self-Admin. 1.00 ± 0.36 0.25 ± 0.25 0.50 ± 0.29 0.58 ± 0.50 --
Alcohol Probe Ext. 1.20 ± 0.59 -- 0.60 ± 0.34 0.30 ± 0.30 --
Sucrose Self-Admin. 0.00 ± 0.00 1.00 ± 0.38 1.71 ± 0.89 2.57 ± 2.57 0.00 ± 0.0
Sucrose Probe Ext. 1.57 ± 0.92 -- 0.43 ± 0.20 0.57 ± 0.30 --
Females 0 10 25 50 100
Alcohol Self-Admin. 1.42 ± 0.43 1.58 ± 0.45 1.00 ± 0.35 0.67 ± 0.19 --
Alcohol Probe Ext. 1.00 ± 0.34 -- 1.00 ± 0.39 0.42 ± 0.15 --
Sucrose Self-Admin. 1.43 ± 0.61 0.86 ± 0.55 1.29 ± 0.42 0.71 ± 0.42 0.00 ± 0.0







Table 4.2 – Alcohol and sucrose intake for Experiments 1 and 3. 
 
Table 2. 
Alcohol and sucrose intake for Experiments 1 and 3.
Spironolactone Dose (mg/kg)
Males 0 10 25 50 100
Alcohol SA (g/kg) 0.84 ± 0.09 0.84 ± 0.09 0.50 ± 0.08* 0.59 ± 0.09 --
Sucrose SA (mL/kg) 7.00 ± 1.56 6.98 ± 0.88 6.70 ± 1.81 7.93 ± 1.53 5.72 ± 1.07
Females 0 10 25 50 100
Alcohol SA (g/kg) 0.95 ± 0.12 1.04 ± 0.11 0.70 ± 0.13 0.54 ± 0.09* --
Sucrose SA (mL/kg) 7.58 ± 1.57 7.83 ± 1.25 10.40 ± 1.82 7.65 ± 1.22 1.70 ± 1.34*





CHAPTER 5 : CENTRAL AMYGDALA MINERALOCORTICOID RECEPTORS 
MODULATE ALCOHOL SELF-ADMINISTRATION 
 
INTRODUCTION 
Our previous findings supplement emerging evidence for the functional role of 
mineralocorticoid receptors (MR) in modulating alcohol self-administration (Makhijani et 
al., 2018). While it has long been known that glucocorticoid receptors (GR) and 
corticosterone influence and mediate alcohol self-administration and alcohol 
dependence (Fahlke et al., 1994a, Fahlke et al., 1994b, Fahlke et al., 1995, Koenig and 
Olive, 2004, Vendruscolo et al., 2012), one study provided convincing evidence for the 
relevance of aldosterone and the MR across multi-species (Aoun et al., 2018). Male 
rhesus macaques, Wistar rats, and humans with significant alcohol experience showed 
inverse correlations between central amygdala (CeA) MR expression and measures of 
alcohol drinking (Aoun et al., 2018). Our previous study (Chapter 3) built upon these 
findings by demonstrating that the MR antagonist spironolactone reduced alcohol self-
administration and response persistence in male and female rats (Makhijani et al., 
2018). The purpose of the present study was to add to these previous findings by first 
assessing if MR antagonism may mediate reductions in alcohol self-administration by 
impairment of MR-mediated corticosterone negative feedback (Atkinson et al., 2008). 
Second, to identify the brain-regional locus of MR action on alcohol self-administration, 
the selective MR antagonist eplerenone was infused into the dorsal hippocampus (dHC) 




administration, CeA MR was knocked down by antisense oligonucleotide (ASO) infusion 
prior to alcohol self-administration. 
 
METHODS AND MATERIALS 
Animals 
96 Long-Evans rats (60 female and 36 male; Envigo-Harlan, Indianapolis, IN) 
arrived at 7 weeks old and were housed under a 12 hour light/dark cycle (7:00 am/pm). 
In Experiments 1 and 2 rats were single housed throughout the study, in Experiments 3 
and 4 rats were double housed until surgery and then single housed through the rest of 
the study. Prior to all experiments rats were handled for 1-2 minutes for 5 days. All 
experiments were conducted during the light cycle. Animals were under the care of the 
UNC-Chapel Hill Division of Comparative Medicine veterinary staff. All procedures were 
carried out in accordance with the NIH Guide for Care and Use of Laboratory Animals, 
and institutional guidelines. All protocols were approved by the UNC Institutional Animal 
Care and Use Committee (IACUC). UNC-Chapel Hill is accredited by the Association for 
Assessment and Accreditation of Laboratory Animal Care (AAALAC).    
Behavioral and surgical protocols 
Self-administration apparatus 
Self-administration was conducted in operant chambers (Med Associates, 
Georgia, VT) within sound-attenuating cabinets which contained an exhaust fan to 
provide ventilation and mask external noise. Chambers were equipped with two 
retractable levers on opposite sides of the chamber (left and right), and a cue light was 




lever, a cue light (directly above the lever) and a stimulus tone were presented for the 
duration of the alcohol reinforcer delivery (0.1mL of solution into a well on the left side of 
the chamber across 1.66s via a syringe pump). Responding during reinforcer delivery 
and on the right (inactive) lever was recorded, but had no programmed consequences. 
Chambers were also equipped with 4 parallel infrared beams across the bar floor to 
measure general locomotor activity during the session. The number of beam breaks for 
the entire session was totaled and divided by the session length (30 min) to calculate 
the locomotor rate (beam breaks/min). 
Alcohol self-administration 
Rats were trained to self-administer a 20% (v/v) alcohol solution (20A) on a fixed 
ratio 2 (FR2) reinforcement schedule across 30 minute sessions, five days a week (M-
F) via sucrose fading as described in (Randall et al., 2017). Sucrose fading began with 
self-administration of 2% alcohol/10% (w/v) sucrose (2A/10S), then 5A/10S, 10A/10S, 
10A/5S, 15A/5S, 15A/2S, and 20A/2S on subsequent sessions, ending with 20A which 
remained the reinforcer through the remainder of the study. Rats in Experiments 1 and 
2 had approximately 8 weeks of self-administration training and were used in an 
unrelated study (i.e., involved exposure to a single stressor and self-administration was 
unaltered (unpublished)) two months prior to the initiation of this study. 
Surgical procedures and microinjections 
For Experiment 2, rats were anesthetized with isofluroane (3-5% in 98% oxygen; 
Baxter, Deerfield, IL) and received implantation of 22-gauge guide cannulae (P1 
Technologies, Roanoke, VA) aimed to terminate 2 mm above the central nucleus of the 




dorsal hippocampus (n=14; bilateral coordinates: AP -2.5, ML ±1.5 mm, DV −1.4 mm). 
For Experiments 3 and 4, anesthetized rats received implantation of 26-gauge guide 
cannulae (P1 Technologies) aimed to terminate 2 mm above the CeA (Experiment 3 
n=12 males, Experiment 4 n = 24/sex). Coordinates were based on (Paxinos and 
Watson, 2013).  
Site-specific microinjections were delivered by a microinfusion pump (Harvard 
Apparatus, Holliston, MA) using 5.0 μl Hamilton syringes connected to 28 (Experiment 
2) or 33-gauge (Experiments 3 & 4) injectors (P1 Technologies). 
Bilateral microinjections were delivered through injectors extending 2 mm below 
the guide cannulae at a volume of 0.5 μl/side across 1 minute (eplerenone) or 5 minutes 
(ASO). The injector(s) remained in place for an additional 2 minutes (eplerenone) or 5 
minutes (ASO) after the infusion to allow for diffusion. Additional microinjection 
procedures are described in detail in (Besheer et al., 2012a, Jaramillo et al., 2018b). 
At the end of Experiments 2, 3, and 4 brain tissue was stained with cresyl violet 
to verify cannulae placement. Only data from rats with both cannulae/injector tracts 
determined to be in the target brain regions were used in the analyses. In Experiment 2, 
2 rats (1 in the dHC group, 1 in the CeA group) had one or both cannula(e) outside the 
target region (depicted as open triangles on Fig 5.2A and Fig. 5.3A respectively), and 
were considered misses and excluded from analyses. There were no misses in 
Experiment 3, and verifications for Experiment 4 have not yet been completed, but 





Tissue collection and molecular analyses 
Blood collection and corticosterone EIA 
Tail blood was collected immediately after alcohol self-administration on the 
spironolactone test day in Experiment 1 for assessment of plasma corticosterone. Blood 
was collected into heparinized tubes and immediately centrifuged at 4°C for 5 minutes 
at 2000 rcf. Plasma supernatant was then collected and stored at -80°C until analysis. 5 
µL plasma samples were then analyzed in duplicate using a commercially available 
colorimetric EIA kit (ArborAssays, Ann Arbor, MI) according to the manufacturer’s 
instructions. 
Tissue collection and preparation 
Rats were sacrificed by rapid decapitation under deep isoflurane anesthesia 
(Baxter, Deerfield, IL). Brains were flash-frozen in isopentane chilled on dry ice and 
stored at -80°C until tissue punching. Frozen brains were sectioned coronally by 
cryostat and bilateral 1.2 mm diameter punches were taken of central amygdala (CeA; 
AP -1.8 to -2.8). One tissue punch was processed for western blotting and one was 
processed for qPCR as follows. Western blot samples were homogenized by sonication 
(Branson SLPe; Emerson Industrial, St. Louis, MO) in homogenization buffer (10mM 
Tris-HCl, 1% (w/v) SDS, 1% (v/v) HALT protease inhibitor, 5mM EDTA). Protein 
concentration from lysates were determined using a BCA assay (Thermo-Fisher; 
Rockford, IL). RNA was extracted from qPCR samples using the RNeasy Mini Kit 
(Qiagen, Venlo, Netherlands) according to manufacturer’s instructions and eluted in 




and purity for each sample were determined using a spectrophometer (Nanodrop 2000, 
Thermo-Fisher).  
Western blotting 
10 µg of protein lysate was mixed with LDS sample buffer (Life Technologies, 
Carlsbad, CA), reducing agent (Life Technologies) and sterile water and denatured at 
70°C for 5 minutes. Protein samples were then separated using an 18-well 4-20% 
Criterion TGX gel (BioRad, Herculues, CA) in a BioRad western blot apparatus. All 
samples were run on one gel. After electrophoresis, proteins were transferred to PVDF 
membrane using the iBlot system (Thermo-Fisher). Blots were blocked in 3% non-fat 
dry milk (Nestle, Solon, OH) in 0.1% PBST (0.1% Tween-20 in PBS) prior to incubation 
with antibodies against the mineralocorticoid receptor (1:400, Lot #’s: 3237523, 
3083584; MABS496, EMD Millipore, Temecula, CA) and the loading control actin 
(1:5000, Lot#: 3086655; MAB1501, EMD Millipore). After incubation with primary 
antibody, blots were washed and incubated with an HRP anti-mouse secondary 
antibody (1:10,000, Lot#: X0328; Vector Labs, Burlingame, CA). Blots were then 
developed in chemiluminescent substrate (ECL-Prime, GE Healthcare, Little Chalfont, 
UK) and imaged using an Imagequant LAS 4000 (GE Healthcare). Band optical density 
measurements were collected and analyzed using ImageQuantTL software (GE 
Healthcare).  
Reverse transcription and qPCR 
 RNA was reverse transcribed into circular DNA (cDNA) using the QuantiNova 
Reverse Transcription Kit (Qiagen, Venlo, Netherlands) according to manufacturer’s 




experiments. All qPCR reactions were run with a QuantStudio3 real-time PCR machine 
(ThermoFisher) was used for all experiments. Using a 96-well plate, each sample was 
run in triplicate using 10uL total volume per well with the following components: 
PowerUp Syber green dye (ThermoFisher), forward and reverse primers (Eton 
Biosciences Inc., NC, USA), and cDNA template. The PCR was run with an initial 
activation for 10 mins at 95°C, followed by 40 cycles of the following: denaturation (95°C 
for 15s), annealing (60°C for 30s), and extension (72°C for 45s). Melt curves were 
obtained for all experiments to verify synthesis of a single amplicon. Primers used were 
mineralocorticoid receptor (NR3C2): F: 5’- GAT CCA GGT CGT GAA GTG GG-3’, R: 5’-
AGA GGA GTT GGC TGT TCG TG-3’; β-actin (ACTB) (loading control): F: 5’-CTA CAA 
TGA GCT GCG TGT GGC-3’, R: 5’-CAG GTC CAG ACG CAG GAT GGC-3’.  
Oligonucleotides, drugs, and reagents 
Oligonucleotide sequences were sourced from previous literature (Sakai et al., 
2000, Johnson and Greenwood-Van Meerveld, 2015) which had functionally validated 
MR knockdown using these sequences. 18-mer phosphorothiate oligonucleotide 
sequences were: MR antisense (ASO): 5′-TTC CAT GTC TAG GCC TTC-3′, MR 
scrambled (SCR): 5′-CAT TTT GAA GGT TCC GGT-3′. Oligonucleotides were 
synthesized by Eurofins Genomics (Louisville, KY) and supplied as dried, salt-free 
stocks that were suspended in artificial cerebrospinal fluid (ACSF; Tocris, Bristol, UK) 
for microinjection. 
Spironolactone (Lot #’s MKCD7812, MKCG6303; Sigma-Aldrich, St. Louis, MO) and 
eplerenone (Lot #’s: 1B/209648, 1B/205653, 1B/210844; Sigma-Aldrich, St. Louis, MO) 




and microinjection. Alcohol (95% (v/v), Pharmaco-AAPER, Shelbyville, KY) and sucrose 
(Great Value, Bentonville, AR) were diluted with tap water for all self-administration 
sessions. 
Experimental procedures 
For all studies, experimenters were blind to animal treatment conditions. 
Experiment 1: Role of inhibited glucocorticoid negative feedback in spironolactone 
suppression of alcohol self-administration 
The purpose of this experiment was 1) to quantify the effect of mineralocorticoid 
receptor antagonism by spironolactone on glucocorticoid negative feedback, as 
mineralocorticoid receptor signaling is important in maintaining basal corticosterone 
levels (Joels and de Kloet, 2017), and 2) to determine if changes in corticosterone may 
underlie spironolactone-induced decreases in alcohol self-administration. 
Following establishment of stable alcohol self-administration (approximately 40 
sessions), female rats (n = 18/group) received spironolactone (0, 50 mg/kg; IP; 1 mL/kg) 
30 minutes prior to an alcohol self-administration session. We have previously 
demonstrated that this dose of spironolactone reduces alcohol self-administration in 
female rats (Makhijani et al., 2018). Immediately after self-administration, blood was 
collected for analysis of plasma corticosterone as described above. Testing was 







Experiment 2: Effect of intra-dorsal hippocampus and intra-central amygdala 
eplerenone on alcohol self-administration 
The purpose of this study was to determine the brain regional locus of MR 
antagonism-induced reduction of alcohol self-administration by using site specific 
microinjection of the more selective MR antagonist eplerenone. 
Following Experiment 1, female rats were implanted with bilateral cannulae 
aimed at the dHC (n = 14) or CeA (n = 18). To determine the role of CeA and dHC MR 
in alcohol self-administration, rats received a bilateral infusion of eplerenone (0, 100, 
1000, 5000 ng/0.5 μL/side) immediately before an alcohol self-administration session. A 
within-subject design was used such that each rat received each treatment in a random 
order and doses were equally represented on each test day. Test days were on 
Tuesdays and Thursdays with standard self-administration sessions on Monday, 
Wednesday, and Friday. Alcohol lever responses had to be at least 80% of baseline 
(average responding in the 2 sessions preceding the study) self-administration on the 
days preceding a test day in order for a rat to be tested, all rats met this criterion. 
Experiment 3: Confirmation of gene knockdown using ASO infusion 
The purpose of this experiment was to confirm that ASO infusion would knock 
down MR expression, and to determine the longevity of gene knockdown. 
Naïve male rats were implanted with bilateral cannulae aimed at the CeA and 
allowed 1 week for recovery. Rats (n = 3/group) were then infused with either ASO or 
SCR and sacrificed by rapid decapitation under deep isoflurane (Baxter) anesthesia 
either 2 or 7 days later. Brains were collected for confirmation of gene and protein 




Experiment 4: Effect of central amygdala mineralocorticoid receptor knockdown on 
alcohol self-administration 
The purpose of this experiment was to assess the role of CeA mineralocorticoid 
receptor tone in moderating alcohol self-administration. 
Following establishment of stable alcohol self-administration (15 sessions at 
maintenance concentration), rats (n = 24/sex) were implanted with bilateral cannulae 
aimed at the CeA and allowed 1 week for recovery and then returned to alcohol self-
administration. After 5 alcohol self-administration sessions, rats received a bilateral 
infusion of ASO (n = 11 males, 12 females) or SCR (n = 9 males, 12 females) 3 μg/0.5 
μL/side. 24 hours after the infusion, alcohol self-administration continued for two weeks 
(10 sessions). Male and female rats were run in separate cohorts and are represented 
and analyzed separately. 
Data analysis  
Alcohol self-administration 
In Experiment 1, alcohol lever responses, inactive lever responses, alcohol 
intake, and locomotor rate were compared by student’s t-test.  
In Experiment 2, alcohol lever responses, inactive lever responses, alcohol 
intake, and locomotor rate were compared by one-way RM-ANOVA with eplerenone 
dose as the within-subjects repeated measure. Cumulative alcohol lever responses are 
examined by two-way RM-ANOVA with eplerenone dose and time as within-subjects 
repeated measures. 
In Experiment 4, baseline self-administration measures are taken from the 5 




lever responses, inactive lever responses, and locomotor rate were compared by two-
way RM-ANOVA with oligonucleotide as the between-subjects measure, and session as 
the within-subjects repeated measure. Alcohol consumption is represented as an 
average across all post-infusion self-administration sessions and compared by two-way 
RM-ANOA with oligonucleotide as the between-subjects measure, and pre/post-infusion 
as the within-subjects measure. 
Western blotting 
Mineralocorticoid receptor band densities were normalized to actin band density 
to account for loading variation, normalized protein levels in the ASO group were then 
expressed as a percent of the average normalized protein level for the pooled SCR 
groups (i.e. 2 day and 7 day as the SCR infusion was presumably inert). Due to unequal 
standard deviations between groups as detected by Brown-Forsythe test, protein 
expression between SCR and ASO groups were compared by Welch’s ANOVA and 
Dunnet’s T3 multiple comparisons test. 
qPCR 
 The threshold cycle (CT) of each target product was determined by software and 
the ΔΔCT method was used to calculate the percent change relative to control (CON). 
The ΔΔCT of NR3C2 (mineralocorticoid receptor) was then normalized to the ΔΔCT of 
ACTB (beta actin) and all values were expressed as a percentage of the pooled (2 and 
7 days) SCR group’s normalized NR3C2 levels. mRNA levels were compared by one-
way ANOVA, given the unequal standard deviation between the SCR and 2 day ASO 
groups (confirmed by F-Test), a follow up Welch’s t-test was conducted to confirm the 





For all experiments using a between-subjects design, groups were 
counterbalanced by alcohol self-administration history (average session alcohol lever 
responses and alcohol intake) across the past week (5 sessions) of self-administration. 
Plasma corticosterone following alcohol self-administration was compared by 
student’s t-test and relationships between plasma corticosterone and alcohol self-
administration were evaluated by Spearman’s rank order correlation. 
RESULTS 
Experiment 1: Role of inhibited glucocorticoid negative feedback in 
spironolactone suppression of alcohol self-administration. 
The purpose of this experiment was to quantify the effect of MR antagonism on 
plasma corticosterone levels following alcohol self-administration and determine if 
increases in plasma corticosterone were related to reductions in alcohol self-
administration. Blood was not collected from one animal in the spironolactone group 
and this animal was excluded from the analyses in Figs 5.1C&D. 
The MR antagonist spironolactone reduces alcohol self-administration in female rats, 
and increases plasma corticosterone following self-administration. 
Following treatment with the MR antagonist spironolactone, female rats showed 
significant reductions in alcohol self-administration (Fig 5.1A; t(34) = 2.28, p = 0.029), 
and alcohol intake (Table 5.1; t(34) = 2.08, p = 0.045). There were no effects on 
locomotor rate (Fig 5.1B) or inactive lever responses (Table 5.1). Plasma corticosterone 
was also significantly elevated in the spironolactone treated animals (Fig 5.1C; t(33) = 




Elevated plasma corticosterone in spironolactone treated animals correlates with 
reduced alcohol self-administration. 
In order to determine if reductions in self-administration were related to increased 
plasma corticosterone, the relationship between the two measures was examined by 
Spearman’s rank order correlation given the non-linear nature of the relationship 
between corticosterone and behavior (Calabrese, 2008)(Fig 5.1D). There was a 
significant correlation between alcohol intake and plasma corticosterone in the 
spironolactone treated group (R2 = 0.265, p = 0.037), but not the control group (r = -
0.090, p = 0.723). This indicates that the effects of spironolactone on alcohol self-
administration may be mediated by stimulation of the HPA axis through inhibition of 
glucocorticoid negative feedback. 
Experiment 2: Effect of intra-dHC and intra-CeA eplerenone on alcohol self-
administration 
In order to determine the functional role of MR in alcohol self-administration, the 
MR antagonist eplerenone was infused into the dHC and CeA. 2 rats in the dHC group, 
and 6 rats in the CeA group were excluded from the study due to lost cannula implants 
during the experiment.  
Intra-CeA but not intra-dHC eplerenone reduces alcohol self-administration 
Intra-dHC eplerenone had no effect on total alcohol lever responses, cumulative 
alcohol lever responses, inactive lever responses, locomotor rate (Fig 5.2), or alcohol 
intake (Table 5.2). In contrast, intra-CeA eplerenone significantly reduced alcohol self-
administration as confirmed by a significant main effect of drug on total alcohol lever 




= 7.90, p < 0.001). Tukey’s post-hoc test revealed significantly reduced alcohol lever 
responses at the 5000 ng dose compared to vehicle, and significantly reduced alcohol 
intake at both the 1000 and 5000 ng doses. Analysis of cumulative alcohol lever 
responses (Fig 5.3C) found significant main effects of drug (F(3, 27) = 5.37, p = 0.005), 
time (F(5, 45) = 59.5, p < 0.001), and a drug by time interaction (F(15, 135) = 5.40, p < 
0.001). Post-hoc analysis showed that the 5000 ng dose significantly reduced 
responding relative to vehicle from minute 10 onwards and the 1000 ng dose 
significantly reduced responding from minute 15 onwards. There was no effect of 
eplerenone on inactive lever responses (Fig 5.3D) or locomotor rate (Fig 5.3E). This 
suggests that CeA and not dHC MR regulate alcohol self-administration. 
Experiment 3: Confirmation of MR knockdown using ASO infusion 
The purpose of this experiment was to confirm that ASO infusion would knock 
down MR expression, and to determine whether gene knockdown would persist for 7 
days. 
CeA MR protein was quantified by western blot (Fig 5.4A). Welch’s ANOVA 
showed a main effect of ASO treatment (Fig 5.5B; W(2, 4.16) = 74.88, p < 0.001) on 
CeA MR protein expression, with the ASO-2D group showing significantly reduced CeA 
MR protein relative to the SCR group. 
There was a trend for a significant effect of ASO treatment on CeA MR mRNA 
(Fig 5.5C; p = 0.101). Given unequal standard deviations between the ASO-2D and 
SCR control groups, Welch’s t-test was used to confirm the western blot findings and 





Experiment 4: Effect of central amygdala mineralocorticoid receptor knockdown 
on alcohol self-administration 
 The purpose of this experiment was to assess the functional role of CeA MR tone 
in alcohol self-administration. One male rat in the SCR group was excluded from the 
study due to a lost cannula implant during the experiment. 
 In male rats, there was a significant effect of time on alcohol lever responses (Fig 
5.5C; F(9, 162) = 3.30, p = 0.001) with increased responses later in the study, and no 
effects of ASO or ASO by session interaction. There were no effects of ASO, time, or 
ASO by time interaction on average alcohol intake (Fig 5.5D) or inactive lever 
responses (Fig 5.5E). There was a significant effect of time on locomotor rate (Fig 5.5F; 
F(9, 162) = 3.10, p = 0.002), and no effects of ASO or ASO by infusion interaction, 
indicating increased locomotor rate across the study. 
 The female cohort has not concluded testing, however preliminary results are 
detailed in Figure 5.6. There was a significant ASO by session interaction on alcohol 
lever responses (Fig 5.6C; F(1, 22) = 10.25, p =0.004), with no effects of ASO or 
session. Sidak’s post-hoc analysis showed alcohol responses in the ASO group were 
reduced versus SCR 1 day post-infusion. There were no significant effects of ASO, 
session, or ASO by session interaction on average alcohol intake (Fig 5.6D), inactive 
lever responses (Fig 5.6E), or locomotor rate (Fig 5.6F). These findings support those 







The results of this study provide further evidence for the functional role of MR in 
modulating alcohol consumption. First it was confirmed that systemic MR antagonism 
with spironolactone increases plasma corticosterone while reducing alcohol self-
administration in female rats, and that the reductions in self-administration correlate with 
increased plasma corticosterone. Next, local microinjections demonstrated that CeA but 
not dHC MR antagonism with the more selective MR antagonist eplerenone reduced 
alcohol self-administration in female rats. Finally, it was shown that ASO knockdown of 
CeA MR did not affect alcohol drinking in male rats, but transiently reduced alcohol self-
administration in female rats. Together, these data suggest that CeA MRs modulate 
alcohol self-administration and could pose an interesting target for pharmacological 
treatment of alcohol use disorders. 
 As MR regulate basal levels of the hormone corticosterone (Joels and de Kloet, 
2017) which is known to modulate alcohol self-administration (Fahlke et al., 1994a, 
Fahlke et al., 1994b) we hypothesized that the observed reduction in alcohol self-
administration following spironolactone pretreatment (Makhijani et al., 2018) was due to 
stimulation of the HPA axis by inhibition of glucocorticoid negative feedback (Atkinson et 
al., 2008). Indeed, systemic administration of spironolactone (50 mg/kg) increased 
plasma corticosterone similar to other MR antagonists (Ratka et al., 1989, Bitran et al., 
1998). Furthermore, there was significant correlation between reduced self-
administration and increased corticosterone, suggesting a relationship between these 
two effects. This relationship is similar to the purported mechanism of action for 




mechanism by which MR antagonists mediate anxiolytic effects (Bitran et al., 1998). In 
contrast, Experiment 2 also showed reduction in alcohol self-administration following 
intra-CeA infusion of the MR antagonist eplerenone, which is not known to impact 
corticosterone levels when injected systemically (Hlavacova and Jezova, 2008, 
Hlavacova et al., 2010). Therefore it is possible that increased corticosterone is 
immaterial to the observed reductions in self-administration; however, as we did not 
assess corticosterone levels following eplerenone infusion in this study we cannot 
definitively exclude the role of increased corticosterone. An alternative explanation is 
that the effects of MR antagonism on alcohol self-administration are mediated by 
different peripheral versus central mechanisms (i.e. corticosterone may mediate the 
effects of peripheral MR antagonism but not intra-CeA antagonism). While Experiment 1 
adds to our previous findings in elucidating a potential mechanism of action for the 
systemically administered MR antagonist modulation of alcohol self-administration, 
there remain several caveats such as the contribution of peripheral versus central MR 
effects (Jaisser and Farman, 2016), and off target spironolactone effects discussed in 
(Makhijani et al., 2018). 
 To address these questions, Experiment 2 utilized regional microinjections of the 
more selective MR antagonist eplerenone (de Gasparo et al., 1987). Infusion of 
eplerenone into the CeA dose-dependently decreased alcohol self-administration while 
dHC infusion had no effect on alcohol self-administration. This finding is in agreement 
with literature suggesting CeA MR are involved in alcohol drinking (Aoun et al., 2018), 
and dHC MR are involved in other behaviors including response to novelty, spatial 




et al., 2019). Interestingly, while MR is implicated in regulating memory (Ninomiya et al., 
2010, Zhou et al., 2010, McCann et al., 2019) there was no alteration in discrimination 
between the alcohol and inactive levers in any of our studies. In addition to identifying 
the brain locus of MR effects on drinking, this study increases confidence that MR 
antagonism alone mediates the reduction in alcohol self-administration as eplerenone 
has considerably less off-target effects than spironolactone, which is active at the 
glucocorticoid, androgen, progesterone receptor, and estrogen receptors in addition to 
the MR (de Gasparo et al., 1987). Future studies could examine if this increased 
receptor selectivity may reduce or eliminate the sex-differences in MR antagonist effects 
on locomotor rate during self-administration seen in Chapter 3. Furthermore, this study 
increases the translational relevance of these findings as eplerenone has a greater 
safety profile than spironolactone which has an FDA black box warning (Lainscak et al., 
2015). 
Surprisingly, the directionality of MR antagonism and pharmacological knockdown 
effects on alcohol self-administration differ from those described in Aoun et al., 2018. 
While Aoun et al. showed lower levels of MR expression and higher levels of 
aldosterone correlate with higher drinking behaviors across multiple species, here we 
demonstrate that antagonism and pharmacological knockdown of CeA MR reduces 
alcohol self-administration. This paradoxical disconnect between MR tone and 
pharmacological manipulation is not unique to these self-administration studies, there is 
a similar inverse relationship between MR expression and anxiety-like/fear behavior. 
Genomic MR knockdown reduces anxiety-like/fear behavior (Brinks et al., 2009, 




al., 2007, Rozeboom et al., 2007, Ter Horst et al., 2012); however, MR antagonists are 
shown to have anxiolytic effects (Bitran et al., 1998, Hlavacova and Jezova, 2008, 
Hlavacova et al., 2010, Lopez-Rubalcava et al., 2013). Possible explanations for this 
phenomenon include differences in intra-CeA distribution of MR expression versus 
antagonist effects, genomic versus non-genomic effects of MR, and the developmental 
role of MR. While the MR is known to be expressed widely throughout limbic brain 
systems (McEwen et al., 1968, Reul and de Kloet, 1985), little is known about its 
expression pattern within the CeA, a region with complex microcircuitry (Gilpin et al., 
2015). Differences in MR expression that impact alcohol drinking may be biased in 
localization towards GABAergic interneurons, projection neurons, or glutamatergic 
afferents, while the effect of an antagonist or ASO would presumably be uniform which 
may explain these conflicting findings. Alternatively, while the timing of MR antagonist 
effects on alcohol self-administration (within minutes) suggest that they are non-
genomically mediated (Karst et al., 2005, Khaksari et al., 2007), the effect of MR tone 
on alcohol drinking may be mediated, partially or in full, by genomic MR action as a 
ligand-dependent transcription factor (Fuller et al., 2000, Ruhs et al., 2017). Notably, the 
ASO knockdown utilized in these studies is transient and results in a similar effect to 
MR antagonism, while the knockdown studies finding opposite results to antagonism 
utilize genomic manipulation of MR (Cobden et al., 1988, Lai et al., 2007, Rozeboom et 
al., 2007, Brinks et al., 2009, Ter Horst et al., 2012). As MR plays an important 
developmental role in differentiation of cells, it is possible that the relationship between 
MR expression and alcohol drinking observed in Aoun et al. is due to downstream 




transient manipulations in MR signaling during adulthood.  Differences in the impact of 
MR expression and antagonism on alcohol self-administration could be further clarified 
by characterizing CeA MR expression patterns between animals with high and low MR 
expression, or by assessing alcohol self-administration in animals with genomically 
altered CeA MR expression. 
 To directly assess the impact of CeA MR tone on alcohol self-administration a 
validated ASO construct (Fig 5.4)(Sakai et al., 2000, Johnson and Greenwood-Van 
Meerveld, 2015) was infused into the CeA of male and female rats prior to alcohol self-
administration (Experiment 4). Surprisingly there was no effect of MR knockdown on 
alcohol self-administration in male rats, and a transient decrease in self-administration 
female rats. Possible explanations for the lack of effect in males include a lack of 
significant alcohol experience prior to ASO infusion or sex-differences in the functional 
role of CeA MR in alcohol self-administration. As discussed in our previous studies 
(Makhijani et al., 2018), while alcohol dependence is not necessary to observe the 
effects of MR antagonism and MR tone on alcohol drinking, the relationship between 
MR and drinking does not exist in non-dependent animals (Aoun et al., 2018). 
Therefore, the shorter alcohol self-administration history in Experiment 4 (4 weeks) as 
compared to Experiments 1 and 2 (8 weeks), and our previous study (15 weeks; 
Makhijani et al. 2018) may be relevant to our negative findings given lower average 
session alcohol intake in males (0.42 g/kg in males versus 0.82 g/kg in females). As our 
previous findings only report sex-differences in the effects of MR antagonism on 
locomotion during alcohol self-administration, and minor differences in dose-sensitivity 




on alcohol self-administration seen in Experiment 4. However, it is worth noting that we 
did not investigate the effect of intra-CeA eplerenone in male rats, and the study finding 
inverse correlations between MR expression and alcohol drinking used only male 
subjects (Aoun et al., 2018).  
 Interestingly, CeA MR knockdown resulted in transient reductions in alcohol self-
administration. The transient nature of the reduction suggests a compensatory 
mechanism, as we confirmed that MR protein is knocked down at least 2 days after 
ASO infusion (Fig 5.4). One possible mechanism is through dysregulation of 
corticosterone, as MR antagonism both increases plasma corticosterone and reduces 
alcohol self-administration (Fig. 5.1). Furthermore, animals with genomic alterations in 
MR expression do not show changes in basal corticosterone tone, indicating the 
presence of compensatory mechanisms for regulating corticosterone in the absence of 
normal MR function (Rozeboom et al., 2007). Future studies could validate this 
hypothesis by examining daily basal corticosterone levels following CeA MR 
knockdown. Additionally, MR knockdown and antagonism reduced alcohol self-
administration, conflicting with the previously reported inverse correlation between CeA 
MR expression and alcohol drinking (Aoun et al., 2018). This suggests that the inverse 
correlation may be mediated by other factors influenced by MR tone during 
development, or by genomic effects of MR that may not have been realized with this 
short-term knockdown. Future studies could expand upon this by utilizing either 
genomic MR knockdown to assay the developmental role of MR, or long-term 





 Together, these results confirm our previous findings that systemic MR 
antagonism reduces alcohol self-administration, proposes a potential mechanism of 
action involving increased plasma corticosterone, and demonstrates the functional role 
of CeA MR in alcohol self-administration utilizing the selective MR antagonist 
eplerenone and ASO knockdown. The effects of MR antagonism on alcohol self-
administration are particularly relevant as eplerenone is also currently used for 
treatment of hypertension and cardiovascular disease (Stewart Coats and Shewan, 
2015), which are exacerbated by and comorbid with alcohol use disorder (Gardner and 
Mouton, 2015). Future studies could further explore the clinical implications of this data 
by analyzing alcohol drinking patterns in patients prescribed eplerenone, or expand 
upon the molecular and circuit implications by probing the role of genomic and 
nongenomic MR signaling in alcohol self-administration, or by characterizing the 
localization of MR within CeA circuitry. Altogether, this study adds to the growing body 
of literature suggesting that MR plays a role in corticosteroid regulation of alcohol 







Figure 5.1 – Spironolactone reduces alcohol self-administration and increases plasma 
corticosterone in female rats. 
 
(A) Spironolactone (50 mg/kg) reduces alcohol self-administration in female rats (n = 
17/group). (B) Spironolactone has no effect on locomotor rate during the self-
administration session. (C) Spironolactone treated animals have significantly higher 
plasma corticosterone following self-administration. (D) Plasma corticosterone 
correlates with reduced alcohol self-administration in spironolactone treated animals (R2 

























































































































Figure 5.2 – Intra-dHC eplerenone does not affect alcohol self-administration. 
 
(A) Bilateral dHC injector placements. (B&C) Eplerenone does not reduce alcohol lever 
responses in female rats (n = 11). (D&E) Eplerenone has no effect on inactive lever 
responding or locomotor rate. 
  



















































































































































Figure 5.3 – Intra-CeA eplerenone dose dependently reduces alcohol self-
administration. 
 
(A) Bilateral CeA injector placements. (B) Eplerenone (5000 ng) reduces alcohol lever 
responding in female rats (n = 10). (C) Eplerenone reduces alcohol lever responses 
from minute 10 onward (5000 ng) and 15 minutes onward (1000 ng). (D&E) Eplerenone 
has no effect on inactive lever responding or locomotor rate. * - p < 0.05 eplerenone 
5000 ng versus 0 ng, $ - p < 0.05 eplerenone 1000 ng versus 0 ng. 
  






























































































































































Figure 5.4 – Verification of CeA MR Knockdown. 
(A) Representative western blot with bands for MR at 107kD and Actin at 42kD. (B) 
ASO treatment significantly reduced CeA MR protein expression 2 days post-infusion (n 
= 3/group ASO and 6/group SCR). (C) ASO treatment significantly reduced CeA MR 


















































































Figure 5.5 – Knockdown of CeA MR has no effect on alcohol self-administration in male 
rats. 
 
(A) Timeline depicting dates of ASO infusion and alcohol self-administration testing. (B) 
Bilateral CeA cannulae placements. (C-F) CeA MR knockdown has no effect on alcohol 
self-administration, average alcohol intake, inactive lever responses, or locomotor rate 
in male rats (n = 11/group ASO, 9/group SCR). 
  











































































































































Figure 5.6 – Transient reduction in alcohol self-administration following CeA MR 
knockdown in female rats. 
 
(A) Timeline depicting dates of ASO infusion and alcohol self-administration testing. (B) 
Bilateral CeA Cannulae placements. (C) CeA MR knockdown results in a transient 
reduction in alcohol self-administration in female rats (n = 12/group). (D-F) CeA MR 
knockdown had no effect on average alcohol intake, inactive lever responses, or 
locomotor rate. * - p < 0.05 versus SCR. 
  














































































































































Inactive lever responses and alcohol intake for Experiment 1
Group Inactive Lever Responses Alcohol Intake (g/kg)
0 mg/kg Spironolactone 1.8 ± 0.4 0.79 ± 0.06
50 mg/kg Spironolactone 1.6 ± 0.6 0.60 ± 0.06*




Table 5.2 – Alcohol intake for Experiment 2. 
  
Table 2.
Alcohol intake for Experiment 2
Alcohol Intake (g/kg)
Eplerenone (ng/0.5µL/side) 0 100 1000 5000
dHC 0.81 ± 0.08 0.74 ± 0.09 0.68 ± 0.13 0.64 ± 0.08
CeA 0.78 ± 0.08 0.67 ± 0.07 0.47 ± 0.06 0.38 ± 0.06





CHAPTER 6 : GENERAL DISCUSSION 
 
Alcohol Use Disorder is a significant public health concern, affecting about 1 in 9 
regular alcohol drinkers, with numbers up to 3-fold higher in PTSD patients ((Jacobsen 
et al., 2001, Shorter et al., 2015, SAMHSA, 2018 Kessler, 1997 #349). Despite the 
significant societal cost of these comorbid conditions there remains a lack of animal 
models developed to study this relationship, and many of these models utilize naturally-
derived predator odors such as soiled rat bedding, bobcat urine or cat litter (Edwards et 
al., 2013, Manjoch et al., 2016, Finn et al., 2018), which can differ based on the 
saturation of bedding/litter or diet and hydration of the animal (Mattina et al., 1991, 
Apfelbach et al., 2015). Thus, the purpose of Aim 1 was to characterize exposure to 
synthetically produced TMT, a pheromone component of fox feces, and its effects on 
anxiety-like behavior, hyperarousal, alcohol self-administration, plasma corticosterone, 
and neuronal response to alcohol. This is important as the experimenter would have 
greater control over the concentration and purity of synthetically produced TMT. 
Additionally, MR is involved in formation and recall of fear conditioning memories (Zhou 
et al., 2010, Zhou et al., 2011), downregulated by the SPS model of PTSD (Zhe et al., 
2008, Han et al., 2014), and inversely correlates with measures of alcohol drinking 
(Aoun et al., 2018). Therefore, the goal of Aim 2 was to assess the effect of TMT 
exposure on MR expression, and to assess the role of MR in the development of 
increased anxiety-like behavior, hyperarousal, context reactivity, and alcohol self-




drinking is only correlative (Aoun et al., 2018), the purpose of Aim 3 was to expand 
upon these findings and identify the functional role of MR in alcohol self-administration. 
We hypothesized that TMT exposure would produce increased anxiety-like behavior, 
hyperarousal, and alcohol self-administration, similar to effects observed with natural 
PO exposure. Additionally, we hypothesized that TMT exposure would reduce MR 
expression across the brain, and that MR antagonism prior to TMT exposure would 
block the development of the TMT-induced behavioral sequelae. Furthermore, we 
hypothesized that MR antagonism would reduce alcohol self-administration, and that 
this effect would be mediated by CeA MR. Finally, we hypothesized that knockdown of 
CeA MR would increase alcohol self-administration. Overall, these findings demonstrate 
that TMT exposure increases alcohol self-administration in male rats, which may be 
mediated, in part, by TMT-induced increases in CeA MR expression and blunted BLA 
response to alcohol. Contrary to our hypothesis, TMT did not cause escalations in 
anxiety-like behavior or hyperarousal as seen in other PO models, however there are a 
robust set of acute behaviors induced by TMT exposure such as freezing, avoidance, 
and digging as well as TMT-context induced digging which could be used to classify 
response to TMT.  Additionally, while MR blockade during TMT exposure altered acute 
response to TMT, it had no impact on any behavioral sequelae of TMT exposure. 
Furthermore, our findings from Aim 3 demonstrate a functional role for MR in alcohol 
self-administration as systemic and intra-CeA MR antagonism reduce alcohol self-
administration, while knockdown of CeA MR transiently reduces alcohol self-




Utility of TMT exposure model to study comorbid PTSD and AUD 
 We hypothesized that developing a PO model utilizing synthetically produced 
TMT would offer advantages of greater magnitude of self-administration increases and 
greater reproducibility over those using naturally-derived predator odors given 
supraphysiological concentration of the PO and consistent chemical composition of the 
PO between batches (Apfelbach et al., 2015). This hypothesis was not supported by our 
data as we did not see any differences in the magnitude of increased self-administration 
between our studies or those in the literature. Additionally, studies using a variety of 
POs reported a mix of anxiety-like and hyperarousal effects which were not observed in 
the majority of our experiments (excepting the female rats in Chapter 3 Experiment 1). 
The magnitude of changes in alcohol self-administration seen after TMT exposure 
range from 25-60% increase over control (Fig 2.3, 2.5, and 3.11), while literature reports 
increases in self-administration ranging from 50-100% following exposure to bobcat 
urine (Edwards et al., 2013, Weera et al., 2020) and increases in homecage drinking 
over 200% following exposure to dirty cat litter (Manjoch et al., 2016). Furthermore, in 
Chapter 2 we failed to replicate the effects of repeated TMT exposure on alcohol self-
administration, although the rats in the different studies had different conditioning 
histories. Nevertheless, while these data suggest that synthetic TMT may not be 
superior to natural PO exposure protocols, it can induce escalations in alcohol self-
administration, and maintains the advantage of being a single chemical odorant as 
opposed to a mixture of odorants with unknown composition between batches (Mattina 




While the results from TMT-exposed animals in this dissertation are presented without 
any behavioral clustering or subgrouping into ‘susceptible’ or ‘resilient’ groups, this is an 
emerging trend across studies utilizing PO as a model of PTSD (Edwards et al., 2013, 
Manjoch et al., 2016, Brodnik et al., 2017). The present work did not utilize subgrouping 
due to smaller sample sizes, and lack of behavioral effects seen in other models of 
PTSD (Edwards et al., 2013, Manjoch et al., 2016, Brodnik et al., 2017). While the 
sample sizes used in these studies (n = 9-12) are sufficient for traditional alcohol self-
administration studies (Chapters 4 & 5), they are not sufficient for studies utilizing these 
subgroup analyses (n > 30 for most studies)(Manjoch et al., 2016, Brodnik et al., 2017). 
Additionally, while measures of avoidance, anxiety-like behavior, or hyperarousal are 
used to define these ‘susceptible’ subgroups (Edwards et al., 2013, Manjoch et al., 
2016, Brodnik et al., 2017), this TMT exposure model does not reliably produce those 
effects (Chapters 2 and 3). As such, an important area of research for future studies 
using this model is increasing sample sizes of TMT-exposed animals as well as 
examining measures of acute reactivity to TMT or TMT-paired contexts (e.g. freezing, 
TMT-avoidance, grooming, digging) and using these measures to subgroup animals as 
‘susceptible’ or ‘resilient’. 
 As there is significantly increased prevalence of PTSD in women versus men 
(Kessler et al., 2005), the lack of increased alcohol self-administration in female rats 
(Chapter 3) is particularly striking. As previously mentioned, it is possible this lack of 
effect is due to lack of appropriate subgrouping. For example, it is possible that 
increased alcohol self-administration would be observed specifically in a “susceptible” 




behavior following TMT exposure. This is observed in the only published study 
demonstrating PO enhanced alcohol consumption in females, where only a low-drinking 
subgroup of female mice showed increased drinking following exposure to dirty rat 
bedding (Finn et al., 2018). However, TMT also did not alter CeA MR expression in 
female rats, thus an alternative possibility is that TMT does not increase drinking in 
female rats. Given the disparity between sexes in PTSD epidemiology, sex differences 
in animal models of comorbid PTSD and AUD remains a critical area for future studies 
to address. 
Mechanisms underlying comorbid PTSD and AUD 
It is particularly interesting that the observed increases in alcohol self-
administration are not accompanied by any changes in locomotion, anxiety-like 
behavior, or hyperarousal (Chapters 2 and 3). While these behavioral tests are not 
conducted in the same timeframe that changes in self-administration are observed, data 
from the literature suggests that behavioral effects of PO exposure are detectable prior 
to and can predict changes in alcohol drinking (Edwards et al., 2013, Manjoch et al., 
2016). These data suggest that in this model, persistent anxiety-like or hyperarousal 
states do not drive subsequent increases in alcohol consumption (self-medication 
hypothesis) (Muller et al., 2015, Hawn et al., 2020), but that these are two distinct 
symptoms of trauma that can influence each other due to overlap in their etiology 
(Enman et al., 2014). Based on the finding that TMT-exposed animals show blunted 
BLA response to alcohol (Chapter 4), a response involved in mediating alcohol’s 
anxiolytic effects (Sripada et al., 2011), an alternative theory is that increased alcohol 




anxiolytic effects. This theory is supported by evidence that chronic administration of 
corticosterone reduces the interoceptive effects of alcohol (Besheer et al., 2012b, 
Besheer et al., 2014, Jaramillo et al., 2015) and that this can lead to increased alcohol 
self-administration (Besheer et al., 2013). Future studies could probe this hypothesis by 
examining the effects of TMT exposure on alcohol drug discrimination, and alcohol-
primed self-administration (Jaramillo et al., 2018a). 
An additional mechanism we hypothesized could potentially underlie increases in 
alcohol self-administration following TMT-exposure is reduced CeA MR expression. 
Contrary to our hypotheses, we saw that TMT exposure increased CeA MR expression 
in male rats, while knockdown of CeA MR reduced alcohol self-administration. Although 
both these findings contradict our hypotheses and literature regarding CeA MR 
expression and alcohol drinking (Aoun et al., 2018), they are in agreement with each 
other, as well as the findings from Chapter 4 which show that MR antagonism reduces 
alcohol self-administration. The reasons behind this discrepancy are not entirely clear, 
but could be due to altered distribution of MR across CeA microcircuitry, or genomic 
versus nongenomic signaling as discussed in Chapter 5. Future studies could clarify 
the role of CeA MR in stress-enhanced alcohol self-administration by examining CeA 
MR at multiple timepoints following TMT exposure, as well as testing for a shift in the 
dose response curve of spironolactone on alcohol self-administration in TMT-exposed 
animals. 
Functional role of MR in alcohol drinking, implications for therapeutics 
 Findings from Chapters 4 and 5 build upon a recent publication describing an 




across multiple species (Aoun et al., 2018). We first demonstrated that the systemic MR 
antagonist spironolactone reduced alcohol self-administration and response persistence 
in both male and female rats, then replicated this finding with intra-CeA infusion of the 
more selective MR antagonist eplerenone. This data suggests that MR antagonists hold 
promising potential for treatment of AUD, especially as eplerenone has a far greater 
safety profile than spironolactone which carries an FDA black box warning (Lainscak et 
al., 2015). Pharmacological treatment of AUD is dramatically underutilized, though not 
for lack of efficacy (Anton et al., 2006, Kranzler and Soyka, 2018), research suggests 
that significant barriers to pharmacological treatment include cultural norms, philosophy 
against prescribing, and lack of willing prescribers (Finlay et al., 2017). As existing MR 
antagonists are FDA approved and recommended as second line therapy for 
hypertension (Whelton et al., 2018), a condition comorbid with AUD (Gardner and 
Mouton, 2015) where pharmacological management is commonplace (Poulter et al., 
2015, Whelton et al., 2018), combination therapy of comorbid AUD and hypertension 
with MR antagonists may prove a novel approach to overcome the AUD treatment gap. 
Overall Conclusion 
Together this dissertation establishes an animal model of comorbid PTSD and AUD 
utilizing the synthetically produced PO TMT to induce escalations in alcohol self-
administration in male rats. We utilize this model to identify several neuroadaptations in 
male rats that may underlie comorbidity between these conditions, reduced BLA 
response to alcohol, and increased CeA MR expression. We demonstrate that MR 
signaling is important in the acute reactivity to TMT in both male and female rats, and 




rats. Additionally, this dissertation expands our understanding of functional role of MR in 
alcohol drinking, with systemic and intra-CeA MR antagonism reducing alcohol self-
administration. This work also demonstrates that acute knockdown of CeA MR 
expression reduces alcohol self-administration in female rats, counter to data 
demonstrating an inverse correlation between CeA MR expression and alcohol drinking. 
In conclusion, this dissertation lays groundwork for future understanding of comorbid 
PTSD and AUD, and provides evidence for the MR as a promising new pharmacological 
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